KOL | Rikard HolmdahlNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China | Medical ... |
KOL简历 Rikard Holmdahl
| Year | |
|---|---|
| 2022 | National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Medical Inflammation Research, MediCity Research Laboratory, University of Turku, Turku, Finland |
| 2021 | The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, China Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, 171 77 Stockholm, Sweden;, (M.A.);, (X.C.);, (B.X.);, (G.F.L.);, (M.Y.B.);, (Y.H.);, (L.B.) Division of Medical Inflammation Research, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden |
| 2020 | Dept. of Medical Inflammation Research, Section of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm Section for Medical Inflammation Research, BMCI11, Lund University, Lund, Sweden National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi’an, China Karolinska Institutet |
| 2019 | Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solnavägen 9, 171 65, Solna, Sweden Center for Medical Inflammation Research, Southern Medical University, Guangzhou, China R. Holmdahl and C.I. Svensson contributed equally to this paper. |
| 2018 | School of Pharmaceutical Science, Southern Medical University, Guangzhou, China Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Medicity Research Laboratory, University of Turku, Turku, Finland |
| 2017 | Karolinska Institutet Division of Medical Inflammation Research Stockholm Sweden Center for Medical Immunopharmacology Research, Southern Medical University, 510515 Guangzhou, China. Medicity Research Laboratory, University of Turku, Turku, Finland, . |
Rikard Holmdahl：影响统计
运行报告
| Concept | World rank |
|---|---|
| eae39 study | #1 |
| model rheumatoid arthritis | #1 |
| carcinoma tumors ros | #1 |
| arthritis development severity | #1 |
| cell recognition carbohydrates | #1 |
| clec4b ncf1 | #1 |
| cia caia model | #1 |
| reproductive performance identification | #1 |
| cia antigens haplotypes | #1 |
| cii triple | #1 |
| innate immunity mip | #1 |
| type collagen cxi | #1 |
| myelomonocytic arthritis interleukin2 | #1 |
| h2p susceptibility | #1 |
| controlling onset | #1 |
| nox2derived ros mice | #1 |
| mmc transgene | #1 |
| ncf1m1j mice ncf1 | #1 |
| restricted role fcγr | #1 |
| ztmrhd | #1 |
| glycosylated cii259 | #1 |
| igg2a vivo | #1 |
| cells arthritis progression | #1 |
| increased salt exposure | #1 |
| cii epitope | #1 |
| psoriasis single locus | #1 |
| ecm mab | #1 |
| arthritis multiple | #1 |
| autoimmunogenic hydrocarbon oils | #1 |
| mab mab ciic1 | #1 |
| genetic control sialadenitis | #1 |
| congenic polymorphism | #1 |
| pc8 pc117 | #1 |
| scarce clinical samples | #1 |
| mannan mice | #1 |
| g6pi acute arthritis | #1 |
| sialadenitis arthritis | #1 |
| oestrogen lupus disease | #1 |
| eae chromosomes | #1 |
| chronic relapsing arthritis | #1 |
| human α‐enolase | #1 |
| contrast nodq | #1 |
| chromosome cia | #1 |
| cxi cii | #1 |
| mice ncf1 | #1 |
| acpa discriminate | #1 |
| dependent autoimmune | #1 |
| rt1u lew1w | #1 |
| inbred strains severity | #1 |
| mabs cii | #1 |
| mbq mouse | #1 |
| homologous type | #1 |
| ll37 rcramp | #1 |
| kupffer cells mir144 | #1 |
| qtl positional cloning | #1 |
| healthy nzw | #1 |
| autoimmune response cii | #1 |
| major epitopes patients | #1 |
| ncf1 deficient | #1 |
| macrophages cii degradation | #1 |
| glycosylation hla | #1 |
| arthritis adjuvants | #1 |
| rat rt1ba genes | #1 |
| kgf cia | #1 |
| lymphocytes collagen | #1 |
| h‐2b | #1 |
| arthritis males | #1 |
| flss tlr3 expression | #1 |
| rheumatoid collagen | #1 |
| rheumatoid disease models | #1 |
| b10riii riiis | #1 |
| pia blocking arthritis | #1 |
| induced relapsing | #1 |
| galactosylated peptide | #1 |
| ros ncf1 | #1 |
| arthritis ncf1 allele | #1 |
| cathelicidin expression blood | #1 |
| ciipeptide cells | #1 |
| proteolipoprotein peptide | #1 |
| eae3 chromosome | #1 |
| dth nzb mice | #1 |
| cii immunization | #1 |
| autoimmune priming | #1 |
| injection adjuvant oils | #1 |
| ncf1 339 | #1 |
| mannaninduced | #1 |
| plasminogendeficient mice arthritis | #1 |
| arthritis severity rats | #1 |
| ros nox2 complex | #1 |
| autoimmunity mineral oils | #1 |
| differences ncf1 | #1 |
| type epitopes | #1 |
| environments mice | #1 |
| cia | #1 |
| suppression collagen arthritis | #1 |
| arthritogenicity cells | #1 |
| anticii autoantibodies | #1 |
| m1j | #1 |
| c3hq | #1 |
| vivo experimental arthritis | #1 |
| cia induced arthritis | #1 |
| cells autologous cii | #1 |
| caia mutant mice | #1 |
| polychondritis autoimmune disease | #1 |
| arthritis loci | #1 |
| development cia | #1 |
| polymorphism autoimmune diseases | #1 |
| dr4 glycopeptides | #1 |
| emerging glyco‐based strategies | #1 |
| arthritis susceptibility rats | #1 |
| elimination carbohydrates | #1 |
| mhc genetic region | #1 |
| cia12 | #1 |
| polyi pia rats | #1 |
| act389949 fpr2 | #1 |
| daxlewf1 | #1 |
| inbred dba prolactin | #1 |
| oxa nzb mice | #1 |
| caia monoclonal | #1 |
| cia ul1 | #1 |
| development inflammatory attack | #1 |
| act389949 fpr | #1 |
| ncf1 association | #1 |
| dth antibody response | #1 |
| neonatal mortality milk | #1 |
| pia8 | #1 |
| pc4 pc8 | #1 |
| cd4 treatment | #1 |
| thymectomy transgenes | #1 |
| increased incidence cia | #1 |
| native comp | #1 |
| ciic1 m2139 | #1 |
| defined polymeric adjuvant | #1 |
| targeted deletion ncf1 | #1 |
| comp cxi | #1 |
| cii cell | #1 |
| antitlr3 antibody | #1 |
| thps cii | #1 |
| peptide characterisation | #1 |
| chronic arthritis rats | #1 |
| collagen cii | #1 |
| modified glycopeptides | #1 |
| antibody responses cii | #1 |
| position 264 | #1 |
| cia oestrogen | #1 |
| early onset development | #1 |
| frequency igaproducing cells | #1 |
| collagen iiinduced arthritis | #1 |
| inflammatory phase cia | #1 |
| arthritis rabeximod | #1 |
| day cii immunisation | #1 |
| antigen presentation cii | #1 |
| ftirm mice | #1 |
| onset animals arthritis | #1 |
| lpscaia | #1 |
| loci arthritis | #1 |
| resistance collageninduced arthritis | #1 |
| acute arthritis neutrophils | #1 |
| congenic mice vdr | #1 |
| homologous cii | #1 |
| dth response mrl | #1 |
| cii 256270 peptide | #1 |
| p47phoxv232 | #1 |
| cia5 qtl | #1 |
| ox8 monoclonal | #1 |
| mhc cii | #1 |
| activation cii | #1 |
| cii lewis rats | #1 |
| cia antibody response | #1 |
| dnp epitopes lysine | #1 |
| cia rheumatoid autoantibodies | #1 |
| cii peptides | #1 |
| cii histocompatibility complex | #1 |
| cii259 | #1 |
| cd43expressing cells | #1 |
| collagen hybridomas | #1 |
| tlr expression synovium | #1 |
| caia cii | #1 |
| mannan immune | #1 |
| eae39 control disease | #1 |
| cii vivo | #1 |
| pristane macrophages | #1 |
| ability gut protection | #1 |
| sialadenitis congenic mice | #1 |
| arthritis tlr3 upregulation | #1 |
| type disease | #1 |
| flss polyi | #1 |
| p47phox ncf1 | #1 |
| nod incidence | #1 |
| mice ncf1m1j mutation | #1 |
| chronic active arthritis | #1 |
| cholera toxin study | #1 |
| congenic fragments | #1 |
| col2259 | #1 |
| epitope cartilage | #1 |
| cii cartilage | #1 |
| susceptibility collagen | #1 |
| administration antibodies hyaluronanreceptor | #1 |
| dominant hypersensitivity dth | #1 |
| aq molecule | #1 |
| new arthritis therapy | #1 |
| arthritis autoantibody | #1 |
| experimental arthritis articular | #1 |
| da1f | #1 |
| eae2 chromosome | #1 |
| cii induced arthritis | #1 |
| valphachain | #1 |
| collagen antibodies | #1 |
| established arthritis | #1 |
| arthritis transfer | #1 |
| animal models arthritis | #1 |
| mgpi325 | #1 |
| ftirm cii | #1 |
| pia4 chromosome | #1 |
| b10dr4ncf1 | #1 |
| caia gene segments | #1 |
| b10riii | #1 |
| methods | #1 |
| autoimmune arthritis activation | #1 |
| hladrβ10402 | #1 |
| mcaia ncf1 | #1 |
| biodegradation cryogels | #1 |
| liver contributes hfdmets | #1 |
| eae2 eae3 | #1 |
| cd200 btla | #1 |
| hufcgammariia | #1 |
| severity pia | #1 |
| haplotype ltab | #1 |
| mice burkholderia cepacia | #1 |
| autologous type collagen | #1 |
| clec4b activation | #1 |
| pristaneinduced arthritis rats | #1 |
| severe polyarthritis | #1 |
| animal genes cia | #1 |
| cii sera | #1 |
| epitopes arthritis | #1 |
| incidence arthritis | #1 |
| phytol arthritis | #1 |
| homologous type collagen | #1 |
| citrullinated variants | #1 |
| arthritis mcaia | #1 |
| arthritis gene regions | #1 |
| mip ncf4 | #1 |
| cia pathogenesis | #1 |
| backcrosses nzb mice | #1 |
| methodspurified | #1 |
| cii peptide molecules | #1 |
| new arthritis | #1 |
| induction postpartum flare | #1 |
| oxidases receptors | #1 |
| pia7 | #1 |
| plasminogen deficiency cia | #1 |
| mice b10q | #1 |
| experimental chromosomes | #1 |
| cix cii | #1 |
| eae b10riii mice | #1 |
| rheumatoid arthritis eae | #1 |
| response cii | #1 |
| arthritis independent | #1 |
| cia comp | #1 |
| congenic | #1 |
| ncf1 p47phox | #1 |
| pia model | #1 |
| cii260 | #1 |
| tlr3 expression flss | #1 |
| deficient neonatal | #1 |
| cells mgps | #1 |
| ciic1 ciif4 | #1 |
| comp arthritis models | #1 |
| arthritogenic mab ciic1 | #1 |
| c1iii type collagen | #1 |
| protective alleles eae2 | #1 |
| u1 epitope | #1 |
| region eae3 | #1 |
| major role rp | #1 |
| nfr origin | #1 |
| representative swedish | #1 |
| induction oia | #1 |
| sle‐prone mrl | #1 |
| mhc mbp | #1 |
| cii monoclonal arthritis | #1 |
| development humanized models | #1 |
| vivo imaging l012 | #1 |
| mutated ncf1 | #1 |
| olive oil cii | #1 |
| phagocyte oxidative burst | #1 |
| experimental autoimmunity cells | #1 |
| rat pia | #1 |
| cxi collagen fibers | #1 |
| snat proteins | #1 |
| collageninduced arthritis loci | #1 |
| lys264 | #1 |
| melatonin cia | #1 |
| positional identification | #1 |
| downregulating oestradiol | #1 |
| chemiluminescent probe l012 | #1 |
| hydrocarbon oil structure | #1 |
| tlr3 tlr3 expression | #1 |
| pia3 | #1 |
| f1 hybrids disease | #1 |
| tcell experimental cartilage | #1 |
| role major epitopes | #1 |
| t‐cell epitope cii260‐270 | #1 |
| hybridomas multispecific antibodies | #1 |
| cia development | #1 |
| bcell activities | #1 |
| phagocytic nox2 complex | #1 |
| 1 ncf1 | #1 |
| estrogen immune responses | #1 |
| b10q mice | #1 |
| cii recognition | #1 |
| mrl mice estrogen | #1 |
| hfdmets | #1 |
| development chronic arthritis | #1 |
| polychondritis mice | #1 |
| genetic control pia | #1 |
| ym1deficient mice | #1 |
| presence sex hormones | #1 |
| arthritis ul1 | #1 |
| arthritis monoclonal arthritis | #1 |
| riiis segment chromosome | #1 |
| post‐partum exacerbation | #1 |
| serum interferon activity | #1 |
| act389949 agonist | #1 |
| ciiderived | #1 |
| cii lewis | #1 |
| mcii707 | #1 |
| functional selective fpr1 | #1 |
| models collagen | #1 |
| controlling collagen | #1 |
| drb10401 col2259 | #1 |
| cii | #1 |
| cd68‐expressing cells | #1 |
| disease susceptibility castration | #1 |
| pia model rats | #1 |
| oestrogen‐induced | #1 |
| cia13 pia7 | #1 |
| citrullination cii | #1 |
| cix disease | #1 |
| strains polychondritis | #1 |
| cia dominant epitope | #1 |
| psa mip | #1 |
| paamcryogel | #1 |
| glycosylated determinant peptides | #1 |
| estrogen manifestations | #1 |
| oestradiol exacerbation | #1 |
| illness terpenes | #1 |
| cii treatment | #1 |
| oxidative burst disease | #1 |
| active arthritis complex | #1 |
| locus arthritis | #1 |
| dominant susceptibility loci | #1 |
| chlorophyll component | #1 |
| phemagelatin | #1 |
| caia mab | #1 |
| mice h2q | #1 |
| cii saline | #1 |
| rat cii | #1 |
| comp experimental autoantibodies | #1 |
| rat placenta uterus | #1 |
| protein ncf1m1j mice | #1 |
| riiis alleles eae2 | #1 |
| naive experimental chromosomes | #1 |
| pristaneprimed cells | #1 |
| nodq nod | #1 |
| ros glucose transporter | #1 |
| psich2nh2 | #1 |
| citrullinated collagen | #1 |
| recombinants rt1u | #1 |
| milk titers | #1 |
| functional nox2 | #1 |
| mir144 tlr2 expression | #1 |
| animals arthritis | #1 |
| hladr1transgenic mice | #1 |
| formation arthritis | #1 |
| model rheumatoid | #1 |
| reduced oxidative burst | #1 |
| cells dba mouse | #1 |
| arthritis susceptibility mice | #1 |
| rats synthetic peptide | #1 |
| dba 1jpfp | #1 |
| pv cd4 cells | #1 |
| acute phase arthritis | #1 |
| mice cii immunization | #1 |
| synthetic peptides cii | #1 |
| collagen antibody arthritis | #1 |
| suggestive locus chromosome | #1 |
| fibroblast induced arthritis | #1 |
| cii arthritis | #1 |
| cxi 6 | #1 |
| tlr3 synovium | #1 |
| mutant p47phox | #1 |
| dth mice trait | #1 |
| ncf1 nos2 | #1 |
| vivo treatment | #1 |
| ciif4 cartilage damage | #1 |
| c4bp alternative pathway | #1 |
| sialadenitis cell phenotypes | #1 |
| receptor γ pparγ | #1 |
| targeted mutation ncf4 | #1 |
| estrogeninduced suppression | #1 |
| phytol rna | #1 |
| epitopes cb11 fragment | #1 |
| mouse chromosome eae39 | #1 |
| cii immunization mice | #1 |
| glut4dependent glucose transport | #1 |
| cartilage‐specific antibodiesis | #1 |
| cii cxi | #1 |
| hydrolyzed igg | #1 |
| b10q b10riii | #1 |
| cia model strains | #1 |
| cia b10q | #1 |
| ul1 vivo | #1 |
| cia homologous cii | #1 |
| inbred dba cii | #1 |
| autoantibodies cartilage | #1 |
| expression liver receptor | #1 |
| antibodies cii | #1 |
| arthritis naive mice | #1 |
| cii vaccination | #1 |
| tolerance immunodominant | #1 |
| caia experimental arthritis | #1 |
| genetic variants ncf1 | #1 |
| arthritis development immunisation | #1 |
| ciic1 antibody | #1 |
| arthritis cia | #1 |
| kgf chondrocytes | #1 |
| diagnostic accuracy acpa | #1 |
| dba1 mice | #1 |
| native cii | #1 |
| cells heterologous cii | #1 |
| rats pristaneinduced arthritis | #1 |
| arthritis cell | #1 |
| cb11 fragment | #1 |
| patients china cohort | #1 |
| h2w17 | #1 |
| cii swr mice | #1 |
| protective role cia | #1 |
| arthritis estrogen | #1 |
| streptococcal endo | #1 |
| periodontitis pristaneinduced arthritis | #1 |
| position mouse cii | #1 |
| cuiiidaligands | #1 |
| mice c3h background | #1 |
| rat recombinants | #1 |
| cii articular cartilage | #1 |
| disease collagen | #1 |
| genetically segregating crosses | #1 |
| h2p cia | #1 |
| pristane primed | #1 |
| mcia1 | #1 |
| m1j mice | #1 |
| wo2012127214 | #1 |
| rt1f haplotype | #1 |
| identification genetic regions | #1 |
| autoantibodies collagen | #1 |
| chronic stage arthritis | #1 |
| immune priming events | #1 |
| il10 cia | #1 |
| antigenic adjuvant | #1 |
| experimental carcinogens | #1 |
| type collagens rats | #1 |
| genetic encephalomyelitis autoimmune | #1 |
| ncf1 ncf1m1j mutation | #1 |
| region eae2 | #1 |
| j1 epitope | #1 |
| polymorphism mitochondrial genome | #1 |
| proteins gay | #1 |
| obs electrophoresis | #1 |
| congenic polymorphism illness | #1 |
| hyaluronanreceptor | #1 |
| cxiia | #1 |
| injection mannan | #1 |
| incidence nod | #1 |
| histology vaccination | #1 |
| major antigenic epitope | #1 |
| ncf1 mutation mice | #1 |
| dancf1da rats | #1 |
| idd5 loci | #1 |
| suppression collagen | #1 |
| rats chronic disease | #1 |
| idiotype‐specific binding | #1 |
| bb2bb3 regulation | #1 |
| synovial cells macrophages | #1 |
| experimental collagen | #1 |
| mice mutated type | #1 |
| anticii antibodies | #1 |
| 2 nox2 | #1 |
| aq glycopeptide | #1 |
| plcpip | #1 |
| mumt mice oestrogen | #1 |
| p47phox mutant | #1 |
| h2p mice cia | #1 |
| oxidases polymers | #1 |
| differential susceptibility cia | #1 |
| inflammation caia | #1 |
| ciispecific cells day | #1 |
| new loci controlling | #1 |
| citrullinated cii | #1 |
| aplec locus | #1 |
| ciic1 mabs | #1 |
| cii h2q | #1 |
| selfcii | #1 |
| inability collagen | #1 |
| stromal cells osteoclasts | #1 |
| loci controlling diabetes | #1 |
| role eosinophilia | #1 |
| pathogenesis cia | #1 |
| signaling characterization | #1 |
| immunization cii | #1 |
| rats pristane | #1 |
| lewis oia | #1 |
| arthritis antibody | #1 |
| findings new therapy | #1 |
| fibroblasts ifnbetadeficient mice | #1 |
| existence periodontitis | #1 |
| peptides aq | #1 |
| disease suggestive locus | #1 |
| cii antibodies | #1 |
| susceptible strain cross | #1 |
| cia olive oil | #1 |
| suppressive development | #1 |
| cii cartilage explants | #1 |
| nucleotide reactive | #1 |
| cia animal models | #1 |
| congenic c57bl mice | #1 |
| models rheumatoid arthritis | #1 |
| salivary glands antigen | #1 |
| antibodies pc4 | #1 |
| h2q h2r | #1 |
| pepsin lewis | #1 |
| human gpi protein | #1 |
| ncf4 nox2 complex | #1 |
| cxi | #1 |
| severity ides | #1 |
| collagen epitopes | #1 |
| collagen reactivity cxi | #1 |
| pia cix | #1 |
| cxi arthritis | #1 |
| animal epitopes | #1 |
| pia2–8 | #1 |
| lack arthritis | #1 |
| b10q mice authors | #1 |
| nod loci genes | #1 |
| diabetes sialadenitis | #1 |
| dth dominant hypersensitivity | #1 |
| congenic strains cia | #1 |
| arthritis arthritis loci | #1 |
| joint inflammatory phase | #1 |
| ncf1339 allele | #1 |
| fecq4 fragment | #1 |
| illness cia | #1 |
| acpa general population | #1 |
| arthritis ides | #1 |
| b10q1 | #1 |
| rp autoimmune disease | #1 |
| arthritis development cross | #1 |
| congenic arthritis | #1 |
| cia5 cia21 | #1 |
| arthritismodulating | #1 |
| 6 cii | #1 |
| chronic pristane | #1 |
| 15a11 | #1 |
| insulitis nodq | #1 |
| b10qnfr | #1 |
| intracellular processing cii | #1 |
| potent disease accelerator | #1 |
| fecq4 | #1 |
| arthritis immunization | #1 |
| cii experimental arthritis | #1 |
| cells cii | #1 |
| tumors immunosuppressive leukocytes | #1 |
| ciiinduced | #1 |
| cii induce | #1 |
| collagen reactive | #1 |
| cii comp | #1 |
| confers arthritis susceptibility | #1 |
| cia cartilage | #1 |
| mice l012 | #1 |
| ciif4 ciic1 | #1 |
| pia eae | #1 |
| hdac3 pparγ | #1 |
| cells chronic arthritis | #1 |
| ros autoimmune diseases | #1 |
| arthritis collagen arthritis | #1 |
| experimental autoantigens | #1 |
| cartilage stability cartilage | #1 |
| ides treatment severity | #1 |
| surface redox levels | #1 |
| cii molecule | #1 |
| arthritis mhc | #1 |
| clonal expansion arthritis | #1 |
| antiidiotypic antibodies cd4 | #1 |
| liver histone deacetylase | #1 |
| h2p h2q | #1 |
| cii olive oil | #1 |
| arthritis animal | #1 |
| comp disease monitoring | #1 |
| cii immunisation | #1 |
| rat congenic data | #1 |
| development oia | #1 |
| antibodies consensus motif | #1 |
| pia3 pia4 | #1 |
| ciif4 adverse effects | #1 |
| female preponderance development | #1 |
| single bout hiit | #1 |
| phase cia | #1 |
| rats ncf1 gene | #1 |
| re04001activatedfpr1 | #1 |
| ros continental ancestry | #1 |
| cii polymer | #1 |
| cia melatonin | #1 |
| macrophages autoimmune priming | #1 |
| ncf1 allele | #1 |
| cia eae39 | #1 |
| cxi rats | #1 |
| disease lew | #1 |
| cells caia | #1 |
| mice ncf4 | #1 |
| dendritic cells collagen | #1 |
| avridine arthritis | #1 |
| ciispecific | #1 |
| ii‐induced arthritis | #1 |
| glycosylated epitope | #1 |
| cartilage cii | #1 |
| pristane stimulation | #1 |
| denatured cii | #1 |
| c57bl 10q | #1 |
| mediate pulmonary inflammation | #1 |
| b10q | #1 |
| immunization heterologous cii | #1 |
| nox2 complex ncf4 | #1 |
| ncf1 | #1 |
| arthritis b10q mice | #1 |
| rats clec4b | #1 |
| cia h2p | #1 |
| monoclonal cartilage cattle | #1 |
| ncf1 mutation | #1 |
| 4 histone deacetylases | #1 |
| mice developed | #1 |
| b10b | #1 |
| hladrbound peptides | #1 |
| arthritis pnipaam | #1 |
| vridine‐induced arthritis | #1 |
| major locus cia | #1 |
| cii responsiveness | #1 |
| immunization type | #1 |
| cnbr‐fragment | #1 |
| ala261gly262 | #1 |
| epitopes collagen | #1 |
| cells galactosylated peptide | #1 |
| ncf1 knockout | #1 |
| fcγr3 | #1 |
| cartilaginous joints | #1 |
| breeding capacity | #1 |
| pia4 | #1 |
| gia expansion | #1 |
| fpr act389949 | #1 |
| cii pia | #1 |
| ncf1da | #1 |
| adaptive immunity fcγrs | #1 |
| mice cii epitopes | #1 |
| exacerbation arthritis | #1 |
| ltabncr3 | #1 |
| collagen 256 | #1 |
| rabeximod arthritis | #1 |
| collagen arthritis progesterone | #1 |
| cia7 chromosome | #1 |
| arthritis castration | #1 |
| chronic arthritis development | #1 |
| phytol molecular pathways | #1 |
| mice darkness | #1 |
| drb10401positive | #1 |
| cii259273 peptide | #1 |
| ifa cii ifa | #1 |
| pia rats tlr3 | #1 |
| dth nzb | #1 |
| immunization mouse | #1 |
| single monoclonal | #1 |
| compdeficient mice | #1 |
| fpr1 agonist neutrophils | #1 |
| arthritis autoimmune | #1 |
| lpr mice granulocytes | #1 |
| b10qacb | #1 |
| monoclonal arthritis arthritis | #1 |
| collagens antibody | #1 |
| dependent autoimmune arthritis | #1 |
| function single | #1 |
| h2w3 | #1 |
| cia5 region | #1 |
| cia locus | #1 |
| cryogel matrix cells | #1 |
| cia swr mouse | #1 |
| beta 10b beta | #1 |
| hg6pi325 | #1 |
| cia ifa | #1 |
| response splenocytes | #1 |
| anticd4 treatment immunization | #1 |
| chemical cartilage | #1 |
| mice interferon gamma | #1 |
| ncf1 ros | #1 |
| pc4 pc117 | #1 |
| wild type ncf1 | #1 |
| elevated th17 cells | #1 |
| mice salt intake | #1 |
| sialadenitis strains | #1 |
| decreasing activation | #1 |
| cii caia | #1 |
| immunodominant cii | #1 |
| ciilysdnp | #1 |
| greater osteoclasts | #1 |
| cia21 | #1 |
| collagen induced | #1 |
| nox2 complex | #1 |
| spontaneous tissue inflammation | #1 |
| arthritis‐susceptibility loci | #1 |
| estrogenmediated suppression | #1 |
| tolerance arthritis susceptibility | #1 |
| cia32 | #1 |
| rheumatoid arthritis complexity | #1 |
| spleen pristane injection | #1 |
| oestradiol dth | #1 |
| cia2 cia9 | #1 |
| antibody cartilage blymphocyte | #1 |
| mbq mouse macrophages | #1 |
| pia experimental arthritis | #1 |
| ncf1 genes | #1 |
| rats arthritis | #1 |
| tracheolaryngeal | #1 |
| collagen langerhans cells | #1 |
| data act389949 | #1 |
| swr mice immunization | #1 |
| immunization rat | #1 |
| non‐mhc genes | #1 |
| disease affinity | #1 |
| dba 1 background | #1 |
| 371115tetramethyl2hexadecene1ol | #1 |
| cia oia | #1 |
| arthritis animals | #1 |
| cii cix | #1 |
| pia rheumatoid arthritis | #1 |
| cia mip | #1 |
| immunization autologous peptide | #1 |
| ciic1 mab ciif4 | #1 |
| complex aq molecules | #1 |
| rheumatoid drug evaluation | #1 |
| eae39 | #1 |
| δ228 | #1 |
| cia collagen | #1 |
| engagement fcgammar | #1 |
| arthritis rat | #1 |
| cii severe arthritis | #1 |
| saline arthritis | #1 |
| ox8 antibodies | #1 |
| b10qnss1 | #1 |
| cartilage explants m2139 | #1 |
| function nox2 | #1 |
| congenic mice genes | #1 |
| b10q dba 1f1 | #1 |
| mhc influence | #1 |
| arthritis amino | #1 |
| ciic1scfv | #1 |
| autoantibody responses cii | #1 |
| immunisation cells | #1 |
| nod nss1 loci | #1 |
| regulates severity | #1 |
| developed severe | #1 |
| tracheolaryngeal cartilage | #1 |
| cia22 | #1 |
| h2g7 haplotype nod | #1 |
| cia pia | #1 |
| endos hydrolyzed igg | #1 |
| development pristaneinduced arthritis | #1 |
| arthritis rheumatoid arthritis | #1 |
| animal models complexity | #1 |
| arthritis toe stiffness | #1 |
| collagen type‐ii epitope | #1 |
| denidritic cells | #1 |
| b10q mice ncf1 | #1 |
| arthritis pia | #1 |
| bqncf1m1j | #1 |
| strains developed | #1 |
| promoter regions antigens | #1 |
| nox2 function | #1 |
| functional nox2 complex | #1 |
| mice functional ncf1 | #1 |
| cii ros | #1 |
| enhanced autoimmunity arthritis | #1 |
| anticcp2negative patients | #1 |
| rats rt1f mhc | #1 |
| rats pia9 alleles | #1 |
| cells ncf1 | #1 |
| cartilage explants ciic1 | #1 |
| da1u rat liver | #1 |
| h2r h2q | #1 |
| socalled collagen antibody | #1 |
| arthritis incidence severity | #1 |
| phenotypes ncf1m1j mice | #1 |
| antibody ciic1 | #1 |
| cartilage damage vivo | #1 |
| cii mouse | #1 |
| humans animals arthritis | #1 |
| beta 10b mrl | #1 |
| qa2 ncf1 | #1 |
| antibody induced | #1 |
| nodq locus | #1 |
| ros immunohistochemistry implants | #1 |
| macrophage ros | #1 |
| susceptible collagen | #1 |
| antibodies citrullinated peptide | #1 |
| cia opportunities | #1 |
| innate‐associated disease | #1 |
| oia induction | #1 |
| immunization rat cii | #1 |
| mice mutated cii | #1 |
| ncf4 | #1 |
| rats severity | #1 |
| cii256 | #1 |
| dba mouse epitopes | #1 |
| glycoprotein alpha1microglobulin | #1 |
| anticii antibody response | #1 |
| dominant traits | #1 |
| cia21 lymph nodes | #1 |
| development aureus arthritis | #1 |
| clec4b | #1 |
| partial advanced intercross | #1 |
| disease genotype immunoglobulin | #1 |
| arthritis rat strains | #1 |
| rat cii cii | #1 |
| pia experimental chromosomes | #1 |
| rt1ba | #1 |
| citc1iiip | #1 |
| role nox2derived ros | #1 |
| rats pia | #1 |
| pia disease | #1 |
| ul1 ciif4 | #1 |
| cartilagespecific protein | #1 |
| features arthritis | #1 |
| rheumatoid arthritis cii | #1 |
| c3hq mice cii | #1 |
| psicoch2 | #1 |
| arthritis epitopes | #1 |
| peptide agonist fmlf | #1 |
| tlr3 upregulation flss | #1 |
| mice ros | #1 |
| transgenic mice mhcii | #1 |
| phase arthritis | #1 |
| clever1 type macrophages | #1 |
| act389949 | #1 |
| ciiinduced arthritis | #1 |
| olive oil arthritis | #1 |
| mice anticd4 treatment | #1 |
| qtl chip | #1 |
| rats hfdmets | #1 |
| e3xda | #1 |
| estrogen differential outcome | #1 |
| glycosylation cell recognition | #1 |
| experimental collagen type | #1 |
| increase ncf1 | #1 |
| comp cii | #1 |
| dapia3 | #1 |
| peripheral cells alphachains | #1 |
| genome b10riii | #1 |
| psoriasis spread | #1 |
| inflammatory phase arthritis | #1 |
| mabs monoclonal arthritis | #1 |
| ncf1 polymorphisms | #1 |
| 22 variant r620w | #1 |
| established pia disease | #1 |
| rats ncf1 allele | #1 |
| cii ciif4 | #1 |
| strains b10q | #1 |
| cartilage explants mabs | #1 |
| congenic strains rats | #1 |
| severity arthritis | #1 |
| nzb dth | #1 |
| frequency chronic arthritis | #1 |
| comp lack | #1 |
| rheumatoid arthritis cia | #1 |
| fecq3 | #1 |
| recognition lysine | #1 |
| ciif4 mab | #1 |
| oxoethyl6h | #1 |
| qa2 gene clusters | #1 |
| comp mabs | #1 |
| oxazolone inflammatory response | #1 |
| impact etoposide | #1 |
| treatment cii immunization | #1 |
| loci eae39 | #1 |
| cii ecm | #1 |
| cii matrix protein | #1 |
| eae39 locus cia | #1 |
| nzw parental strain | #1 |
| ros rns inflammation | #1 |
| injection lewis rat | #1 |
| mir144 tlr2 | #1 |
| caia riiis segment | #1 |
| ncf1 mutated | #1 |
| pia cii | #1 |
| synovium pia rats | #1 |
| rheumatoid arthritis autoimmunity | #1 |
| kgf treatment onset | #1 |
| sensitive wkymvm | #1 |
| b10dr4ncf1 mice cii | #1 |
| b10qc5δ | #1 |
| cells mouse cii | #1 |
| rats cxi | #1 |
| nephritis nodq | #1 |
| pia5 | #1 |
| rat pristaneinduced arthritis | #1 |
| preformed cartilage | #1 |
| ccp2 negative | #1 |
| ncf1m1j | #1 |
| periodontitis rats pia | #1 |
| dba 1 mouse | #1 |
| fecq4 locus | #1 |
| immune cartilage | #1 |
| specificity arthritis | #1 |
| aq molecules | #1 |
| lnchc cholesterol metabolism | #1 |
| compsufficient mice | #1 |
| acpas specificity | #1 |
| cii rheumatoid autoantibodies | #1 |
| macrophages hladr1transgenic mice | #1 |
| cxi pia | #1 |
| cii immunization treatment | #1 |
| presence mhv | #1 |
| cii disease | #1 |
| recombinant vaccine inflammation | #1 |
| glycopeptide stimulation | #1 |
| eae2 resistant locus | #1 |
| daiu | #1 |
| concentrations mouse cii | #1 |
| cia9 | #1 |
| cia f1 males | #1 |
| tlr2 tlr2 regulation | #1 |
| nrc ova | #1 |
| cii rats | #1 |
| ncf1deficient mice | #1 |
| cii cia | #1 |
| cii 256 | #1 |
| specific antibody protection | #1 |
| arthritis monoclonal | #1 |
| cia lysine | #1 |
| transgenic tolerance tlymphocytes | #1 |
| anti type | #1 |
| anticii abs | #1 |
| disease dba 1jpfp | #1 |
| disease c4bp | #1 |
| mip cia | #1 |
| caia cia | #1 |
| immune response mbp | #1 |
| placental mhc class | #1 |
| oestrogen cia | #1 |
| cia experimental arthritis | #1 |
| 270 peptide | #1 |
| nox2derived ros | #1 |
| mab ecm | #1 |
| dba 1 | #1 |
| ncf1 lyme arthritis | #1 |
| reactivity cii | #1 |
| cxb10qf2 | #1 |
| rats ncf1 | #1 |
| cartilage specific | #1 |
| chromosome congenic strains | #1 |
| pristaneinduced arthritis pia | #1 |
| ncf4 gene | #1 |
| tcell congenic arthritis | #1 |
| ifnbeta arthritis | #1 |
| minimal glycopeptide core | #1 |
| cii citrullinated | #1 |
| qtl animal genes | #1 |
| cii development | #1 |
| autologous cii | #1 |
| polymer adjuvant activity | #1 |
| ciid3 | #1 |
| antibody response cii | #1 |
| disease arthritis | #1 |
| arthritis darkness | #1 |
| collageninduced arthritis | #1 |
| autoantibodies cii | #1 |
| type collagen cia | #1 |
| substrains ztmrhd | #1 |
| male mice arthritis | #1 |
| cd2 human cells | #1 |
| oestrogen treated | #1 |
| cii dendritic cells | #1 |
| ifn signature mice | #1 |
| copy variation ncf1 | #1 |
| impact topoisomerase antagonist | #1 |
| experimental arthritis autoimmune | #1 |
| bal cells work | #1 |
| inflammatory arthritis assessment | #1 |
| position ros production | #1 |
| muscle nox2 | #1 |
| autologous peptide cells | #1 |
| arthritis induced | #1 |
| rat cb10 cb11 | #1 |
| tolerance cia | #1 |
| polymorphism ncf1 | #1 |
| genistein collagen | #1 |
| striking phenotypic similarities | #1 |
| inconsistent susceptibility | #1 |
| strong response epitopes | #1 |
| animal genetic predisposition | #1 |
| tumor colonization | #1 |
| oxa backcrosses | #1 |
| fls ppt medium | #1 |
| ccp positive patients | #1 |
| respiratory burst severity | #1 |
| nonglycosylated epitope | #1 |
| large numbers hybridomas | #1 |
| daf2cross | #1 |
| collagen cxi | #1 |
| rfig lambda | #1 |
| cii epitopes | #1 |
| ncf1 ncf1 mice | #1 |
| mutation ptdins3pbinding site | #1 |
| concentrations rat cii | #1 |
| arthritis incidence | #1 |
| h2p h2q haplotype | #1 |
| cii anticd4 treatment | #1 |
| epitopes cb10 fragment | #1 |
| hla–dr1 | #1 |
| transgenic nadph | #1 |
| lew mol strain | #1 |
| cia31 | #1 |
| swr nfr | #1 |
| concentrations cii | #1 |
| cii mhc | #1 |
| tumor models ncf1 | #1 |
| 2 months beta | #1 |
| heterologous cii | #1 |
| cii human | #1 |
| peritonitis transgenic | #1 |
| arthritogenic mabs | #1 |
| cells cia | #1 |
| c1iii | #1 |
| ros experimental arthritis | #1 |
| loci sialadenitis | #1 |
| myeloid effector functions | #1 |
| argltgrpgda | #1 |
| h2q mice | #1 |
| dominant hypersensitivity | #1 |
| pristane cell death | #1 |
| 256 270 | #1 |
| cells arthritogenicity | #1 |
| ncf1m1j mice function | #1 |
| cia cii | #1 |
| ncf1m1j mutation | #1 |
| mediating arthritis | #1 |
| citrulline collagen | #1 |
| susceptible cia | #1 |
| role ncf1 | #1 |
| multiple sclerosis rabeximod | #1 |
| humanized models disease | #1 |
| cia cells | #1 |
| lps caia | #1 |
| cii antigen presentation | #1 |
| rat type collagen | #1 |
| glycosylated epitope structures | #1 |
| leukosialin rats | #1 |
| arthritis protection | #1 |
| antitype collagen | #1 |
| cb11 sequence cii | #1 |
| cb268 cii | #1 |
| cia ul1 mab | #1 |
| new therapy arthritis | #1 |
| emulsions induction | #1 |
| ros antigens | #1 |
| heterologous cii cells | #1 |
| igg1 igg2b isotypes | #1 |
| ncf1 mutant mice | #1 |
| mbp c5a | #1 |
| ros adaptive immunity | #1 |
| effector phase arthritis | #1 |
| genes arthritis | #1 |
| arthritis pepsin | #1 |
| ncf1 mice | #1 |
| cartilage antibody | #1 |
| ncf1 gene | #1 |
| therapeutic cleavage igg | #1 |
| rns type collagen | #1 |
| sterically privileged | #1 |
| c3bireceptors | #1 |
| w33t | #1 |
| mice cryogels | #1 |
| functional ncf1 | #1 |
| oils induce | #1 |
| ciif4 cartilage explants | #1 |
| caia acute arthritis | #1 |
| pathway arthritis | #1 |
| cii mab | #1 |
| cia mtx | #1 |
| cia congenic arthritis | #1 |
| h2q c3hnb | #1 |
| ncf1 copy variation | #1 |
| inbred dba pepsin | #1 |
| compia | #1 |
| tlr3 expression fls | #1 |
| murine psoriasis model | #1 |
| severe arthritis | #1 |
| siliac | #1 |
| cell tolerance cii | #1 |
| satellite encephalomyelitis autoimmune | #1 |
| arthritis estrus cycle | #1 |
| 237 females | #1 |
| ncf1 m1j | #1 |
| cageeffects | #1 |
| cii severity | #1 |
| arthritis injection | #1 |
| rats rheumatoid | #1 |
| lower capacity ros | #1 |
| alphachains cell surface | #1 |
| rats antibody cartilage | #1 |
| cii specific | #1 |
| cix cartilage | #1 |
| tolerance collagen | #1 |
| citrullinated type collagen | #1 |
| congenic fragment | #1 |
| melatonin release pinealectomy | #1 |
| mab ciif4 ciic1 | #1 |
| celldependent disease | #1 |
| susceptibility collageninduced arthritis | #1 |
| satellite encephalomyelitis | #1 |
| eae2 | #1 |
| u1 antibodies patients | #1 |
| rat cii response | #1 |
| encephalomyelitis arthritis | #1 |
| nox2 functionality | #1 |
| sod3 peritonitis | #1 |
| rabeximod | #1 |
| immunological transmitter | #1 |
| c3hnb h2p | #1 |
| specific cii | #1 |
| pia cia | #1 |
| vpba pnipaam | #1 |
| ciispecific cells | #1 |
| complex cia | #1 |
| rat cii arthritis | #1 |
| rt1bβ | #1 |
| pristane induced | #1 |
| genes animal models | #1 |
| spread psoriasis | #1 |
| collagen dendritic cells | #1 |
| adjuvanticity autoimmunity | #1 |
| ncf1mutation | #1 |
| caia model | #1 |
| ifnbeta experimental arthritis | #1 |
| arthritis promoting | #1 |
| pia9 | #1 |
| animal models polychondritis | #1 |
| citrullinated type | #1 |
| lymphocytes cartilage | #1 |
| animal models acpa | #1 |
| headache paradigm | #1 |
| hexadecane induce arthritis | #1 |
| anti comp | #1 |
| cii induced | #1 |
| ciiglycopeptides | #1 |
| rats rt1 | #1 |
| arthritogenic antibody | #1 |
| cells cb11 | #1 |
| rabeximod inflammatory cells | #1 |
| effects fab2 | #1 |
| tlr3 expression tnfα | #1 |
| cii chronic | #1 |
| rats congenic arthritis | #1 |
| relapsing arthritis | #1 |
| mhc aq | #1 |
| mab cb268 | #1 |
| collagen immunization | #1 |
| cii rat cii | #1 |
| cii experimental autoantigens | #1 |
| specificity ros rns | #1 |
| arthritis ncf1 | #1 |
| human cii cartilage | #1 |
| cii cells | #1 |
| cia2 arthritis | #1 |
| csfspecific | #1 |
| rabeximod treatment | #1 |
| topoisomerase antagonist | #1 |
| rats mhc genes | #1 |
| insulitis strains | #1 |
| lewis rats pepsin | #1 |
| chemical collagen | #1 |
| induced arthritis cia | #1 |
| nox2complex | #1 |
| nodp nod | #1 |
| autoimmune diseases identification | #1 |
| wt ncf1 | #1 |
| arthritis chronic | #1 |
| congenic arthritis rats | #1 |
| toxin‐1‐producing staphylococci | #1 |
| nasal treatment ctbcii | #1 |
| cia rat cii | #1 |
| ncf4 mip | #1 |
| cii259 273 | #1 |
| h‐2q mice | #1 |
| g6pi peptide | #1 |
| rats terpenes | #1 |
| nzb mice trait | #1 |
| ncf4 mice | #1 |
| pregq2 fragment | #1 |
| collagen citrullination | #1 |
| locus cia development | #1 |
| strains nodq | #1 |
| ncf1 mutant | #1 |
| nox2 agonists | #1 |
| disease development effects | #1 |
| pc117 | #1 |
| susceptibility cia | #1 |
| arthritis male | #1 |
| cia reduction | #1 |
| ncf1m1j m1j mice | #1 |
| mechanism autoimmune | #1 |
| ncf1 sle | #1 |
| genetic association ncf1 | #1 |
| authors hgpi325339 peptide | #1 |
| upregulation tlr3 | #1 |
| arthritis genetics | #1 |
| chronic arthritis mice | #1 |
| arthritis collagen | #1 |
| rat cb11 immunization | #1 |
| chick cii cii | #1 |
| disease th1 immunity | #1 |
| rats phytol | #1 |
| arthritis locus | #1 |
| fecq3 locus | #1 |
| arthritis anticii abs | #1 |
| nox2 complex addition | #1 |
| pristane hydrocarbon oils | #1 |
| arthritis synovial tlr3 | #1 |
| c57bl strains loci | #1 |
| rt1l haplotypes | #1 |
| mice chronic arthritis | #1 |
| established sialadenitis | #1 |
| chromosome pia | #1 |
| 339 polymorphism | #1 |
| cxi comp | #1 |
| cell determinants cii | #1 |
| marginal ankylosis | #1 |
| loci cia2 | #1 |
| spread induced psoriasis | #1 |
| minor cartilage proteins | #1 |
| adjuvant oils | #1 |
| type cii | #1 |
| lathyritic cii | #1 |
| beta haplotype | #1 |
| epitopes cii | #1 |
| pia11 | #1 |
| ifa rats | #1 |
| spleen cluster | #1 |
| cia recognition | #1 |
| stages arthritis | #1 |
| cia11 | #1 |
| arthritis driven | #1 |
| oestrogen induced | #1 |
| cia21 cia22 | #1 |
| mhc‐congenic mouse strains | #1 |
| cii cross reactivity | #1 |
| nodq×b10q | #1 |
| dba 1jpfp cia | #1 |
| cxi chronic arthritis | #1 |
| cb268 | #1 |
| cii256270 | #1 |
| ym1 pneumonitis | #1 |
| epitopes vivo | #1 |
| g6pi chronic arthritis | #1 |
| collagen‐induced arthritis | #1 |
| cell recognition cii | #1 |
| arthritis onset severity | #1 |
| tlr3 pristane | #1 |
| rheumatoid arthritis immunization | #1 |
| cii major epitope | #1 |
| nod nss1 | #1 |
| collagen arthritis hyaluronanreceptor | #1 |
| cia il10 | #1 |
| c3hnb | #1 |
| ciipeptide | #1 |
| congenic cia40 | #1 |
| b10qbalb | #1 |
| mbpc5a | #1 |
| cii acpa | #1 |
| qa2 natural mutations | #1 |
| sialadenitis nodq | #1 |
| cia induced | #1 |
| developed arthritis | #1 |
| region ncf1 | #1 |
| genetic regions | #1 |
| rats antibody response | #1 |
| peritonitis sod3 | #1 |
| transient joint inflammation | #1 |
| fab2 ciic1 | #1 |
| chondrocytes kgf | #1 |
| b10q h2q | #1 |
| il10 mmc | #1 |
| reactivity cb268 | #1 |
| maintained pregnancy levels | #1 |
| collagen arthritis iii | #1 |
| joint proteins | #1 |
| oestradiol suppression | #1 |
| arthritis qtl pia7 | #1 |
| cii response | #1 |
| skg mutation | #1 |
| models rheumatoid | #1 |
| ros rheumatoid humans | #1 |
| expressions cyp7a1 | #1 |
| disease glycoproteins | #1 |
| cia12 pia4 | #1 |
| function acpas | #1 |
| haplotypes h2q | #1 |
| dimethyl6n | #1 |
| disease monitoring rats | #1 |
| arthritis experimental | #1 |
| immunization heterologous peptide | #1 |
| polyi arthritis | #1 |
| mouse cii | #1 |
| arthritogenic mabs cii | #1 |
| induction phase cia | #1 |
| anticii response | #1 |
| pparγ cbrh7919 cells | #1 |
| pepsin cii | #1 |
| mice deficient ncf1 | #1 |
| f1 males influence | #1 |
| pathogenesisis | #1 |
| polymorphic fragment | #1 |
| cii 6 | #1 |
| cia compdeficient mice | #1 |
| igg response cii | #1 |
| aq class | #1 |
| publication animals arthritis | #1 |
| immunization mouse cii | #1 |
| da1u rats expression | #1 |
| lewis rat cia | #1 |
| maintenance arthritis | #1 |
| mcaia | #1 |
| transgenic nadph oxidase | #1 |
| ncf1 mice wt | #1 |
| ros mip | #1 |
| keratinocytes dth reaction | #1 |
| b10q strain | #1 |
| macrophages mannans | #1 |
| pia3 chromosome | #1 |
| ctbcii | #1 |
| function targeted deletion | #1 |
| autoimmune arthritis apcs | #1 |
| ifnbeta deficiency | #1 |
| induced arthritis rats | #1 |
| arthritis intraperitoneal injection | #1 |
| rat comp arthritis | #1 |
| arthritis mutant strains | #1 |
| hfdmets expression | #1 |
| cia rat | #1 |
| rs201802880 | #1 |
| severity cia | #1 |
| hiit nox2 activity | #1 |
| spe acute phase | #1 |
| caia effects | #1 |
| presentation arthritis | #1 |
| homologous type pia | #1 |
| ftirm ciic1 | #1 |
| arthritis aim | #1 |
| mice th1 cytokines | #1 |
| antibody binding vivo | #1 |
| arthritis suppression | #1 |
| mice salt concentrations | #1 |
| sialadenitis incidence | #1 |
| induction cii | #1 |
| cartilage collagen type | #1 |
| pristaneinduced arthritis | #1 |
| chronic intervention | #1 |
| chronicity arthritis | #1 |
| cii carbohydrates | #1 |
| blocking arthritis | #1 |
| cii256 270 | #1 |
| ppt medium | #1 |
| cell‐deficient mice | #1 |
| tolerance arthritis protection | #1 |
| type collagen cii256−270 | #1 |
| chromosomes eae loci | #1 |
| dapia6 | #1 |
| arthritis qtl chip | #1 |
| arthritis pristane | #1 |
| abetachains | #1 |
| cia chromosome | #1 |
| nodq nod nodp | #1 |
| presentation cii | #1 |
| arthritis congenic | #1 |
| 17βestradiolregulation | #1 |
| cii antibody | #1 |
| tlr3 flss | #1 |
| animal immunosuppressive agents | #1 |
| mem lglutamine | #1 |
| cii h2p | #1 |
| cia40 | #1 |
| urokinase enzyme | #1 |
| genes congenic | #1 |
| cia tsc transgenic | #1 |
| cii pepsin | #1 |
| partial advanced | #1 |
| pinealectomy exposure | #1 |
| pc117 extracellular structures | #1 |
| nzw parental | #1 |
| cii260‐270 | #1 |
| mhc class injections | #1 |
| c3hnb mice | #1 |
| cells synthetic glycopeptides | #1 |
| chromosome f1 males | #1 |
| elisagenetyping | #1 |
| arthritis humans | #1 |
| mannan joints | #1 |
| ciic1 fab | #1 |
| interacting subloci | #1 |
| mhc cia | #1 |
| inflammation living mice | #1 |
| experimental autoantibodies | #1 |
| l012 vivo imaging | #1 |
| arthritis animal mice | #1 |
| cell specificity cii | #1 |
| h‐2q | #1 |
| β1helix | #1 |
| induce arthritis | #1 |
| development collageninduced arthritis | #1 |
| dba 1j | #1 |
| fumia | #1 |
| day acute arthritis | #1 |
| autoimmune diseases cnvs | #1 |
| therapeutic c4bp | #1 |
| lew avridineinduced arthritis | #1 |
| bb2bb3 | #1 |
| treatment pia | #1 |
| terpenes toll | #1 |
| cia mhc | #1 |
| tnfα tlr3 expression | #1 |
| mhv runting neonates | #1 |
| ciilysdnp mice | #1 |
| collagen epitope expression | #1 |
| macrophages cii | #1 |
| evokes peptide | #1 |
| functional ncf1 macrophages | #1 |
| c3hq mice | #1 |
| psiechch | #1 |
| rats adjuvant oil | #1 |
| mice arthritis | #1 |
| eae mtx | #1 |
| autoantibody formation cia | #1 |
| eae strains severity | #1 |
| cia rheumatoid arthritis | #1 |
| alpha type collagen | #1 |
| normal cartilage arthritis | #1 |
| synovial membranes joints | #1 |
| damage type collagen | #1 |
| collagen type cii | #1 |
| cia vivo priming | #1 |
| day ciispecific cells | #1 |
| function ncf1 gene | #1 |
| nox2 complex–derived ros | #1 |
| experimental arthritis antibodies | #1 |
| animal epitopes injections | #1 |
| arthritogenic antibodies | #1 |
| arthritis control mice | #1 |
| treatment physiological doses | #1 |
| autoimmune accelerating | #1 |
| caia kgf | #1 |
| immunization lathyritic cii | #1 |
| arthritis traits | #1 |
| fcbinding | #1 |
| lew1w rt1u | #1 |
| animal histocompatibility | #1 |
| pepsin immunization | #1 |
| hyaluronanreceptor cd44 | #1 |
| immunization heterologous | #1 |
| emission tomography mannan | #1 |
| visual signs arthritis | #1 |
| cii cb fragments | #1 |
| arthritis immunisation | #1 |
| cii261 | #1 |
| cii ncf1 | #1 |
| rat comp | #1 |
| protein expression genes | #1 |
| development collagen | #1 |
| extraarticular cartilage | #1 |
| immunologic animals arthritis | #1 |
| chronic development | #1 |
| m2139 arthritogenic mab | #1 |
| genetic crossbreeding | #1 |
| ncf1 ptpn22 | #1 |
| pregq2 | #1 |
| collagen ii‐induced | #1 |
| eae2 locus | #1 |
| mouse cii reactivity | #1 |
| dth dba 1 | #1 |
| arthritis encephalomyelitis | #1 |
| m1s1a | #1 |
| cii256−270 | #1 |
| cia animal epitopes | #1 |
| cia ros | #1 |
| cii u1 | #1 |
| driven psoriatic arthritis | #1 |
| severe arthritis immunization | #1 |
| deficient ncf1 | #1 |
| mucosal tolerance cii | #1 |
| chromosome caia | #1 |
| inclusion negative predictive | #1 |
| chromosome arthritis severity | #1 |
| tcell hybridomas cells | #1 |
| anticlever1 antibody treatment | #1 |
| genes antibodies | #1 |
| ethylene isostere | #1 |
| heterologous peptide response | #1 |
| molecule aq | #1 |
| nss1 | #1 |
| arthritis b6n mice | #1 |
| phosphatase 22 | #1 |
| collagen autoantibody | #1 |
| anti collagen | #1 |
| cia13 | #1 |
| nonglycosylated peptide | #1 |
| carbohydrates cii | #1 |
| ciispecific cell responses | #1 |
| major epitopes | #1 |
| prevents arthritis | #1 |
| cartilage‐specific | #1 |
| ncf1 polymorphism | #1 |
| tlr3 rna interference | #1 |
| major cii | #1 |
| arthritis caia | #1 |
| collagen chains antibody | #1 |
| b10dr4ncf1 mice | #1 |
| kgf thymus | #1 |
| realtime pcr flss | #1 |
| induced arthritis | #1 |
| oxidative burst inducers | #1 |
| cells rat cii | #1 |
| immunospecific reactions | #1 |
| position ciilysdnp | #1 |
| superovulation rate | #1 |
| hg6pi | #1 |
| predominant selection | #1 |
| rats comp | #1 |
| etoposide topoisomerase antagonist | #1 |
| ul1 ciif4 mab | #1 |
| disease transgenic models | #1 |
| pia rats arthritis | #1 |
| genes ncf1 | #1 |
| manifestations lupus disease | #1 |
| cii heterologous cii | #1 |
| cia caia | #1 |
| vivo monoclonal | #1 |
| cii mabs | #1 |
| serum chromosome | #1 |
| collagen‐induced | #1 |
| position cii256270 | #1 |
| inflammatory tissue attack | #1 |
| glycosylated cii | #1 |
| effects ciif4 | #1 |
| ciispecific antibodies | #1 |
| critical restriction site | #1 |
| disease cd8 deficiency | #1 |
| enhanced autoimmunity | #1 |
| cii immunodominant | #1 |
| caia lps | #1 |
| therapeutic cleavage | #1 |
| heterologous collagen | #1 |
| expression ncf1 | #1 |
| rats established pia | #1 |
| pristane tlr3 expression | #1 |
| tregs ros | #1 |
| innate rats | #1 |
| physiological doses development | #1 |
| oestrogen‐induced suppression | #1 |
| bond requirements | #1 |
| gergaagiagpk | #1 |
| inbred strains cia | #1 |
| estrogen physiological doses | #1 |
| nadph activation | #1 |
| cia molecular basis | #1 |
| gene ncf1 | #1 |
| constant light order | #1 |
| anti cii acpa | #1 |
| tissue attack | #1 |
| ym1 alternative activation | #1 |
| vivo monoclonal mouse | #1 |
| effects cia | #1 |
| pristane hexadecane | #1 |
| isolated fragment chromosome | #1 |
| pepsin arthritis | #1 |
| arthritis | #1 |
| lew ztm ncf1 | #1 |
| cia experimental autoantibodies | #1 |
| tolerance induction cii | #1 |
| cryogel column antibodies | #1 |
| human immunopeptidome lung | #1 |
| h2q haplotype | #1 |
| caia induced | #1 |
| citrullinated collagen arthritis | #1 |
| anticardiolipin antibodies p005 | #1 |
| double deficiency qa2 | #1 |
| ncf1 spread | #1 |
| chromosome 17 mhc | #1 |
| pia cia13 pia7 | #1 |
| arthritis tlr3 | #1 |
| arthritis estrogen treatment | #1 |
| ciispecific monoclonal | #1 |
| ncf1m1j mice | #1 |
| beta 812 | #1 |
| epitope type | #1 |
| presence arthritogenic mabs | #1 |
| function p47phox | #1 |
| tolerance arthritis | #1 |
| genetic background rats | #1 |
| selected anti‐t‐cell | #1 |
| m2139 ciic1 | #1 |
| g6pi arthritis | #2 |
| arthritogenic mab cii | #2 |
| diseases collagen | #2 |
| symptoms anti ccp2 | #2 |
| b10qncf1 mice cia | #2 |
| cii injection | #2 |
| oestrogen myelin | #2 |
| raloxifene oestradiol | #2 |
| w3 13 | #2 |
| mhcii experimental arthritis | #2 |
| antibodies development | #2 |
| c2ta mhcii expression | #2 |
| α3xi | #2 |
| arthritis oia | #2 |
| ean6 | #2 |
| ovx ncf1 mice | #2 |
| comp cia | #2 |
| microscopic scoring arthritis | #2 |
| dominant suppressive | #2 |
| matrilin 1 | #2 |
| sequence analysis indel | #2 |
| arthritogenic capacity | #2 |
| matrilin vivo | #2 |
| antibody cartilage | #2 |
| rt1bb | #2 |
| multiple antibody reactivities | #2 |
| igke | #2 |
| flow cytometry ovx | #2 |
| tlymphocyte arthritis arthritis | #2 |
| cartilage respiratory | #2 |
| oestradiol cia | #2 |
| lack ifngamma | #2 |
| circulating medium | #2 |
| l10d9 antibody cartilage | #2 |
| congenic mice autoimmune | #2 |
| anticcp2negative | #2 |
| symptoms antibodies | #2 |
| hiit skeletal muscle | #2 |
| injection w3 13 | #2 |
| citcii | #2 |
| nodq | #2 |
| liver histone | #2 |
| caia oestradiol | #2 |
| osteoclasts flow cytometry | #2 |
| arthritis ethanol | #2 |
| mab cii | #2 |
| sialadenitis animals | #2 |
| arthritis scoring | #2 |
| maintenance induced resistance | #2 |
| mice bacterial infections | #2 |
| rats heterologous cii | #2 |
| macrophagespecific nox2 | #2 |
| type collagen cii | #2 |
| rats lymphocytes | #2 |
| bmd caia | #2 |
| rats utility | #2 |
| antibodies cartilage | #2 |
| suppressive oestrogen | #2 |
| heterologous collagens arthritis | #2 |
| acpa reactivities | #2 |
| oestrogen suppressive | #2 |
| mph induction | #2 |
| development combination | #2 |
| adjuvant oils arthritis | #2 |
| eae protein rna | #2 |
| egfp cd19 cells | #2 |
| cxi l10d9 antibody | #2 |
| l10d9 | #2 |
| autoimmune membrane proteins | #2 |
| cia day | #2 |
| wtc5a | #2 |
| mhc congenic | #2 |
| disease 111 | #2 |
| c129s mutant disulfide | #2 |
| mhc iii | #2 |
| enhanced arthritis | #2 |
| pristane injection | #2 |
| functional ncf1 variants | #2 |
| cells arthritis | #2 |
| h2q response | #2 |
| c57bl 10 background | #2 |
| igg glycosylation arthritis | #2 |
| b10qf1 | #2 |
| rp animal ear | #2 |
| dr4 cii259 | #2 |
| suggestive locus | #2 |
| mbp peptides immunization | #2 |
| arthritis development rats | #2 |
| c2ta genetic | #2 |
| new immunomodulatory drug | #2 |
| selective fpr1 | #2 |
| glycan activation | #2 |
| eae dxea strain | #2 |
| caia effector phase | #2 |
| cia anti | #2 |
| antibody response development | #2 |
| neuroendocrine profile | #2 |
| cd8 cells incidence | #2 |
| severity collagen arthritis | #2 |
| glycopeptides histocompatibility | #2 |
| staphylococcal infections mice | #2 |
| dxea strain tgfbeta | #2 |
| beta 10b | #2 |
| rats polymorphism | #2 |
| anticii antibody | #2 |
| lymphocytes animals | #2 |
| eae cia | #2 |
| arthritogenic | #2 |
| redox regulation ptpn22 | #2 |
| cii depletion | #2 |
| arthritis g6pi | #2 |
| l10d9 antibody | #2 |
| incidence nephritis | #2 |
| re04 | #2 |
| ptpn22 protein disulfide | #2 |
| fpr1 signaling | #2 |
| rats da1u | #2 |
| m2139 ciif4 | #2 |
| monodeoxygenation | #2 |
| oestrogen pregnancy | #2 |
| dancf1da | #2 |
| macrophagespecific nox2 development | #2 |
| rno12 | #2 |
| tracheolaryngeal cartilage rp | #2 |
| antileukoproteinase modulation | #2 |
| synovial immune reactions | #2 |
| cii ciic1 | #2 |
| raloxifene estradiol treatment | #2 |
| tregs mph | #2 |
| 111 vivo treatment | #2 |
| pristane rats | #2 |
| sialadenitis mice | #2 |
| mabs collagen | #2 |
| collageninduced arthritis mice | #2 |
| nox2 complex sle | #2 |
| comp titers | #2 |
| igke promoter | #2 |
| glycopeptide complexes | #2 |
| intrinsic tolerance | #2 |
| dxea strain | #2 |
| cd19 cells egfp | #2 |
| prophylactic treatment linomide | #2 |
| allelic variant type | #2 |
| mitochondria polymorphism | #2 |
| cartilage‐specific autoimmunity | #2 |
| induction p47phoxmutated mph | #2 |
| arthritis mice | #2 |
| fibα580 | #2 |
| psychosocial stress hpaaxis | #2 |
| ere activation treatment | #2 |
| arthritis fb | #2 |
| mannan induced | #2 |
| lymphocytelike | #2 |
| mrl mice stages | #2 |
| comp cartilage | #2 |
| arthritis gender | #2 |
| mice susceptible | #2 |
| single nucleotide rats | #2 |
| species susceptible haplotypes | #2 |
| chromosome rats | #2 |
| arthritis treatment | #2 |
| congenic polychondritis | #2 |
| cep1 fibß62 | #2 |
| integrin‐binding‐domain | #2 |
| l10d9 antibody cxi | #2 |
| galactosyl moiety | #2 |
| ncf1gene | #2 |
| nadph oxidase deficiency | #2 |
| conditions igke promoter | #2 |
| mbp 87110 peptide | #2 |
| sera rheumatoid arthritis | #2 |
| cia monkeys | #2 |
| chain l10d9 antibody | #2 |
| dxeb | #2 |
| collagen arthritis cii | #2 |
| mbp89 | #2 |
| analyses comp | #2 |
| transgenic oxidases zymosan | #2 |
| cell tolerance c5a | #2 |
| increased severity development | #2 |
| h2q | #2 |
| cytosolic ros production | #2 |
| genetic encephalomyelitis | #2 |
| oxidation increased severity | #2 |
| animal granulomatous disease | #2 |
| shared epitope cxi | #2 |
| da1u | #2 |
| autoimmune recognition | #2 |
| adjuvant rats | #2 |
| cia animals | #2 |
| animal model arthritis | #2 |
| genetic regions psoriasis | #2 |
| das28 24 months | #2 |
| nox2 neuropathological alterations | #2 |
| antibody fine | #2 |
| liver mice rna | #2 |
| oestradiol induction phase | #2 |
| ptpn22 c129s | #2 |
| macrophages enhances | #2 |
| mhciii | #2 |
| control subjects samples | #2 |
| immunization mouse collagen | #2 |
| rheumatoid binding | #2 |
| fibα563 | #2 |
| cia arthritis | #2 |
| da1u rats | #2 |
| terpenes animals | #2 |
| rats ifngamma | #2 |
| cms eae | #2 |
| apc naïve cells | #2 |
| alterations neuroendocrine profile | #2 |
| alp monoclonal arthritis | #2 |
| human animal models | #2 |
| homologous cia | #2 |
| ccp2 diagnostic accuracy | #2 |
| nox2 macrophages | #2 |
| clever1 tumor | #2 |
| ros source | #2 |
| castrated mice day | #2 |
| oestrogen ean | #2 |
| fpr1 agonist | #2 |
| higher levels anas | #2 |
| gender rats | #2 |
| mycobacteria granulomas | #2 |
| agonist fpr2 | #2 |
| m2139 | #2 |
| transgenic protein processing | #2 |
| ability arthritis | #2 |
| ncf1 oxidation | #2 |
| glut4dependent | #2 |
| mog rats | #2 |
| utility comp | #2 |
| fibβ36 | #2 |
| smash recommendations | #2 |
| tregs mph ros | #2 |
| toe stiffness | #2 |
| models autoimmune | #2 |
| murine locus eae2 | #2 |
| peptides chronic eae | #2 |
| chronic autoimmune polyarthritis | #2 |
| pathogenic igg antibodies | #2 |
| arthritogenic challenge | #2 |
| mabs comp | #2 |
| epitopes rat | #2 |
| pia rats | #2 |
| cartilage proteins sera | #2 |
| b10qncf1 mice | #2 |
| immunization sch | #2 |
| micro dams transgenic | #2 |
| anticcp2negative presence | #2 |
| cia disease | #2 |
| collagen antibody | #2 |
| positive anticcp2 test | #2 |
| ros tregs | #2 |
| salt intake vivo | #2 |
| snecs neutrophils | #2 |
| antibody‐mediated arthritis | #2 |
| c5ay35 | #2 |
| cii311 | #2 |
| hladr2dq6 | #2 |
| c2ta genetic polymorphisms | #2 |
| eae caia | #2 |
| neutrophil functions modulation | #2 |
| exclusive reactivity | #2 |
| iaexpressing cells | #2 |
| collagen arthritis immunization | #2 |
| caia eae | #2 |
| antibodies cep1 | #2 |
| knockout illness | #2 |
| autoimmunity autoantibodies | #2 |
| arthritis antibody response | #2 |
| arthritis female | #2 |
| disease humanized mice | #2 |
| b10g | #2 |
| tgfbeta spinal cord | #2 |
| citcii311 | #2 |
| hydroxyethylene | #2 |
| dxeb strain immunization | #2 |
| ciic1 | #2 |
| chronic relapsing disease | #2 |
| citc1359 | #2 |
| nadph oxidase 2 | #2 |
| linomide homologous cia | #2 |
| induction cia | #2 |
| genotypes ovx | #2 |
| 12 590 | #2 |
| epitope glycosylation | #2 |
| h2q mice mice | #2 |
| 034positive | #2 |
| 18ffluoromannan | #2 |
| chronic arthritis treatment | #2 |
| rats arthritogenic challenge | #2 |
| tcells recognition | #2 |
| eno5 | #2 |
| tolerance cii | #2 |
| matrilin cartilage proteins | #2 |
| immunocap isac performance | #2 |
| ifngamma spinal cord | #2 |
| fibß62 | #2 |
| paws mice | #2 |
| ptpn22 disulfide | #2 |
| myelin ppd | #2 |
| hiit skeletal | #2 |
| kinloch | #2 |
| ros peroxide | #2 |
| 18fbicyclo610nonyne | #2 |
| osteoclastogenesis endogenous dna | #2 |
| sle cgd | #2 |
| binding sites autoimmune | #2 |
| citrullinated peptides development | #2 |
| antibodies fibß62 | #2 |
| igke promoter expression | #2 |
| cartilage respiratory tract | #2 |
| implanted melanoma | #2 |
| immunization mbp89 | #2 |
| ß62 | #2 |
| sequences mbp89 | #2 |
| experimental cloning | #2 |
| hkatpasecontaining vesicles | #2 |
| autoimmune congenic arthritis | #2 |
| chitosanagarosegelatin | #2 |
| antitoxin immunoglobulin | #2 |
| cii citrullination | #2 |
| fibroblast induced | #2 |
| collagen ii‐induced arthritis | #2 |
| agonist study | #2 |
| altered formation | #2 |
| design glycopeptides | #2 |
| binding cartilage | #2 |
| rats da1u rats | #2 |
| arthritis heterologous cia | #2 |
| cpg2088 | #2 |
| antipan | #2 |
| oxidation c129s | #2 |
| disease cyclosporin treatment | #2 |
| cia mice mice | #2 |
| das28 acpa reactivities | #2 |
| granulocytes alp | #2 |
| collagen citrullination adhesion | #2 |
| ptpn22 ncf1 | #2 |
| skg model | #2 |
| percentage peripheral cells | #2 |
| derived ros | #2 |
| anticd4 treatment | #2 |
| igkeegfp lentivirus expression | #2 |
| mice collagen | #2 |
| arthritis progression | #2 |
| rats disease onset | #2 |
| cgd mice kynurenine | #2 |
| endoglycosidase treatment | #2 |
| pnipaam vpba | #2 |
| arthritis models rats | #2 |
| lymphoproliferative gene | #2 |
| psoriatic disease models | #2 |
| human lung nox2 | #2 |
| ncf1 mutants | #2 |
| mbp peptide eae | #2 |
| lack functional nox2 | #2 |
| incidence insulitis | #2 |
| ides treatment | #2 |
| p47phoxmutated | #2 |
| mrl joints stages | #2 |
| vaccination strategy c5a | #2 |
| ala261 | #2 |
| mph ros | #2 |
| fpr1 neutrophils | #2 |
| etoposide serum concentrations | #2 |
| mog79 | #2 |
| mice genistein treatment | #2 |
| granulomas cgd mice | #2 |
| cia mechanisms | #2 |
| granulomas ros | #2 |
| vivo cii | #2 |
| receptor‐specific manner | #2 |
| eosinophilia arthritis | #2 |
| das28 values p001 | #2 |
| epitope‐specific recognition | #2 |
| i‐a molecule | #2 |
| anti cii | #2 |
| disease development presence | #2 |
| c1epitope | #2 |
| snp position | #2 |
| transgenic osteoporosis oestradiol | #2 |
| nadph oxidase elevations | #2 |
| disease genotype hybridization | #2 |
| putative vulnerability locus | #2 |
| pia rat | #2 |
| immunological requirements | #2 |
| lew mol | #2 |
| elastaseinduced emphysema nox2 | #2 |
| antibodies disease onset | #2 |
| igkeegfp lentivirus | #2 |
| granulomas macrophages | #2 |
| biologicals 24 months | #2 |
| ciif4 | #2 |
| severity collagen | #2 |
| h12919 | #2 |
| disease promoting | #2 |
| igsecretors | #2 |
| fil307 | #2 |
| animal haplotypes | #2 |
| influence chromosome | #2 |
| antileukoproteinase alp | #2 |
| titres ccp2 | #2 |
| cell dependent | #2 |
| celldependent phase | #2 |
| aetiology2–4 | #2 |
| multiple sclerosis maps | #2 |
| early onset severity | #2 |
| sle nadph oxidase | #2 |
| mbp89 peptides | #2 |
| neutrophil fpr2 | #2 |
| ncf1 ean6 | #2 |
| caia | #2 |
| class immunoenzyme | #2 |
| wildtype mice macrophages | #2 |
| immunosuppressive leukocytes | #2 |
| ros granulomas | #2 |
| arthritis raloxifene | #2 |
| eae1 | #3 |
| cvrelated death | #3 |
| cryogel bioreactor | #3 |
| cvrelated death adjustment | #3 |
| 81b | #3 |
| rs729749 | #3 |
| arthritis susceptible | #3 |
| models arthritis | #3 |
| class antigens keratinocytes | #3 |
| ifngammali | #3 |
| rats mog | #3 |
| neutrophil cytosolic factor | #3 |
| activated cells mice | #3 |
| occurrence subspecificities | #3 |
| ifnbetadeficient mice | #3 |
| clever1 macrophages | #3 |
| arthritis effects | #3 |
| vim60 | #3 |
| genetic influence susceptibility | #3 |
| arthritis model | #3 |
| citc1iii fibα573 | #3 |
| chronic collagen | #3 |
| hdac1 pathogenesis | #3 |
| hladrb104 mann whitney | #3 |
| complex genetic control | #3 |
| cep1 filaggrin | #3 |
| cbrh7919 cells | #3 |
| acpas fine specificities | #3 |
| h2p mice | #3 |
| dce spe | #3 |
| nox2 pathogenesis | #3 |
| mnc salivary glands | #3 |
| loci antibodies | #3 |
| wildtype mice granulomas | #3 |
| eae17 | #3 |
| acpa specificities presence | #3 |
| cells naïve mice | #3 |
| stroke cvrelated death | #3 |
| twins acpas | #3 |
| cd4∶cd8 lineage | #3 |
| citc1iii | #3 |
| igl genes | #3 |
| antigens keratinocytes | #3 |
| osteoclasts release | #3 |
| immuniozation | #3 |
| recombination rt1a | #3 |
| carriers hladrb104 | #3 |
| citrullinated peptides time | #3 |
| acpas genetic factors | #3 |
| fibα591 | #3 |
| disease immunization | #3 |
| development arthritis | #3 |
| experimental cell | #3 |
| arthritogenic mab | #3 |
| role ros | #3 |
| cii reactive | #3 |
| subspecificities occurrence | #3 |
| antibodies induce | #3 |
| advanced intercross eae5 | #3 |
| disease disease development | #3 |
| h2aalpha | #3 |
| acpas twins | #3 |
| pathogenesis pia | #3 |
| fibα573 | #3 |
| fibβ62 81b | #3 |
| ifngammali neurons | #3 |
| rtlu | #3 |
| height disease | #3 |
| oxidases reactive | #3 |
| arthritogenicity | #3 |
| rt1a tap2 | #3 |
| antigens collagen | #3 |
| inflamed synovial tissues | #3 |
| cyp7a1 abca1 | #3 |
| origin suggestive linkage | #3 |
| acpa combination | #3 |
| differences citrullinated peptides | #3 |
| complex autoimmune diseases | #3 |
| rheumatoid cloning | #3 |
| major cell epitope | #3 |
| female preponderance | #3 |
| cd4∶cd8 lineage commitment | #3 |
| cytotoxic t‐lymphocyte | #3 |
| female immunoenzyme | #3 |
| dxea | #3 |
| h2qbearing | #3 |
| cia strains | #3 |
| induced immunospecific tolerance | #3 |
| autoimmunity cartilage | #3 |
| citcii355 | #3 |
| arthritis animal model | #3 |
| rheumatoid crosses | #3 |
| cvrelated death association | #3 |
| ean mca | #3 |
| keratinocytes langerhans cells | #3 |
| eae17 genetic heterogeneity | #3 |
| antibodies citc1iii | #3 |
| type c2ta | #3 |
| acpas plasma | #3 |
| citc1iii filaggrin | #3 |
| fibα573 fibα591 | #3 |
| disease genotype immunity | #3 |
| chromosome eae17 | #3 |
| arthritis review | #3 |
| db1 treatment day | #3 |
| cystatin cdeficient mice | #3 |
| mhc class betachain | #3 |
| disease risk subsets | #3 |
| fibα573 fibβ74 | #3 |
| total abrogation | #3 |
| acpa multiplex | #3 |
| cd8 cells ean | #3 |
| minimal adjuvant requirement | #3 |
| fibβ74 onset | #3 |
| bcg ros | #3 |
| cia hdac1 | #3 |
| restricted role | #3 |
| disease development contribution | #3 |
| incidence antinuclear antibodies | #3 |
| citrulline inflammation | #3 |
| lew ztm | #3 |
| antigen monoclonal arthritis | #3 |
| arthritis resistance | #3 |
| development collagen arthritis | #3 |
| autoimmunity pia | #3 |
| levels fibα591 | #3 |
| allopregnancy | #3 |
| species lymphocytes | #3 |
| vivo control mice | #3 |
| rt11 rats | #3 |
| mice constant light | #3 |
| arthritis levels | #3 |
| c57bl mice illness | #3 |
| cia animals arthritis | #3 |
| hdac1 rheumatoid arthritis | #3 |
| combination acpa | #3 |
| reactive idiotope | #3 |
| anticollagen antibody | #3 |
| antibodies vim60 | #3 |
| lupus nets | #3 |
| crossreactive idiotope | #3 |
| ncf4 rs729749 | #3 |
| db1 treatment | #3 |
| disease height | #3 |
| transgenic osteoporosis | #3 |
| mca ean | #3 |
| mmc mice | #3 |
| animal glycosylation humans | #3 |
| acpa subspecificities | #3 |
| dancf1e3 | #3 |
| mice environments | #3 |
| rheumatoid arthritis complement | #3 |
| targeting toll | #3 |
| spe dce | #3 |
| c2ta | #3 |
| treatment arthritis | #3 |
| model arthritis | #3 |
| presence drb104 | #3 |
| antigen presentation mhcii | #3 |
| endogenous ifnbeta | #3 |
| 95 cvrelated death | #3 |
| monoclonal cartilage sections | #3 |
| antibodies citrullinated | #3 |
| eae16 | #3 |
| nox2 cgd | #3 |
| common mouse model | #3 |
| eae31 | #3 |
| early phase disease | #3 |
| pnippam | #3 |
| autoimmune models | #3 |
| swedish patients antibodies | #3 |
| mice rheumatoid | #3 |
| rheumatoid autoimmune | #3 |
| anticollagen antibodies | #3 |
| cartilage proteins | #3 |
| ciic1 cii | #3 |
| citrullinated peptides multiplex | #3 |
| hfdmets rats | #3 |
| hydrocarbon oils | #3 |
| cdk6 padi4 | #3 |
| anti‐type | #3 |
| eae5r1 | #3 |
| ifngamma neurons | #3 |
| cii species | #3 |
| multiple sclerosis hladr2 | #3 |
| acpa titers | #3 |
| natural alleles genes | #3 |
| aureus arthritis mice | #3 |
| rs729749 ncf4 | #3 |
| mice copolymers | #3 |
| processing cii | #3 |
| disease w3 13 | #3 |
| allogeneic pregnancy | #3 |
| eae5 ncf1 | #3 |
| immunization addition | #3 |
| patients monoclonal chimeric | #3 |
| oxidase 2 | #3 |
| pfp mice | #3 |
| macroporous gel particles | #3 |
| experimental arthritis | #3 |
| neutrophils eae | #3 |
| genes disease development | #3 |
| binding aq | #3 |
| pristane‐induced arthritis | #3 |
| pia | #3 |
| day disease duration | #3 |
| rats disease | #3 |
| sialadenitis | #3 |
| ctla4 deletion | #3 |
| dual manner | #3 |
| rodents6 | #3 |
| subspecificities associations | #3 |
| nadph oxidase complex | #3 |
| nerve terminallike profiles | #3 |
| macrophages involvement | #3 |
| arthritis autoimmunity | #3 |
| hladrb104 cochranmantelhaenszel test | #3 |
| isotypes acpas | #3 |
| twins acpapositive | #3 |
| mice development | #3 |
| rats rheumatoid arthritis | #3 |
| low production | #3 |
| fibα591 vim60 | #3 |
| dnfb ears | #3 |
| acpas human serum | #3 |
| human cii | #3 |
| apc cia | #3 |
| glycosylated type | #3 |
| points acs | #3 |
| onset combination | #3 |
| ncf1 cldn4 | #3 |
| acpapositive twins | #3 |
| lew1f | #3 |
| citrullinated cyclic | #3 |
| eae5 pia4 | #3 |
| genotype knowledge | #3 |
| eae17 chromosome | #3 |
| antibodies specific sets | #3 |
| ctla4 adult mice | #3 |
| type collagen vivo | #3 |
| dthreaction | #3 |
| arthritis susceptibility | #3 |
| disease anti lymphocyte | #3 |
| development acpas | #3 |
| cii elisa | #3 |
| pia6 | #3 |
| fibβ74 | #3 |
| ros deficiency | #3 |
| response immune response | #3 |
| experimental cattle cells | #4 |
| subsets presence | #4 |
| shared autoimmunity | #4 |
| fcγr regulation | #4 |
| autoimmune experimental phenotype | #4 |
| type‐ii collagen | #4 |
| cellular transfer | #4 |
| experimental arthritis cii | #4 |
| rheumatoid arthritis rats | #4 |
| candidate genes rats | #4 |
| cyclic software | #4 |
| normal mouse igg | #4 |
| response arthritis | #4 |
| estrogen levels levels | #4 |
| adjuvant oil | #4 |
| type collagen arthritis | #4 |
| lnchc | #4 |
| experimental genetic | #4 |
| cryogel matrix | #4 |
| onset clinical arthritis | #4 |
| interaction monoclonal antibody | #4 |
| arthritis severity | #4 |
| type collagen rat | #4 |
| autoimmune mrl | #4 |
| cia lia | #4 |
| epitope collagen | #4 |
| smoking antibodies | #4 |
| glend2 | #4 |
| rs682626 | #4 |
| genetic association vav1 | #4 |
| rs12979659 | #4 |
| cells maternal origin | #4 |
| bxsb chromosome | #4 |
| tnfα p38 mapk | #4 |
| fibβ62 | #4 |
| diseases rheumatoid | #4 |
| tsc mice | #4 |
| parathyroid antibodies | #4 |
| cia mouse | #4 |
| cii ifa | #4 |
| multispecific antibodies | #4 |
| synovial endothelium | #4 |
| pristane‐induced | #4 |
| sh3gl1 | #4 |
| arthritis mouse | #4 |
| knowledge genetic association | #4 |
| dead cell remnants | #4 |
| elimination cd8 cells | #4 |
| collagen immune | #4 |
| arthritis defined | #4 |
| genistein addition | #4 |
| congenic c57bl | #4 |
| catabolism kynurenine | #4 |
| dth reaction | #4 |
| strains arthritis | #4 |
| citrullinated protein antibodies | #4 |
| autoantibodies type collagen | #4 |
| potent immunomodulator | #4 |
| endos igg | #4 |
| pathogenesis histone | #4 |
| immunodominant cell | #4 |
| cells cryogel | #4 |
| il‐4‐deficient mice | #4 |
| estrus cycling | #4 |
| cytosolic ros | #4 |
| mhc eae | #4 |
| placental mhc | #4 |
| ox8 | #4 |
| rp sle | #4 |
| antigen sequence deletion | #4 |
| cia suppression | #4 |
| mrl b6 | #4 |
| acpas serum | #4 |
| cia b10q mice | #4 |
| development sialadenitis | #4 |
| dth mrl | #4 |
| type collagen autoimmunity | #4 |
| ethylene isosteres | #4 |
| collagen rheumatoid | #4 |
| cii peptide | #4 |
| antitype collagen antibodies | #4 |
| immune response cii | #4 |
| cii animal epitopes | #4 |
| mutation ncf1 | #4 |
| locus mouse chromosome | #4 |
| lxrα pparγ | #4 |
| macrophages mycobacteria | #4 |
| cd4 cells stage | #4 |
| cell response immunization | #4 |
| experimental arthritis humans | #4 |
| krönke | #4 |
| pathogenic antibody | #4 |
| autoimmunity rats | #4 |
| estrogen cia | #4 |
| elevated th1 | #4 |
| mrl dth | #4 |
| arthritis collageninduced arthritis | #4 |
| cells cryogel column | #4 |
| vav1 rheumatoid arthritis | #4 |
| affinity case | #4 |
| c129s | #4 |
| anti‐t‐cell | #4 |
| cb10 fragment | #4 |
| collagen glycopeptides | #4 |
| antibodies citrullinated peptides | #4 |
| positional cloning genes | #4 |
| mice etoposide | #4 |
| strain eae | #4 |
| tcell activation development | #4 |
| collagen type | #4 |
| dae3 | #4 |
| inpp4b474r 548p | #4 |
| variance animals arthritis | #4 |
| citrullinated peptides autoantibodies | #4 |
| treg cells ctla4 | #4 |
| stages disease development | #4 |
| peptide mbp | #4 |
| antibody response mog | #4 |
| mp‐lpr | #4 |
| immunoglobulin deficient | #4 |
| cathelicidins ll37 | #4 |
| glands sialadenitis | #4 |
| fpr2 recognition | #4 |
| inbred dba peptides | #4 |
| cia6 | #4 |
| arthritis comp | #4 |
| k8 k8 mice | #4 |
| species regulate | #4 |
| α1ii chain | #4 |
| congenic rats rats | #4 |
| mip mice | #4 |
| eae5 | #5 |
| antileukoproteinase | #5 |
| multiplex analyses | #5 |
| apc cii | #5 |
| regulating rat | #5 |
| collageninduced arthritis cia | #5 |
| interaction cartilage | #5 |
| glycopeptide fragment | #5 |
| lipidomic remodeling | #5 |
| mice acpa | #5 |
| o2• h2o2 nox | #5 |
| immunization male | #5 |
| immunization type collagen | #5 |
| rt1eu | #5 |
| severe arthritis mice | #5 |
| cia model | #5 |
| autoimmune disease models | #5 |
| ros mca | #5 |
| dba mouse | #5 |
| asparaginelinked glycan | #5 |
| pineal gland development | #5 |
| avridineinduced arthritis | #5 |
| beta 11 cells | #5 |
| ros macrophages | #5 |
| classical adjuvant | #5 |
| α10i | #5 |
| cd8 deficiency | #5 |
| tsst1producing | #5 |
| symptom onset frequency | #5 |
| rats developed | #5 |
| autologous type | #5 |
| symptoms rheumatoid arthritis | #5 |
| cartilage type | #5 |
| nox animal models | #5 |
| commonly model | #5 |
| ii‐induced | #5 |
| backcrossed | #5 |
| dba 1 mice | #5 |
| overexpression hdac3 | #5 |
| oia | #5 |
| development acpa | #5 |
| citrullinated peptides ccp | #5 |
| collagen anti | #5 |
| streptococcus pyogenes ides | #5 |
| tlr3 expression | #5 |
| oxidative radicals | #5 |
| raloxifene disease activity | #5 |
| tcell mrl | #5 |
| tbb infection | #5 |
| lew1n | #5 |
| arthritogenic cells | #5 |
| cbrh7919 | #5 |
| higher levels melatonin | #5 |
| congenic nod | #5 |
| tcell hybridomas | #5 |
| cia type collagen | #5 |
| b‐cell epitope | #5 |
| c‐glycoside analogue | #5 |
| position type collagen | #5 |
| pathogenesis autoimmune arthritis | #5 |
| smoking prior | #5 |
| arthritis onset | #5 |
| egfp flow cytometry | #5 |
| measurement nox activity | #5 |
| puccetti | #5 |
| aureus arthritis | #5 |
| delayed immunization rats | #5 |
| monoclonal antibody alpha | #5 |
| mrvalues | #5 |
| glycopeptide | #5 |
| chromosome cia7 | #5 |
| igg endos | #5 |
| wellknown role | #5 |
| recovery ean | #5 |
| arthritis rats | #5 |
| painlike behavior | #5 |
| immunological involvement | #5 |
| immunized animals controls | #5 |
| multiplex array | #5 |
| oestradiol vehicle | #5 |
| tubule cells kidney | #5 |
| exercise hiit | #5 |
| chick cii | #5 |
| subsets rheumatoid arthritis | #5 |
| cgd mice | #5 |
| cgd hyperinflammation | #5 |
| tlr3 macrophages | #5 |
| biomarkers 2 polyradiculoneuropathy | #5 |
| low dose tolerance | #5 |
| field nox | #5 |
| osteoclasts stromal cells | #5 |
| lethal inflammatory disorder | #5 |
| type collagen cix | #5 |
| experimental breeding | #5 |
| swr mouse | #5 |
| patients acpa levels | #5 |
| nox o2• h2o2 | #5 |
| ly female | #5 |
| symptoms development | #5 |
| uterus cells | #5 |
| il4deficient mice | #5 |
| nox complex | #5 |
| absence c5 | #5 |
| multiparous mice | #5 |
| severe sialadenitis | #5 |
| hydroxynorvaline | #5 |
| resistance cia | #5 |
| glycopeptidomimetics | #5 |
| ovalbumin pepsin | #5 |
| antibodies filaggrin | #5 |
| citrullinated peptides | #5 |
| epitope cii | #5 |
| monoclonal encephalomyelitis autoimmune | #6 |
| b10 mouse | #6 |
| collagen arthritis | #6 |
| data ros | #6 |
| mice investigated | #6 |
| rcramp | #6 |
| betaoestradiol | #6 |
| arthritis autoantibodies | #6 |
| mice sialadenitis | #6 |
| cells affinity surface | #6 |
| contrasting roles | #6 |
| functional selective | #6 |
| hdac1 class | #6 |
| erosive polyarthritis | #6 |
| knockout receptors igg | #6 |
| activity neuroinflammation | #6 |
| animal genetic | #6 |
| l3t4positive cells | #6 |
| relapsing polychondritis rp | #6 |
| anti ccp2 | #6 |
| experimental postmenopausal | #6 |
| female lymphocyte | #6 |
| macrophages mph | #6 |
| isotypes patients | #6 |
| mhcii alleles | #6 |
| mrna tgfbeta | #6 |
| acpa anti | #6 |
| loci controlling | #6 |
| active arthritis | #6 |
| pristane squalene | #6 |
| pathogenic events | #6 |
| affinity ligand protein | #6 |
| arthritis models | #6 |
| lys270 | #6 |
| rheumatoid arthritis comp | #6 |
| recombinant rat interferongamma | #6 |
| rheumatoid arthritis model | #6 |
| ccp2 positive | #6 |
| collagen cia | #6 |
| cd4∶cd8 | #6 |
| ltab | #6 |
| transgenic mice arthritis | #6 |
| joints rats | #6 |
| c57bl 6 background | #6 |
| cartilage collagens | #6 |
| disease protective | #6 |
| cia cd4 cells | #6 |
| rheumatoid arthritis collagen | #6 |
| peptides arthritis | #6 |
| induced psoriasis | #6 |
| glycopeptide specificity | #6 |
| collagen cells | #6 |
| autoimmunity arthritis | #6 |
| develop arthritis | #6 |
| controls arthritis | #6 |
| cell recognition | #6 |
| eae mhc | #6 |
| mice congenic | #6 |
| glycoproteins nadph | #6 |
| autoimmune experimental genes | #6 |
| arthritis antibodies | #6 |
| complex mhc | #6 |
| murine loci | #6 |
| metabolic nuclear receptors | #6 |
| pyramidal neurons loss | #6 |
| k8 mice | #6 |
| cia26 | #6 |
| tsst1 mice | #6 |
| pv loss | #6 |
| nox2 mediates | #6 |
| igg autoantibodies sera | #6 |
| immunization peptides | #6 |
| heterogeneous stock mice | #6 |
| acpa specificities | #6 |
| dominant suppression | #6 |
| staphylococcus aureus arthritis | #6 |
| treatment oestradiol | #6 |
| snecs | #7 |
| glycosylated collagen | #7 |
| impaired induction | #7 |
| chronic experimental | #7 |
| locus chromosome | #7 |
| arthritis strains | #7 |
| antibodyinduced arthritis | #7 |
| oestrogen rats | #7 |
| ciireactive cells | #7 |
| autoimmunity collagen | #7 |
| autoantibodies citrullinated peptides | #7 |
| raassociated molecules | #7 |
| mice constant darkness | #7 |
| cii anti | #7 |
| type collagen | #7 |
| murine psoriasis | #7 |
| region syntenic | #7 |
| 3xi | #7 |
| rheumatoid arthritis role | #7 |
| animal immunization injections | #7 |
| collagen arthritis rats | #7 |
| autoantibodies lymphocytes | #7 |
| collagen arthritis cia | #7 |
| mediated vasculitis | #7 |
| conventional environment | #7 |
| effector phase | #7 |
| castrated females | #7 |
| induction arthritis | #7 |
| cia5 | #7 |
| antibodies citrullinated antigens | #7 |
| mbp peptide | #7 |
| mouse collagen | #7 |
| polychondritis relapsing | #7 |
| transgenic class | #7 |
| cryogel column | #7 |
| congenic mouse | #7 |
| cia mice | #7 |
| aplec | #7 |
| ean animals | #7 |
| impact cia | #7 |
| chronic phase arthritis | #7 |
| symptoms disease onset | #7 |
| nonarthritogenic | #7 |
| strains disease | #7 |
| macrophages alternative activation | #7 |
| autoimmune human | #7 |
| arthritis type collagen | #7 |
| cii apc | #7 |
| citrullinated peptide antigens | #7 |
| rats phases | #7 |
| collagen epitope | #7 |
| analysis crosses | #7 |
| periodontitis arthritis | #7 |
| cognate activation | #7 |
| responses cii | #7 |
| isomerase peptide | #7 |
| antigens differentiation arthritis | #7 |
| role raloxifene | #7 |
| g6pi | #7 |
| hydrolases polymorphism | #7 |
| congenic strains | #7 |
| response immunization | #7 |
| cab3 | #7 |
| regulatory cells macrophages | #7 |
| arthritis genes | #7 |
| acpa titres | #7 |
| protective influences | #7 |
| yaa gene | #7 |
| psoriasiform skin disease | #7 |
| induced neuropathology | #8 |
| murinised | #8 |
| rt1f | #8 |
| dominant cell epitope | #8 |
| hladrb11001 | #8 |
| oxidized peptides | #8 |
| ros interplay | #8 |
| mice ifnbeta | #8 |
| onset incidence | #8 |
| antibody vivo | #8 |
| inflamed synovia | #8 |
| supermacroporous cryogel | #8 |
| b10 background | #8 |
| eae genetic encephalomyelitis | #8 |
| murine locus | #8 |
| experimental autoimmune disease | #8 |
| rheumatoid chromosome | #8 |
| eae3 | #8 |
| hdac3 expression | #8 |
| rats mhc | #8 |
| rheumatoid autoimmunity | #8 |
| non‐mhc | #8 |
| haematogenously | #8 |
| antigenspecific priming | #8 |
| underlying genes | #8 |
| 297 cases | #8 |
| cia animal model | #8 |
| autoantibodies subset | #8 |
| autologous peptide | #8 |
| illness igg | #8 |
| t‐cell priming | #8 |
| ifa cii | #8 |
| hybridomas antibodies | #8 |
| lyme arthritis severity | #8 |
| autoimmune congenic mice | #8 |
| cia2 | #8 |
| polymeric cryogels | #8 |
| fcγr2b | #8 |
| sialadenitis mrl | #8 |
| 42 rats | #8 |
| incidence cia | #8 |
| humans experimental arthritis | #8 |
| arthritis lymphocytes | #8 |
| chromosomes loci | #8 |
| oia2 | #8 |
| onset day day | #8 |
| chronic autoimmune arthritis | #8 |
| destructive effects | #8 |
| clinical signs ean | #8 |
| antibodies acpas | #8 |
| mumt mice | #8 |
| persistent joint pain | #8 |
| medium mem | #8 |
| diseases loci | #8 |
| neutrophil cytosolic | #8 |
| expression hdac3 | #8 |
| treatment monoclonal | #8 |
| experimental binding | #8 |
| parathyroid glands receptors | #8 |
| ptpn22620w | #8 |
| α1‐microglobulin | #8 |
| typeii collagen | #8 |
| hlase alleles | #8 |
| autoantibodies collagen type | #8 |
| patients type collagen | #8 |
| heterologous peptide | #8 |
| mice techniques | #8 |
| cosphox | #8 |
| mbp mog | #8 |
| ean myelin | #9 |
| il10 role | #9 |
| histone 1 hdac1 | #9 |
| nodp | #9 |
| adaptive inflammation | #9 |
| rheumatoid autoantibodies | #9 |
| response mouse | #9 |
| arthritis skg mice | #9 |
| hgpi325 | #9 |
| experimental arthritis rats | #9 |
| patients acpas | #9 |
| postmenopausal arthritis | #9 |
| bovine cii | #9 |
| bound carbohydrates | #9 |
| autoimmunogenic | #9 |
| illness receptor | #9 |
| arthritis cross | #9 |
| effects mabs | #9 |
| intranasal animals arthritis | #9 |
| inbred lew tlymphocytes | #9 |
| development autoimmune arthritis | #9 |
| collagen complement | #9 |
| early joint erosions | #9 |
| specific nox2 | #9 |
| pristane | #9 |
| rheumatoid joints | #9 |
| variants acpa | #9 |
| induced metabolic syndrome | #9 |
| antibody alpha | #9 |
| antibodies vivo | #9 |
| reduced arthritis | #9 |
| disease strains | #9 |
| avridine | #9 |
| inbred dba mice | #9 |
| collagen female | #9 |
| acpas patients | #9 |
| rt1u | #9 |
| cia transgenic mice | #9 |
| alpha1inhibitor3 | #9 |
| rats rat | #9 |
| murine collagen | #9 |
| animal models urgent | #9 |
| posttranslational glycosylation | #9 |
| acpas | #9 |
| oligomeric matrix | #9 |
| oil adjuvants | #9 |
| hitr | #9 |
| idiotype‐specific | #9 |
| psychological tyrosine | #9 |
| serum interferon | #9 |
| mammalian disease models | #9 |
| class allele | #9 |
| experimental genes | #9 |
| specific sets | #9 |
| eae immunization | #9 |
| loci rats | #9 |
| mouse peptide | #9 |
| b10riii mice | #9 |
| 2 nadph | #9 |
| differentiation autoimmune | #9 |
| ox19 | #9 |
| human immunopeptidome | #9 |
| inbred dba | #10 |
| immunization rats | #10 |
| acutephase response rats | #10 |
| oestrogen | #10 |
| cartilage oligomeric | #10 |
| mice nadph | #10 |
| knockout nadph | #10 |
| tertbutylacrylamide | #10 |
| citrullinated antigen | #10 |
| cells increased production | #10 |
| axotomized motor neurons | #10 |
| monoclonal antigens rats | #10 |
| animal models | #10 |
| hlase smoking | #10 |
| presence acpa | #10 |
| mice cii | #10 |
| cii mice | #10 |
| antibodies specific | #10 |
| pain animal models | #10 |
| collagen autoimmunity | #10 |
| h2ap | #10 |
| cells development | #10 |
| native collagen type | #10 |
| stock mice | #10 |
| severe erosive | #10 |
| acpa diagnosis | #10 |
| ifnbeta mice | #10 |
| rats lewis rats | #10 |
| alpha collagen chains | #10 |
| reactivity acpas | #10 |
| extracellular cartilage | #10 |
| nih heterogeneous stock | #10 |
| cell‐deficient | #10 |
| rheumatoid arthritis dr4 | #10 |
| prl effects | #10 |
| development severity | #10 |
| mice genistein | #10 |
| onset chromosome | #10 |
| mbp peptides | #10 |
| experimental cartilage | #10 |
| autoimmune disease humans | #10 |
| passive transfer experiments | #10 |
| beta 11 | #10 |
| endogenous collagen | #10 |
| mutated mice | #10 |
| cartilage collagen fibrils | #10 |
| genetic experiments | #10 |
| antibody collagen | #10 |
| o2• h2o2 | #10 |
| monoclonal arthritis | #10 |
| activation male | #10 |
| cartilage arthritis | #10 |
| cd4 cells spleen | #10 |
| abp gene | #10 |
| dense fractions | #10 |
| cells pia | #11 |
| arthritis absence | #11 |
| antigen variability | #11 |
| rat arthritis | #11 |
| lentiviral vector expression | #11 |
| loci regulating | #11 |
| gad6 | #11 |
| tailbase | #11 |
| 84–102 | #11 |
| potential autoantigens | #11 |
| naïve cells cells | #11 |
| rat collagen | #11 |
| chondrocytes ecm | #11 |
| chronic arthritis | #11 |
| mhc control | #11 |
| ptpn22 smoking | #11 |
| mice cd1 | #11 |
| rat liver rats | #11 |
| mice mhc | #11 |
| isotypes | #11 |
| 2xi | #11 |
| development rheumatoid | #11 |
| fragments anti | #11 |
| cia7 | #11 |
| cia30 | #11 |
| stromal cells macrophages | #11 |
| species respiratory | #11 |
| antibodies association | #11 |
| individuals onset | #11 |
| nodb10h2b mice | #11 |
| antibody type collagen | #11 |
| liver receptor lxrα | #11 |
| monoclonal rheumatoid factors | #11 |
| inflammatory arthritis role | #11 |
| dss wt | #11 |
| backgroundantibodies | #12 |
| rats expression | #12 |
| antibodies structures | #12 |
| natural polymorphism | #12 |
| hydroxylysines | #12 |
| associations antibodies | #12 |
| treatment experimental arthritis | #12 |
| mutation nadph | #12 |
| fpr2 agonists | #12 |
| matrilin | #12 |
| cell responses cii | #12 |
| illness sex characteristics | #12 |
| peptide study | #12 |
| serum concentrations comp | #12 |
| reduces severity | #12 |
| rats cia | #12 |
| type collagen immunization | #12 |
| mbp response | #12 |
| stages pathogenesis | #12 |
| psoriasis mouse model | #12 |
| cii patients | #12 |
| chronic erosive arthritis | #12 |
| bovine type collagen | #12 |
| qa2 | #12 |
| structure antibodies | #12 |
| autoimmune monoclonal antigens | #12 |
| genetic contamination | #12 |
| α1ii | #12 |
| loci disease | #12 |
| myelin ean | #12 |
| stage cia | #12 |
| riiis | #12 |
| nonselfdiscrimination | #12 |
| study arthritis | #12 |
| psoriasis arthritis | #12 |
| onset symptoms | #12 |
| mutated mouse | #12 |
| immunodominant | #12 |
| role arthritis | #12 |
| major haplotype | #12 |
| natural loss | #12 |
| icmediated | #12 |
| lymphoid cells development | #12 |
| frequencies antibodies | #12 |
| encephalomyelitis induced | #12 |
| pia1 | #12 |
| animal immunohistochemistry | #12 |
| lung macrophages mice | #12 |
| increased litter size | #12 |
| mice comp | #12 |
| cross rats | #12 |
| oxidase nox2 | #13 |
| levels nabs | #13 |
| joints blood | #13 |
| μ chain | #13 |
| advanced intercross | #13 |
| mannan | #13 |
| t‐cell epitope | #13 |
| dr1 transgenic | #13 |
| macroscopic scoring | #13 |
| species deficiency | #13 |
| arthritis knowledge | #13 |
| multispecific | #13 |
| sequence collagen | #13 |
| genes mouse chromosome | #13 |
| idd5 | #13 |
| b10p | #13 |
| complement complement activation | #13 |
| development type collagen | #13 |
| strains incidence | #13 |
| factor isotypes | #13 |
| cyclic citrullinated | #13 |
| dba molecular | #13 |
| immunohistochemistry interferon | #13 |
| mtec aire | #13 |
| hladrb1 ptpn22 | #13 |
| anticii | #13 |
| ho4 | #13 |
| nos2derived | #13 |
| antibodies citrullinated proteins | #13 |
| epitope immunization | #13 |
| bcelldeficient mice | #13 |
| l012 | #13 |
| citrullinated | #13 |
| major loci | #13 |
| cells salivary glands | #13 |
| mouse strains | #13 |
| lew1w | #13 |
| ccp2 antibodies | #13 |
| doses ici | #13 |
| cell epitope | #13 |
| rfigg | #13 |
| nonobese diabetic mouse | #13 |
| 24dinitro1fluorobenzene | #13 |
| expression egfp | #13 |
| behavioral alterations rats | #13 |
| oxidative regulation | #13 |
| native type collagen | #13 |
| molecular disease models | #14 |
| smallmolecule compound | #14 |
| loci interaction | #14 |
| involvement cells | #14 |
| cia expression | #14 |
| macrophages immune response | #14 |
| humans nadph | #14 |
| arthritic paws | #14 |
| protein collagen | #14 |
| experimental interferon | #14 |
| candidate autoantigens | #14 |
| osteoclasts vivo | #14 |
| loci rheumatoid | #14 |
| thr233 | #14 |
| b6n mice | #14 |
| murine collageninduced arthritis | #14 |
| nasal inhalation | #14 |
| efficient promotion | #14 |
| deficient production | #14 |
| autoimmunity animals | #14 |
| antifilaggrin antibodies | #14 |
| blymphocyte female humans | #14 |
| sirt1 mmp9 | #14 |
| arlacel | #14 |
| presence mcv | #14 |
| peptides anti | #14 |
| immune regulators | #14 |
| aggregated nets | #14 |
| autoimmune arthritis | #14 |
| immunized rat | #14 |
| gut protection | #14 |
| collagen comp | #14 |
| mhc class region | #14 |
| collagen disease | #14 |
| specific inflammation | #14 |
| translationally modified | #15 |
| osteoporosis development | #15 |
| dcii | #15 |
| aire mtec | #15 |
| presence anticarp antibodies | #15 |
| exaggerates | #15 |
| experimental allergic neuritis | #15 |
| regulation adaptive immunity | #15 |
| amps development | #15 |
| cultured human chondrocytes | #15 |
| rt1a | #15 |
| mice immunization | #15 |
| monolithic cryogel | #15 |
| polychondritis | #15 |
| nodb10h2b | #15 |
| arthritis role | #15 |
| rats monoclonal antigens | #15 |
| antigenic epitope | #15 |
| citrullinated peptides patients | #15 |
| murine cia | #15 |
| antibodies arthritis | #15 |
| neuritis rats | #15 |
| integrated bioprocess | #15 |
| mice type collagen | #15 |
| apcs macrophages | #15 |
| lentiviral gene delivery | #15 |
| rheumatoid arthritis presence | #15 |
| ros cii | #15 |
| immune complex formation | #15 |
| tflask | #15 |
| congenic rats | #15 |
| arthritis development | #15 |
| rat genetics | #15 |
| raloxifene estradiol | #15 |
| monoclonal arthritis rats | #15 |
| treatment cia | #15 |
| anticollagen | #15 |
| involvement pathogenesis | #15 |
| mhc class molecule | #15 |
| type collagen development | #15 |
| cdr regions | #15 |
| 2 weight | #15 |
| rno10 | #16 |
| subspecificities | #16 |
| cep1 | #16 |
| epitopes mice mice | #16 |
| nonglycosylated form | #16 |
| fewer osteoclasts | #16 |
| matrilin proteins | #16 |
| lethal inflammatory | #16 |
| acute inflammation mice | #16 |
| antinuclear autoimmunity | #16 |
| congenic mice mice | #16 |
| rt1 | #16 |
| pparγ lxrα | #16 |
| indirect genetic predisposition | #16 |
| males onset | #16 |
| arthritis severity mice | #16 |
| rheumatoid arthritis genes | #16 |
| rheumatoid factor production | #16 |
| hla–drb1 shared epitope | #16 |
| anti‐t | #16 |
| mumt | #16 |
| oligomeric matrix protein | #16 |
| h2p | #16 |
| n305 | #16 |
| mhc genes | #16 |
| disease mice mice | #16 |
| lew1 | #16 |
| development rheumatoid arthritis | #16 |
| rats experimental arthritis | #16 |
| levels natural antibodies | #16 |
| arthritis cii | #16 |
| mhcii ciita | #16 |
| class transplantation | #16 |
| genes animals | #16 |
| autologous collagen | #16 |
| staphylococcal arthritis | #16 |
| cells collagen | #17 |
| rats lewis | #17 |
| rheumatoid arthritis subsets | #17 |
| genistein mice | #17 |
| polyphosphate4 | #17 |
| ethanol development | #17 |
| rt1av1 | #17 |
| native denatured | #17 |
| cartilage collagen | #17 |
| triplehelical conformation | #17 |
| progesterone development | #17 |
| cab4 | #17 |
| spleen peyers patches | #17 |
| strains lymphocytes | #17 |
| clever1 | #17 |
| inbred lew | #17 |
| nox2 derived | #17 |
| cells presenting cells | #17 |
| skg | #17 |
| allergic neuritis | #17 |
| human fcγriia | #17 |
| collagen specific | #17 |
| animals congenic | #17 |
| cells female mice | #17 |
| mice rheumatoid arthritis | #17 |
| arthritis rheumatoid autoantibodies | #17 |
| collagen induced arthritis | #17 |
| onset rheumatoid arthritis | #17 |
| leuphe | #17 |
| periodontitis antibodies | #17 |
| joint inflammatory | #18 |
| disease duration onset | #18 |
| salivary glands mice | #18 |
| expression lxrα | #18 |
| moginduced eae | #18 |
| keratinocytes induction | #18 |
| collagen autoantibodies | #18 |
| genes spleen | #18 |
| anti cd44 | #18 |
| cartilage type collagen | #18 |
| purified anti | #18 |
| day arthritis | #18 |
| galactose moiety | #18 |
| h2z | #18 |
| arthritis anti | #18 |
| langerhans cells cells | #18 |
| phenotypic feature | #18 |
| adjuvant arthritis rats | #18 |
| hybridomas mice mice | #18 |
| ros data | #18 |
| humanized transgenic mice | #18 |
| addition ros | #18 |
| autoimmune illness | #18 |
| dra0101 | #18 |
| ealkene | #18 |
| cuiiida | #18 |
| short‐term administration | #18 |
| defined epitope | #18 |
| day immunization | #18 |
| single intradermal injection | #19 |
| citrullinated proteins acpa | #19 |
| new avenues | #19 |
| blood monocytes neutrophils | #19 |
| mrl mp mice | #19 |
| mice develop | #19 |
| peyers patches spleen | #19 |
| three‐dimensional culture | #19 |
| collagen response | #19 |
| cia eae | #19 |
| suppression dth | #19 |
| protein comp | #19 |
| castrated female rats | #19 |
| protective alleles | #19 |
| cd4 transgenic | #19 |
| future utility | #19 |
| beta oestradiol | #19 |
| inflammatory attack | #19 |
| rats snp | #19 |
| trimolecular complex | #19 |
| mice congenic mice | #19 |
| tbetarii gene | #19 |
| vivo elimination | #19 |
| supermacroporous | #19 |
| patients polychondritis | #19 |
| gly262 | #19 |
| elisa cia | #19 |
| stress phospholipids | #20 |
| imaging reactive | #20 |
| underlying gene | #20 |
| human rheumatoid arthritis | #20 |
| enhanced tcr | #20 |
| response mbp | #20 |
| mice cia | #20 |
| monkeys rodents | #20 |
| loci chromosomes | #20 |
| mhc class alleles | #20 |
| pvg1av1 | #20 |
| highly susceptible | #20 |
| glycosylated | #20 |
| development disease | #20 |
| 5r5 | #20 |
| serm raloxifene | #20 |
| mbp rats | #20 |
| antibody treatment | #20 |
| littermate | #20 |
| rt1d | #20 |
| knockout mice transgenic | #20 |
| progesterone oestrogen | #20 |
| experimental autoimmunity | #20 |
| matrilin1 | #20 |
| role nox | #20 |
| 5p14 | #20 |
| ciita mhcii | #20 |
| ncr3 | #20 |
| prominent infiltration | #20 |
| nox1deficient mice | #20 |
| inflammation mice | #20 |
| fls tnfα | #20 |
| α1acidglycoprotein | #21 |
| chronic relapsing | #21 |
| cia treatment | #21 |
| granule mobilization | #21 |
| drb11001 | #21 |
| illness autoimmune | #21 |
| positional cloning | #21 |
| individual acpa | #21 |
| ean rats | #21 |
| olahsd | #21 |
| arthritis pregnancy | #21 |
| n141 | #21 |
| suppressor cytotoxic cells | #21 |
| serum levels comp | #21 |
| genes controlling | #21 |
| linomide treatment | #21 |
| cells adaptive immune | #21 |
| triplehelical peptides | #21 |
| pathogenesis rheumatoid | #21 |
| nox2 mice | #21 |
| nitratenitriteno pathway | #21 |
| nox2 activity | #21 |
| n286 | #21 |
| diseases lymphocytes | #21 |
| rats development | #21 |
| mice mutant strains | #21 |
| muscle ros | #21 |
| supermacroporous cryogels | #21 |
| igg fcgammar | #21 |
| conserved haplotype | #21 |
| experimental rheumatoid | #21 |
| onset severity | #21 |
| ccp negative | #22 |
| association pv | #22 |
| experimental phenotype | #22 |
| cultured hepatic cells | #22 |
| mice independent | #22 |
| rats nonalcoholic steatohepatitis | #22 |
| antiidiotypic antibody | #22 |
| semiallogenic | #22 |
| identification susceptibility genes | #22 |
| 270 | #22 |
| induced eae | #22 |
| ul1 | #22 |
| 81a | #22 |
| rats loss | #22 |
| animal epitopes humans | #22 |
| response myelin | #22 |
| vh j558 | #22 |
| determinant selection | #22 |
| samples onset | #22 |
| c57bl mice subfamily | #22 |
| cells presentation | #23 |
| diseases autoimmunity | #23 |
| mbp eae | #23 |
| b10r | #23 |
| loss collagen | #23 |
| onset cia | #23 |
| anti‐cd5 | #23 |
| experimental chromatography | #23 |
| cryogel beads | #23 |
| antibodies acpa | #23 |
| lymphocytes amino | #23 |
| complex influences | #23 |
| monoclonal antigens autoimmune | #23 |
| arthritis type | #23 |
| comp | #23 |
| citrullinated protein | #23 |
| rats inbred lew | #23 |
| cells b10 | #23 |
| 4npa | #23 |
| immunopeptides | #23 |
| mace association | #23 |
| animal genes | #23 |
| peptide activation | #23 |
| castration rats | #23 |
| 17 betaoestradiol | #23 |
| phage clones | #23 |
| inflammation absence | #23 |
| citrullinated antigens | #23 |
| experimental autoimmune diseases | #23 |
| tgfbeta resistance | #23 |
| citrullinated epitopes | #23 |
| experimental lupus | #24 |
| ftirm | #24 |
| antinuclear apoptosis | #24 |
| mediated arthritis | #24 |
| chronic autoimmune diseases | #24 |
| cells c3h | #24 |
| postpartum flare | #24 |
| controls anti | #24 |
| experimental cells | #24 |
| severity chronicity | #24 |
| subloci | #24 |
| 339 | #24 |
| inflammation arthritis | #24 |
| y35 | #24 |
| c57bl 10 mice | #24 |
| flss patients | #24 |
| monoclonal anti | #24 |
| animal epistasis | #24 |
| levels comp | #24 |
| severity ali | #24 |
| new mouse | #24 |
| loci chromosome | #24 |
| secondary immune response | #24 |
| mice nox2 | #24 |
| mouse models development | #24 |
| autoantibodies rheumatoid | #24 |
| rat induction | #24 |
| cix | #25 |
| 8 antibodies | #25 |
| relapsing polychondritis | #25 |
| b6 balb | #25 |
| autoantibody response | #25 |
| ros | #25 |
| immunization development | #25 |
| rno4 | #25 |
| proteinarginine deiminase type | #25 |
| production monoclonal | #25 |
| cell hybridomas | #25 |
| autoimmune diseases humans | #25 |
| collagen cartilage | #25 |
| beta lymphocytes | #25 |
| arginine arthritis | #25 |
| interleukin2 mice receptors | #25 |
| complex male | #25 |
| inbred lew rats | #25 |
| massive infiltration | #25 |
| tolerized rats | #25 |
| monocytes nadph | #25 |
| immunodominant epitope | #25 |
| autoimmune messenger | #25 |
| rat mhc | #25 |
| common autoimmune disease | #25 |
| arthritis experimental arthritis | #25 |
| cells immunization | #25 |
| murine lyme arthritis | #25 |
| bnda | #25 |
| parasitemia survival | #25 |
| congenic animals | #25 |
| specific epitopes | #25 |
| cells joints | #26 |
| anti citrullinated | #26 |
| hydrocarbon oil | #26 |
| local exposure | #26 |
| post translationally | #26 |
| viable chondrocytes | #26 |
| mice gammadelta cells | #26 |
| igg2a mice | #26 |
| glutamax | #26 |
| helperinducer animals antibodies | #26 |
| granulocytes cells | #26 |
| polychondritis rp | #26 |
| autoantibodies citrullinated proteins | #26 |
| eae development | #26 |
| nitrophenylalanine | #26 |
| gene regions | #26 |
| cb11 | #26 |
| trypsination | #27 |
| immunodominant response | #27 |
| interleukin21 tlymphocytes | #27 |
| c1i | #27 |
| perforin deficiency | #27 |
| immunospecific | #27 |
| physiological level | #27 |
| antibodies type | #27 |
| hladrb1 shared epitope | #27 |
| disease immunoglobulin | #27 |
| individuals antibodies | #27 |
| nonmhc genes | #27 |
| innate interleukin10 | #27 |
| pannus tissue | #27 |
| ccp2 | #27 |
| intercrossed | #27 |
| pointmutation | #27 |
| rheumatoid factor isotypes | #27 |
| lysine position | #28 |
| ros induction | #28 |
| antibodies mab | #28 |
| upregulation cytokines | #28 |
| onset day | #28 |
| w3 25 | #28 |
| animal models neurodegeneration | #28 |
| antigenspecific tolerance | #28 |
| autoimmune inflammatory | #28 |
| chronicity | #28 |
| severity day | #28 |
| mediated effects | #28 |
| eae susceptibility | #28 |
| protein peptides | #28 |
| nr8383 | #28 |
| rat strain | #28 |
| antily6g | #28 |
| mrna ifngamma | #28 |
| cia3 | #28 |
| cartilage vivo | #28 |
| anti rat | #28 |
| presence synovial fluid | #29 |
| mice mab | #29 |
| acpa | #29 |
| parotid secretory protein | #29 |
| hiit exercise | #29 |
| glucose transport capacity | #29 |
| rfigm | #29 |
| absence inflammation | #29 |
| phenomes | #29 |
| 246trinitrophenyl | #29 |
| ros production macrophages | #29 |
| immunopathogenicity | #29 |
| membrane lymphocytes | #29 |
| cfa cia | #29 |
| suboptimal doses | #29 |
| peptide anti | #29 |
| smoking presence | #29 |
| chronic dss | #29 |
| ls2616 | #29 |
| antibody producing cells | #29 |
| increased salt | #30 |
| metabolic syndrome rats | #30 |
| 11 cells | #30 |
| plasminogendeficient mice | #30 |
| ctla4 mice | #30 |
| alphabetat | #30 |
| chronic autoimmune | #30 |
| synovial cells patients | #30 |
| translational rats | #30 |
| development experimental | #30 |
| variable heavy chain | #30 |
| dba mice | #30 |
| treatment raloxifene | #30 |
| adult thymectomy | #30 |
| acpa fine | #30 |
| vivo exercise | #30 |
| vpba | #30 |
| vgenes | #30 |
| cultivation cells | #30 |
| disease immunity | #30 |
| chain collagen | #30 |
| hlase | #30 |
| linkage disease | #30 |
| paws | #30 |
| trimolecular | #31 |
| ige cd23 | #31 |
| comparative genetic analysis | #31 |
| psoriasis model | #31 |
| drugs addition | #31 |
| disease development | #31 |
| selfprotein | #31 |
| acute‐phase response | #31 |
| immunization | #31 |
| human type collagen | #31 |
| monoclonal antibody production | #31 |
| nox2 nox1 | #31 |
| perpetuated | #31 |
| expressing cells | #31 |
| rats autoimmune | #31 |
| pristaneinduced lupus | #31 |
| phytol | #31 |
| apc development | #31 |
| common chain | #31 |
| littermate controls | #31 |
| hiit training | #31 |
| synovial fluid blood | #31 |
| arthritis therapy | #32 |
| nodes mice | #32 |
| h2aq | #32 |
| hladrb104 | #32 |
| beta mice | #32 |
| presence acpas | #32 |
| steen | #32 |
| mucosal tolerance | #32 |
| ros rns | #32 |
| genomewide genotyping | #32 |
| specificity function | #32 |
| bound peptides | #32 |
| receptor preference | #32 |
| nadph oxidases nox | #32 |
| 11 cell | #32 |
| epitope antibodies | #32 |
| methods serum samples | #32 |
| type antibody | #32 |
| congenic mice | #32 |
| cells uterus | #32 |
| caia mice | #32 |
| acpa rheumatoid arthritis | #32 |
| cell ratio | #32 |
| rt11 | #32 |
| ra33 | #32 |
| influence genes | #32 |
| nonb cells | #32 |
| role osteoclastogenesis | #32 |
| polymorphic genes | #32 |
| differentiation arthritis | #32 |
| epitopes antibodies | #33 |
| induced immunization | #33 |
| autoantibody activity | #33 |
| type cross | #33 |
| antigenpresenting cells cells | #33 |
| multiplex analysis | #33 |
| tcell receptor | #33 |
| cytosolic factor | #33 |
| delayed type | #33 |
| modified collagen | #33 |
| role vav1 | #33 |
| rheumatoid joint | #33 |
| tolerance immunization | #33 |
| autoimmune demyelinating disease | #33 |
| skews | #33 |
| arthritic mice | #33 |
| natural antibodies nabs | #34 |
| cells dendritic cells | #34 |
| patients animal models | #34 |
| neurodegeneration role | #34 |
| chronic polyarthritis | #34 |
| c4bp | #34 |
| heterogeneous stock | #34 |
| interferon activity | #34 |
| promiscuous expression | #34 |
| joint pathology | #34 |
| nox2 deficiency | #34 |
| fpr1 | #34 |
| plasminogen deficiency | #35 |
| psoriasiform skin | #35 |
| destructive arthritis | #35 |
| accessible sites | #35 |
| arthritis disease | #35 |
| complex arthritis | #35 |
| antirat | #35 |
| autoreactive | #35 |
| major regulators | #35 |
| patients populations | #35 |
| infectious disease models | #35 |
| 1xi | #35 |
| nets neutrophils | #35 |
| antiarthritis | #35 |
| acs stroke | #35 |
| phagotope | #35 |
| development chronic | #35 |
| triple helical | #35 |
| hybridomas | #35 |
| vdr cells | #35 |
| monoclonal rheumatoid | #35 |
| h2r | #36 |
| flow cytometry expression | #36 |
| variance animals antibodies | #36 |
| oxidases rna | #36 |
| comparative genetics | #36 |
| cii cfa | #36 |
| phagocyte | #36 |
| protein specific | #36 |
| induction tregs | #36 |
| arthritis cartilage | #36 |
| tolerance tlymphocytes | #36 |
| h2g7 | #36 |
| animals antigen | #36 |
| specificity sera | #36 |
| techniques mice | #36 |
| dth | #36 |
| cartilage joints | #36 |
| nk cells recognition | #36 |
| female histocompatibility | #36 |
| dinitro1 | #36 |
| immunopathological features | #37 |
| role gamma interferon | #37 |
| dba1 | #37 |
| cii protein | #37 |
| synthetic glycopeptides | #37 |
| encephalomyelitis | #37 |
| recombinant vaccine | #37 |
| c129 | #37 |
| spontaneous arthritis | #37 |
| oxidases oxidation | #37 |
| susceptibility autoimmune diseases | #37 |
| lymphocytes disease | #37 |
| genetic control | #37 |
| acpa positive | #37 |
| peptides binding | #37 |
| joint cartilage | #37 |
| mif pathogenesis | #37 |
| rich lipid | #37 |
| nitrogen species | #38 |
| cochranmantelhaenszel test | #38 |
| target autoantigens | #38 |
| antibodies animals | #38 |
| animal models pain | #38 |
| sialophorin | #38 |
| human blood neutrophils | #38 |
| cldn4 | #38 |
| snat | #38 |
| innovative tools | #38 |
| nzw | #39 |
| clonal expansion cells | #39 |
| allogeneically | #39 |
| b6n | #39 |
| endoβnacetylglucosaminidase | #39 |
| cell tolerance | #39 |
| autoreactive cells | #39 |
| oestrogen treatment | #39 |
| benoist | #39 |
| measurement activity | #39 |
| ym1 | #39 |
| wasting syndrome | #39 |
| nfr | #39 |
| acpa response | #39 |
| data myelin | #39 |
| ccia | #39 |
| resultsrats | #39 |
| addition impact | #40 |
| positive rheumatoid | #40 |
| genetic complexity | #40 |
| isostere | #40 |
| rt1c | #40 |
| adjuvant induced | #40 |
| disease animal models | #40 |
| polyclonal cell activation | #40 |
| peptide cell | #40 |
| antigens arthritis | #40 |
| autoimmune | #41 |
| effects experiments | #41 |
| congenic mapping | #41 |
| aq | #41 |
| ncii | #41 |
| priming phase | #41 |
| autoimmune inflammatory diseases | #41 |
| rats anti | #41 |
| genes loci | #41 |
| rat myelin | #41 |
| severity incidence | #41 |
| immunocap isac | #41 |
| mhc haplotype | #41 |
| cartilage bone destruction | #42 |
| ptpn22 locus | #42 |
| antibody isotypes | #42 |
| articular collagen | #42 |
| drb1 shared | #42 |
| mhc class class | #42 |
| p38 mapk nfκb | #42 |
| spleen weight | #42 |
| species receptors | #42 |
| th17 axis | #42 |
| fibroblasts mice | #42 |
| expected onset | #42 |
| pineal gland melatonin | #42 |
| mice autoimmune | #43 |
| arthritis data | #43 |
| anticitrullinated | #43 |
| type‐ii | #43 |
| congeneic | #43 |
| cd11bly6g | #43 |
| immunodominant epitopes | #43 |
| lew rats | #43 |
| lew lymphocytes | #43 |
| crosses genetic | #43 |
| pc8 | #43 |
| spinal glia | #43 |
| treatment autoimmune diseases | #43 |
| rats sex | #43 |
| anticyclic | #43 |
| autoreactive cell | #43 |
| kgf treatment | #43 |
| collagen | #43 |
| neuritis ean | #44 |
| peptide induced | #44 |
| defensins humans | #44 |
| c4bbinding protein c4bp | #44 |
| genetic linkage analysis | #44 |
| homozygous form | #44 |
| provocations | #44 |
| mice mice autoimmune | #44 |
| inflammation animals | #44 |
| chloro23 | #44 |
| mice adulthood | #44 |
| addition order | #44 |
| mathis | #44 |
| epitopes lymphocyte | #44 |
| phagotopes | #45 |
| relapsing disease | #45 |
| nzb | #45 |
| outbred rats | #45 |
| susceptibility arthritis | #45 |
| potent suppression | #45 |
| genetic encoding | #45 |
| chromosome development | #45 |
| disease histocompatibility | #45 |
| cocrystallisation | #46 |
| c227 | #46 |
| alphachains | #46 |
| affinity purified | #46 |
| neuritis autoimmune | #46 |
| carp antibodies | #46 |
| locus controlling | #46 |
| disease induction | #46 |
| isosteres | #46 |
| mhc class humans | #46 |
| posttranslationally | #46 |
| specific tolerance | #46 |
| lower severity | #46 |
| rat2 | #46 |
| eae mbp | #46 |
| intercrosses | #47 |
| complex mediated | #47 |
| diagnostic accuracy diagnosis | #47 |
| protective allele | #47 |
| association hladrb1 alleles | #47 |
| antibody reactivities | #47 |
| f1 hybrid mice | #47 |
| rheumatoid factors | #47 |
| idiotypic antibody | #47 |
| posttranslational rats receptors | #47 |
| humanized model | #48 |
| mice nzb | #48 |
| synovial lining layer | #48 |
| lupus disease | #48 |
| mice carrying | #48 |
| acetylchitobiose | #48 |
| tlr12 | #48 |
| f1 crosses | #48 |
| γchains | #48 |
| cia rats | #48 |
| experimental arthritis mice | #48 |
| antibody specificity | #48 |
| collagen peptide | #48 |
| peptide recognized | #48 |
| collagen glycosylation | #48 |
| experimental crosses | #49 |
| sex genes | #49 |
| monoclonal autoimmune diseases | #49 |
| class major | #49 |
| polyvinylcaprolactam | #49 |
| tcell stimulation | #49 |
| mouse cartilage | #49 |
| comp levels | #49 |
| immune nervous | #49 |
| mice caia | #49 |
| histone hdacs | #49 |
| bystander activation | #49 |
| complex region | #50 |
| disease rats | #50 |
| dependent chronic | #50 |
| glycosylated form | #50 |
| animal cell culture | #50 |
| antigenantibody | #50 |
| alagly | #50 |
| monoclonal epitopes | #50 |
| anticarbamylated protein | #50 |
| parathyroid cells | #50 |
| mice tolerance | #50 |
| inflammation kynurenine | #50 |
| loci animals | #50 |
| ciiia | #50 |
| glutamine uptake | #50 |
| cytometry analyses | #50 |
| aire mice | #51 |
| inbred c57bl autoimmune | #51 |
| evidence animal models | #51 |
| lentiviral particles | #51 |
| rheumatoid factor activity | #51 |
| antibodies cells | #51 |
| runting | #51 |
| tolerized | #51 |
| cells ova | #51 |
| c57bl 6j background | #51 |
| autoantibodies rheumatoid arthritis | #51 |
| delayed immunization | #51 |
| fewer cells | #51 |
| tracheal cartilage | #51 |
| derived type | #51 |
| xor activity | #52 |
| macrophages skin | #52 |
| model collagen | #52 |
| matrix protein | #52 |
| antigenpresenting cells | #52 |
| ptpn22 | #52 |
| induced autoimmunity | #53 |
| antibodies epitopes | #53 |
| aged peptides | #53 |
| production reactive | #53 |
| gastric parietal cell | #53 |
| cartilage erosion | #53 |
| physiological doses | #53 |
| triple helical structure | #53 |
| carbamylated proteins | #53 |
| melatonin day | #53 |
| lysosomal compartments | #53 |
| patients rheumatic conditions | #53 |
| arthritis induction | #53 |
| protein antibodies | #53 |
| rats social isolation | #54 |
| carbamylated protein | #54 |
| nodes lymphocyte | #54 |
| major epitope | #54 |
| predating | #54 |
| animals autoimmune | #54 |
| yaa | #54 |
| imitating | #54 |
| crossbreeding | #54 |
| melatonin animals | #54 |
| strain rats | #54 |
| development individuals | #54 |
| antigens myelomonocytic arthritis | #54 |
| arthritis genetic | #55 |
| complex genetic disease | #55 |
| susceptibility autoimmune disease | #55 |
| macrophage mannose receptor | #55 |
| autoimmune nzb | #55 |
| autoimmune reactions | #55 |
| inflammatory manifestations | #55 |
| alpha1microglobulin | #56 |
| new animal | #56 |
| mhc | #56 |
| selfreactive cells | #56 |
| animals antibody | #56 |
| cells salivary | #56 |
| labels superoxide | #56 |
| antibodies | #57 |
| collagen sequence | #57 |
| animals antirheumatic | #57 |
| development autoimmune | #57 |
| igg abs | #57 |
| antibodies bind | #57 |
| vivo depletion | #57 |
| cd1 mice | #57 |
| arthritis pathogenesis | #57 |
| schafer | #58 |
| chronic eae | #58 |
| peptide response | #58 |
| rat type | #58 |
| urokinase activity | #58 |
| oestrogen progesterone | #58 |
| resistance eae | #59 |
| genes mhc | #59 |
| oligoclonal igg bands | #59 |
| cartilage matrix protein | #59 |
| encephalitogenicity | #59 |
| anti cd8 | #59 |
| anticarp antibodies | #59 |
| anti cell | #59 |
| articular joints | #59 |
| hydroxylase diet | #59 |
| macrophage mannose | #60 |
| hpaaxis | #60 |
| protein peptide | #60 |
| alternative activation macrophages | #60 |
| dichotomous effects | #60 |
| joint erosions | #60 |
| inflammatory cells macrophages | #60 |
| assay epitopes | #60 |
| immunohistopathology | #60 |
| species reactive | #61 |
| differentiation myelomonocytic arthritis | #61 |
| serum comp | #61 |
| cells innate immune | #61 |
| incidence severity | #61 |
| experimental evoked potentials | #61 |
| epitope spreading | #61 |
| alpha1m | #61 |
| major histocompatibility | #61 |
| experimental rats rats | #61 |
| interferon‐β | #62 |
| fpr2 | #62 |
| syngeneically | #62 |
| reduced oxidative | #62 |
| toxin1 | #62 |
| antigens class histocompatibility | #62 |
| basic characterization | #62 |
| adaptive immune | #62 |
| mice susceptibility | #62 |
| autoantibody formation | #62 |
| cyclic sensitivity | #62 |
| placenta uterus | #62 |
| post‐partum | #63 |
| induced experimental | #63 |
| specificity tumor | #63 |
| collagen cell | #63 |
| delayed interferon | #63 |
| hypersensitivity dth | #63 |
| rats strain | #63 |
| mog1 | #63 |
| constant darkness | #63 |
| specific stages | #63 |
| peptide specific | #63 |
| protein disease | #63 |
| mice polyi | #63 |
| transfer animals | #63 |
| duval | #63 |
| igaproducing cells | #63 |
| glycoprotein myelin | #63 |
| nadph oxidases | #63 |
| lower capacity | #64 |
| maternal origin | #64 |
| role apc | #64 |
| secondary immune | #64 |
| tolerance model | #64 |
| freund adjuvant | #64 |
| weight variation | #65 |
| flss | #65 |
| autoimmunity humans | #65 |
| hindpaws | #65 |
| model chronic | #65 |
| induced suppression | #65 |
| major subset | #65 |
| histocompatibility complex | #65 |
| hladr2 | #66 |
| thy1 antigen | #66 |
| chromosomes mammalian | #66 |
| spontaneous disease | #66 |
| resemblances | #66 |
| experimental lymphocytes | #66 |
| multispecificity | #66 |
| acute arthritis | #66 |
| rheumatoid synovial cells | #66 |
| peripheral joints | #66 |
| phagocytosis oxidative burst | #66 |
| negative rheumatoid | #66 |
| dendritic cells epitopes | #67 |
| experimental encephalomyelitis | #67 |
| strains susceptible | #67 |
| mice induced | #67 |
| myelomonocytic arthritis | #67 |
| experimental allergic | #67 |
| rheumatoid arthritis susceptibility | #67 |
| development cell | #67 |
| mice cell | #67 |
| fibrinogen genotype | #67 |
| endos | #67 |
| key interactions | #67 |
| cells mhc class | #68 |
| iggrf | #68 |
| frequent infections | #68 |
| helper phenotype | #68 |
| sodium diethyldithiocarbamate | #68 |
| tolerized mice | #68 |
| anti carp | #68 |
| individuals positive | #68 |
| severity periodontitis | #68 |
| rheumatoid chromosomes | #68 |
| complex class | #68 |
| class region | #68 |
| female sex hormones | #68 |
| rheumatoid disease | #69 |
| lymphocytes chronic | #69 |
| frequency antibodies | #69 |
| cells mouse | #69 |
| direct damage | #69 |
| zap‐70 | #69 |
| vertebrate immune | #69 |
| relapsing | #69 |
| translationally | #70 |
| presence rheumatoid factor | #70 |
| prolonged graft survival | #70 |
| mrl mice | #70 |
| immunoglobulin interferon | #70 |
| response type | #70 |
| role cells | #70 |
| isolated rats | #71 |
| human psoriasis | #71 |
| cb10 | #71 |
| susceptibility female | #71 |
| ztm | #71 |
| expression pparγ | #71 |
| cartilage mice | #71 |
| swr | #71 |
| naïve mice | #72 |
| autoimmunity lymphocytes | #72 |
| interphalangeal joints | #72 |
| dark agouti rats | #72 |
| antibodies binding | #72 |
| lathyritic | #72 |
| delayedtype hypersensitivity dth | #72 |
| napdh | #72 |
| study antibodies | #72 |
| mrl lpr | #73 |
| oxidase complex | #73 |
| species ros | #73 |
| environmental lighting | #73 |
| bovine type | #73 |
| knockout protein processing | #73 |
| treatment stages | #73 |
| membrane animals | #73 |
| type ifn signature | #73 |
| hypersensitivity delayed | #74 |
| cartilage explants | #74 |
| antigens class | #74 |
| igarf | #74 |
| peptides sequences | #74 |
| pregnancyinduced | #74 |
| oestradiol | #75 |
| inbred dba receptors | #75 |
| acpapositive | #75 |
| diabetes arthritis | #75 |
| effects development | #75 |
| cell reactivity | #75 |
| genetic disease models | #75 |
| dth mice | #75 |
| rat splenocytes | #76 |
| anti carbamylated | #76 |
| peptide mhc | #76 |
| disease rheumatoid arthritis | #76 |
| type collagens | #76 |
| cell deficient | #77 |
| nerve conduction velocity | #77 |
| inbred mouse strains | #77 |
| rats eae | #77 |
| new animal model | #77 |
| cyp7a1 | #77 |
| pain inflammation | #77 |
| collagen chains | #77 |
| rt1n | #77 |
| lpr mrl | #77 |
| oligomeric | #77 |
| regulatory vaccines | #77 |
| eae induced | #77 |
| development insulitis | #77 |
| pythons | #78 |
| mhc expression | #78 |
| autoantigenic | #78 |
| clinical arthritis | #78 |
| pathogenesis rheumatoid arthritis | #78 |
| cartilage integrity | #78 |
| rats respiratory | #78 |
| mononuclear lung | #79 |
| shared epitope | #79 |
| inflammatory autoimmune | #79 |
| susceptibility disease | #79 |
| autoimmune experimental epitopes | #79 |
| 1ii | #79 |
| detection autoantibodies | #80 |
| chromosome study | #80 |
| oxidases | #80 |
| erosive arthritis | #80 |
| mhcii expression | #81 |
| class antigen expression | #81 |
| hnrnpa2 | #81 |
| aspartic acid position | #81 |
| dr1 antigen | #81 |
| mog mbp | #81 |
| induced leukocyte | #81 |
| arthritis cells | #81 |
| sex linkage | #81 |
| expression ll37 | #81 |
| spleen study | #81 |
| inflammatory phase | #81 |
| estrogen suppression | #81 |
| type macrophages | #81 |
| mrl mp | #81 |
| 14weeks | #82 |
| pannus formation | #82 |
| nadphoxidase | #82 |
| cell independent | #83 |
| tlymphocyte genes | #83 |
| mice igg | #83 |
| drug encephalomyelitis | #83 |
| bcg infection | #83 |
| expression mhc | #83 |
| reactive cells | #84 |
| multiple sclerosis evidence | #84 |
| naïve cells | #84 |
| spontaneous development | #84 |
| strains animals | #84 |
| arthritis day | #84 |
| epidermal cells | #84 |
| rat cardiac allografts | #84 |
| antiifngamma | #85 |
| homopentamer | #85 |
| inflammation joint | #85 |
| knockout receptors | #85 |
| cells recognize | #85 |
| class molecule | #85 |
| inflammation joints | #85 |
| anti cd4 | #86 |
| mutant strains | #86 |
| severe eae | #86 |
| monoclonal antibodies mab | #86 |
| preclinical stage | #86 |
| gfoger | #86 |
| contribution genes | #86 |
| animal humans | #86 |
| classical humans | #86 |
| phagocyte nadph | #86 |
| mhc class gene | #87 |
| alpha1acid glycoprotein | #87 |
| smash | #87 |
| inbred rat strains | #87 |
| estrogen induced | #87 |
| copy variation | #88 |
| narac | #88 |
| inguinal lymph nodes | #88 |
| fine specificities | #88 |
| levels anti | #88 |
| thps | #88 |
| experimental autoimmune | #89 |
| peptide immunization | #89 |
| mabs mab | #89 |
| mice antibodies | #89 |
| depletion cd8 cells | #89 |
| genetic quantitative | #89 |
| arthritic | #89 |
| ilc2 activation | #90 |
| genistein treatment | #90 |
| monkeys mice | #90 |
| susceptible | #90 |
| autoimmune inbred c57bl | #90 |
| pineal hormone melatonin | #90 |
| arthritis compared | #90 |
| adjuvant arthritis | #90 |
| rheumatoid arthritis cells | #90 |
| mediated mechanisms | #90 |
| synovial fluid serum | #91 |
| cells apc | #91 |
| cattle collagen | #91 |
| activation cd4 cells | #91 |
| protein induced | #91 |
| histological sections | #91 |
| backgroundan | #91 |
| humans immunodominant | #92 |
| abdominal region | #92 |
| experimental mouse models | #92 |
| anticitrullinated protein | #92 |
| nod mhc | #92 |
| difco | #92 |
| 290 patients | #93 |
| natural polymorphisms | #93 |
| xor | #93 |
| animals autoantibodies | #93 |
| cellspecific | #93 |
| knockout myelin | #93 |
| mice melatonin | #93 |
| endosomal acidification | #94 |
| activated cells cells | #94 |
| autosomal genes | #94 |
| fcγrs | #94 |
| macrophages development | #94 |
| galactosylated | #94 |
| induced sarcoma | #95 |
| moderateintensity exercise | #95 |
| binding integrins | #95 |
| chronic phase disease | #95 |
| macrophages stimulation | #96 |
| romani | #96 |
| cell alpha | #96 |
| lung emphysema | #96 |
| data rats | #96 |
| fetal rejection | #96 |
| nonglycosylated | #96 |
| pregnancy disease | #96 |
| messenger tolllike receptor | #96 |
| ifnbeta | #96 |
| antiimmunoglobulin | #97 |
| hydroxylysine | #97 |
| il33r | #97 |
| citrullinated fibrinogen | #97 |
| cathelicidins | #97 |
| macrophages fibroblasts | #97 |
| complex mice | #97 |
| rheumatoid lymphocytes | #97 |
| genetic female genes | #97 |
| autoimmune rats | #98 |
| rheumatoid cartilage | #98 |
| autoimmune experimental | #98 |
| acpa igg | #98 |
| swr mice | #98 |
| ean | #98 |
| interleukin‐4 | #99 |
| collagen cytokines | #99 |
| alternative pathways | #99 |
| rat chromosomes | #99 |
| thy1 antigens | #100 |
| cultured crosses | #100 |
| rats monoclonal antibodies | #100 |
| peptides cells | #100 |
| inducer animals | #100 |
| tap2 | #100 |
| invading pathogens | #100 |
| protein antibody | #100 |
| tlymphocyte immunity | #100 |
| ccp anti | #100 |
| bone degradation | #101 |
| safety drugs | #101 |
| fprs | #101 |
| singlenucleotide polymorphism | #101 |
| eira | #101 |
| diarthrodial | #101 |
| susceptible strain | #101 |
| cell determinants | #101 |
| candidate autoantigen | #102 |
| mouse monoclonal antibodies | #102 |
| findings treatment | #102 |
| brucei infection | #102 |
| eae animal encephalomyelitis | #102 |
| pathogenesis emphysema | #103 |
| hla dr1 | #103 |
| agalactosyl | #103 |
| oxidative burst | #103 |
| drb10401 | #103 |
| ros homeostasis | #103 |
| synchrotron infrared | #104 |
| haplotypes histocompatibility | #104 |
| mhcii | #104 |
| thelper cells | #104 |
| f1 males | #104 |
| mutation mice | #104 |
| male mice mice | #104 |
| skg mice | #104 |
| arthritic disease | #104 |
| nonarthritic | #104 |
| type 22 | #105 |
| dmaam | #105 |
| hybridoma cell | #105 |
| vivo macrophages | #105 |
| fcγr | #105 |
| osteoclasts mice | #105 |
| development antibodies | #105 |
| autoreactivity | #105 |
| tcell immunity | #106 |
| limited cross | #106 |
| proteoglycan loss | #106 |
| primed cells | #106 |
| disease dose | #106 |
| arthritis hla | #106 |
| 273 | #106 |
| c3h mice | #107 |
| cells synovial | #107 |
| nzb mice | #107 |
| development autoimmune disease | #108 |
| littermates | #108 |
| fpr | #108 |
| study tolerance | #108 |
| delayedtype hypersensitivity | #109 |
| reactive cell | #109 |
| monoclonal igg | #109 |
| enthesophytes | #109 |
| presentation cells | #109 |
| autoantibodies autoantigens | #109 |
| citrullinated proteins | #109 |
| structural polymorphism | #109 |
| type hypersensitivity | #109 |
| carcinoma tumors | #110 |
| autoimmune encephalomyelitis | #110 |
| female hypersensitivity | #111 |
| backcross | #111 |
| streptococcal cell wall | #111 |
| experimental female | #111 |
| inbred dba microscopy | #111 |
| toxic shock syndrome | #111 |
| mog eae | #111 |
| cartilage | #111 |
| dba 1j mice | #111 |
| amide bond | #112 |
| anti idiotypic antibodies | #112 |
| humoral autoimmunity | #112 |
| alphabeta receptors antigen | #112 |
| extensive literature search | #112 |
| presymptomatic individuals | #112 |
| mice collageninduced arthritis | #113 |
| tcra | #113 |
| xid mice | #113 |
| restricted cell | #113 |
| db1 | #113 |
| adjuvant properties | #113 |
| trait loci | #113 |
| oligoclonality | #113 |
| autoimmune c57bl mice | #113 |
| adjuvantinduced arthritis | #114 |
| ifngammaproducing cells | #114 |
| rats collagen | #115 |
| anti mcv | #115 |
| drb10402 | #115 |
| proinflammatory cytokine | #115 |
| mice disease | #115 |
| autoantigens autoimmunity | #115 |
| immunosorbents | #116 |
| ccp patients | #116 |
| lutz | #116 |
| lymphocyte female | #116 |
| glyco | #116 |
| experimental epitopes | #116 |
| pathogenesis autoimmune diseases | #116 |
| transgenic peptides receptors | #116 |
| susceptibility eae | #116 |
| glycopeptides | #116 |
| congenic lines | #117 |
| antibodies reactive | #117 |
| fluorescence nf | #117 |
| antiarthritic | #117 |
| encephalomyelitis autoimmune | #117 |
| mice type | #117 |
| tolerance induced | #117 |
| rats immunized | #118 |
| myelin oligodendrocyte | #118 |
| α enolase | #118 |
| class expression | #118 |
| samples individuals | #118 |
| alpha1acid | #118 |
| psoriasiform dermatitis | #118 |
| pineal hormone | #118 |
| 05m | #119 |
| rheumatoid arthritis review | #119 |
| cd4 tcells | #119 |
| radiological damage | #119 |
| response cells | #119 |
| psa rheumatoid arthritis | #119 |
| neutrophils nets | #120 |
| protein mbp | #120 |
| experimental animal models | #121 |
| chondrocyte cultures | #121 |
| vivo animal models | #121 |
| genes age | #122 |
| immune complex deposition | #122 |
| treatment progesterone | #122 |
| pharmacological potential | #122 |
| t‐lymphocyte | #122 |
| acpa negative | #122 |
| transfer arthritis | #122 |
| patients acpa | #122 |
| transgenic neurons receptors | #122 |
| c5b | #123 |
| alphabeta cells | #123 |
| symptoms associations | #123 |
| type cytokines | #123 |
| cell monoclonal | #123 |
| nox2 activation | #123 |
| tlr4 stimulation | #124 |
| inbred mouse | #124 |
| cartilage surface | #124 |
| cryogel | #125 |
| preimmunized | #125 |
| blocking antigens | #125 |
| helperinducer | #125 |
| immunodominant peptide | #125 |
| allelic variations | #125 |
| oxidases neutrophils | #125 |
| qtl genes | #125 |
| genetic rats | #125 |
| disease mechanisms | #125 |
| general mechanisms | #125 |
| cyclic polymorphism | #126 |
| nonobese diabetic | #126 |
| pnipaam | #126 |
| nzb nzw | #126 |
| female immunization | #126 |
| atp8 | #127 |
| animal enzyme | #127 |
| knockout murine | #127 |
| absence cells | #127 |
| microarray detection | #127 |
| chronic inflammatory disease | #128 |
| lining layer | #128 |
| deiminases | #128 |
| dominant epitope | #128 |
| anticitrullinated peptide | #128 |
| bxsb | #129 |
| spleen rats | #129 |
| rats patients | #129 |
| multiple epitopes | #129 |
| oestradiol testosterone | #130 |
| vivo absence | #130 |
| cells eae | #130 |
| psd1 | #130 |
| nos2 | #130 |
| disease induced | #130 |
| lipomannan | #131 |
| epitope specific | #131 |
| onset arthritis | #131 |
| disease cgd | #132 |
| intercross | #132 |
| mineral oils | #132 |
| linomide | #132 |
| induction regulatory cells | #132 |
| pronociceptive | #132 |
| kgf | #132 |
| ggaa | #133 |
| rat chromosome | #133 |
| leukosialin | #133 |
| reduced severity | #133 |
| mice estrogen | #134 |
| knockout receptors antigen | #134 |
| interstitial collagens | #134 |
| species animals | #134 |
| accentuate | #134 |
| patients cytokines | #134 |
| eae | #134 |
| myocellular | #134 |
| plasma synovial fluid | #134 |
| spinal glial | #135 |
| peptides cyclic | #135 |
| igg immune complexes | #135 |
| intracellular reactive | #136 |
| immunizing | #136 |
| chronic autoimmune disease | #136 |
| macrophages dendritic | #136 |
| innate lymphocytes | #137 |
| stimulated muscle | #137 |
| receptor upregulation | #137 |
| immunopathological | #137 |
| ditiocarb | #138 |
| mice deficient | #138 |
| dmannitol | #139 |
| control development | #139 |
| immunomodulatory drug | #139 |
| autoimmune mice | #139 |
| tcrdelta | #140 |
| oligoclonal expansion | #141 |
| thermoresponsive polymer | #141 |
| producing cell | #141 |
| single subcutaneous injection | #142 |
| or113 | #142 |
| interferon‐γ | #142 |
| gamma lymphocyte | #142 |
| rejection tolerance | #142 |
| phadia | #142 |
| smfish | #142 |
| genetic factors development | #142 |
| class haplotypes | #143 |
| cell hybridoma | #143 |
| tcell alphabeta receptors | #143 |
| phosphate isomerase | #143 |
| mice beta | #143 |
| mhc haplotypes | #144 |
| synovial hyperplasia | #144 |
| rheumatoid arthritis | #144 |
| rat strains | #144 |
| syngenic | #145 |
| treatment ici | #145 |
| inbred buf rats | #145 |
| tnf production | #145 |
| tcr gamma delta | #145 |
| lyme arthritis | #145 |
| severe chronic | #145 |
| neonatal growth | #146 |
| rats induced | #146 |
| function cells | #147 |
| pregnancy levels | #147 |
| ccp antibodies | #147 |
| cellular heterogeneity | #147 |
| gammainterferon | #147 |
| systemic challenge | #147 |
| cell surface antigen | #148 |
| redox regulation | #148 |
| interestingly | #148 |
| autoimmune disease | #148 |
| phagocyte nadph oxidase | #148 |
| α2i | #148 |
| human autoimmune diseases | #149 |
| complex diseases | #149 |
| larsen score | #150 |
| mhc binding | #150 |
| drb104 | #150 |
| mice animals | #151 |
| epicutaneously | #151 |
| receptor rats | #151 |
| humans hybridomas | #151 |
| differential gene expression | #151 |
| levels antibodies | #151 |
| alphabeta receptors | #152 |
| mononuclear cells | #153 |
| levels pregnancy | #153 |
| pepsin | #153 |
| key player | #153 |
| arthritic animals | #153 |
| joint inflammation | #154 |
| fcgammar | #154 |
| selfpeptides | #154 |
| critical event | #154 |
| expression class | #154 |
| male rats rats | #154 |
| daf1 | #154 |
| c4bbinding protein | #154 |
| immune priming | #154 |
| arthritis rheumatoid | #155 |
| autoantibodies autoimmune | #155 |
| mace acs | #155 |
| serum synovial fluid | #155 |
| padi4 | #155 |
| infiltrating cells | #155 |
| f1 mice | #155 |
| mhc region | #156 |
| suppressive role | #156 |
| stabilin1 | #156 |
| specificities | #156 |
| downstream signals | #157 |
| murine keratinocytes | #157 |
| adjuvanticity | #157 |
| hypersensitivity reaction | #158 |
| parentals | #158 |
| genetic diabetes mellitus | #158 |
| analysis structure | #158 |
| inbred c3h mice | #159 |
| arthritis infectious | #159 |
| meaib | #159 |
| systemic mice mice | #159 |
| consensus motif | #159 |
| animals autoimmunity | #159 |
| benzylated | #161 |
| specific autoimmunity | #161 |
| knockout severity | #161 |
| day onset | #161 |
| factors anti | #161 |
| gamma interferon | #161 |
| nursed | #161 |
| rheumatoid autoantigens | #162 |
| psors1 | #162 |
| epitope | #162 |
| binding collagen | #162 |
| anti ccp | #162 |
| cd152 | #162 |
| arthritis inflammation | #162 |
| βarrestin recruitment | #162 |
| chains humans | #163 |
| laboratory rats | #163 |
| mouse type | #163 |
| onset disease | #163 |
| rats induction | #164 |
| endobetanacetylglucosaminidase | #164 |
| striking similarities | #164 |
| autoantibody responses | #164 |
| progesterone effects | #164 |
| genes qtl | #164 |
| mrl | #164 |
| agalactosyl igg | #164 |
| cells macrophages | #165 |
| animal humans immunity | #165 |
| tolerance induction | #166 |
| nonimmunized | #166 |
| melatonin mice mice | #166 |
| pathogenic pathways | #166 |
| epitope alleles | #166 |
| seronegative | #167 |
| tlymphocyte humans | #167 |
| nox2 | #167 |
| human autoimmunity | #167 |
| ag7 | #167 |
| class mice | #167 |
| genetic backgrounds | #168 |
| mice cd4 cells | #168 |
| phase disease | #168 |
| cd1 | #168 |
| p12 | #169 |
| denoted | #169 |
| acpa levels | #169 |
| oxazole | #169 |
| experimental animal | #170 |
| mirp | #170 |
| pathogenesis arthritis | #170 |
| lymph node cells | #170 |
| joints male | #170 |
| inherited disorder | #170 |
| cryogels | #170 |
| encephalomyelitis eae | #171 |
| oxazolone | #171 |
| ros nitric oxide | #171 |
| lst1 | #172 |
| single nucleotide polymorphism | #172 |
| peripheral lymphoid organs | #172 |
| rheumatoid | #172 |
| rat placenta | #172 |
| autoimmune eae | #172 |
| autoimmunity cell | #172 |
| inbred dba models | #173 |
| monoclonal autoantibodies | #173 |
| sod3 | #173 |
| studies pain | #174 |
| class gene | #174 |
| resistant rats | #174 |
| presence autoantibodies | #174 |
| nasal cartilage | #174 |
| maternal decidua | #175 |
| ifn signature | #175 |
| mice mutation | #175 |
| understanding pathogenesis | #175 |
| strains molecular | #176 |
| new mouse model | #176 |
| secondary challenge | #176 |
| mammalian crosses | #176 |
| tryptophan catabolism | #176 |
| skin disease | #176 |
| moab | #176 |
| lymphotoxinα | #177 |
| histocompatibility | #178 |
| ctla‐4 | #178 |
| hladrb1 alleles | #178 |
| alternative pathway complement | #179 |
| protein anti | #179 |
| dextran sulphate sodium | #179 |
| immunized | #179 |
| nod genes | #179 |
| mice role | #179 |
| arthritis methods | #180 |
| cgd patients | #180 |
| complex disease | #180 |
| epitopes female | #180 |
| autoimmunity disease | #181 |
| alleles arthritis | #181 |
| molecular adaptations | #181 |
| genetic influence | #181 |
| arginine deiminases | #182 |
| hormone melatonin | #182 |
| immunoglobulin mice mice | #185 |
| multistep process | #186 |
| antigen processing presentation | #186 |
| rats reactive | #186 |
| cells lymph nodes | #186 |
| b10 | #187 |
| drb1 chains | #187 |
| tcell recognition | #187 |
| dba | #187 |
| molecular peptide | #188 |
| substrains | #188 |
| chondritis | #188 |
| cells disease | #189 |
| mtec | #189 |
| hnrnpa2b1 | #190 |
| inflamed joint | #190 |
| synovial membranes | #190 |
| positionally | #190 |
| oligodendrocyte glycoprotein | #191 |
| autoantibody profiles | #192 |
| cross‐reactivity | #192 |
| ly1 | #192 |
| fmlf | #193 |
| passive mice mice | #193 |
| proteins myelin | #194 |
| cyclic predictive | #194 |
| glycoprotein peptide | #194 |
| mice mutant | #195 |
| chapter 16 | #195 |
| perpetuate | #195 |
| mhv | #195 |
| lewis rat | #196 |
| mhc class expression | #196 |
| myelin glycoprotein | #196 |
| tcell response | #196 |
| oophorectomized | #196 |
| evidence development | #197 |
| pannus | #197 |
| acutephase response | #197 |
| multiplex assay | #197 |
| swedish patients | #198 |
| igmrf | #198 |
| genetic links | #198 |
| early appearance | #198 |
| dr4 antigen | #199 |
| interleukin17 | #199 |
| rat genome | #199 |
| hla association | #200 |
| cell collagen | #200 |
| citrullinated peptide | #200 |
| pathogenesis autoimmune | #201 |
| acpa status | #202 |
| instigation | #202 |
| myelin proteolipid protein | #202 |
| myelin proteins myelin | #202 |
| dendritic cells macrophages | #202 |
| complete elimination | #203 |
| mice cells | #203 |
| 2 complex | #204 |
| immunization immunoglobulin | #204 |
| class molecules | #204 |
| spleen staining | #204 |
| ides | #205 |
| dth response | #205 |
| nonparametric tlymphocytes | #205 |
| macrophages mice | #205 |
| native collagen | #205 |
| suppresses | #205 |
| betaestradiol | #206 |
| wild rats | #206 |
| defb4 | #206 |
| induced upregulation | #207 |
| noxs | #207 |
| parental strains | #207 |
| insulitis diabetes | #207 |
| alternative complement pathway | #207 |
| mice peptide | #207 |
| desmoglein 3 | #207 |
| intranasal challenge | #207 |
| interleukin4 mice mice | #207 |
| vivo patients | #208 |
| severity disease | #208 |
| immunization mice | #208 |
| highest probability | #208 |
| antigen presenting | #208 |
| naive mice | #208 |
| immunoglobulin vh | #209 |
| cotwins | #209 |
| disease rheumatoid | #209 |
| susceptible strains | #210 |
| valuable tools | #210 |
| specific antibodies | #210 |
| highfatdiet | #210 |
| vav1 | #210 |
| citrullinated vimentin | #210 |
| diseases genetic | #211 |
| hla dr4 | #211 |
| natural antibodies | #211 |
| glucose6 phosphate | #211 |
| purified protein derivative | #211 |
| cells immobilized | #212 |
| large numbers | #212 |
| association rheumatoid arthritis | #212 |
| mice injected | #213 |
| antibody binding | #213 |
| psoriasiform | #213 |
| tsst1 | #214 |
| central tolerance | #215 |
| mhc class antigens | #215 |
| inbred rat | #215 |
| cytofluorometric | #215 |
| antigen induced | #215 |
| triethylsilane | #215 |
| dissect | #216 |
| lower level | #216 |
| training hiit | #216 |
| cd23 | #217 |
| induced autoimmune | #217 |
| inflammatory infiltrates | #217 |
| resistant strain | #217 |
| lentiviral vector | #217 |
| rats immunization | #217 |
| joints mice | #217 |
| antigen tcell | #218 |
| treatment onset | #218 |
| k8 | #219 |
| granuloma formation | #219 |
| autoimmunity | #219 |
| peptide antibodies | #219 |
| fcrγ | #219 |
| cells autoimmune | #220 |
| hyl | #220 |
| bone erosions | #220 |
| peptidylarginine deiminases | #220 |
| redox signaling | #221 |
| cyclosporin treatment | #221 |
| cells dendritic | #221 |
| fine specificity | #221 |
| agouti rats | #221 |
| targeted deletion | #221 |
| rheumatoid factor | #221 |
| pinealectomy | #221 |
| thymectomized | #222 |
| cybb | #222 |
| monoclonal antigens differentiation | #222 |
| wkymvm | #222 |
| cartilage damage | #222 |
| igg2a | #223 |
| multiplex | #223 |
| experimental autoimmune neuritis | #223 |
| carbamylated | #223 |
| expressing | #224 |
| inflammation vivo | #224 |
| clinical scoring | #225 |
| interleukin‐10 | #225 |
| cells antigen | #225 |
| lew | #225 |
| established disease | #225 |
| disease locus | #226 |
| pathogenic antibodies | #226 |
| j1 | #227 |
| macrophagelike cells | #227 |
| delayed type hypersensitivity | #228 |
| presenting cells | #228 |
| arthritis objective | #228 |
| cell selection | #229 |
| presence anti | #229 |
| site inflammation | #230 |
| eae rats | #230 |
| ls1 | #231 |
| human rheumatoid | #231 |
| reactive oxygen | #232 |
| monoclonal immunohistochemistry | #232 |
| lack expression | #233 |
| ameliorated | #233 |
| synovial joints | #233 |
| role eosinophils | #233 |
| production ros | #233 |
| lower numbers | #234 |
| centimorgan | #234 |
| mhc gene | #235 |
| staphylococcal infection | #235 |
| chromosome 14 | #235 |
| chronic psychosocial stress | #235 |
| immune complex | #236 |
| specificity animals | #236 |
| pathological mechanisms | #237 |
| control strain | #237 |
| progression arthritis | #238 |
| autoimmune chronic | #238 |
| c5 | #239 |
| trait locus | #239 |
| inbred dba tlymphocytes | #240 |
| study plasma | #241 |
| strong influence | #242 |
| joint pain | #242 |
| positive anti | #243 |
| protected | #243 |
| class genetic | #243 |
| monoclonal antigen | #243 |
| multicomponent | #243 |
| hla drb1 | #243 |
| cutaneous infection | #244 |
| common denominator | #244 |
| estrus cycle | #244 |
| treatment autoimmune | #244 |
| crosses | #244 |
| inflammation cartilage | #244 |
| binding antibodies | #245 |
| allelic differences | #246 |
| development emphysema | #246 |
| rt1l | #246 |
| antibody response | #247 |
| normal cartilage | #247 |
| antibodies anti | #247 |
| florescence | #247 |
| new model | #247 |
| inbred strain | #247 |
| efficient expression | #248 |
| activity assays | #248 |
| induced chronic | #249 |
| oxygen species | #249 |
| picryl | #250 |
| inflammation score | #250 |
| node cells | #250 |
| arthritic joints | #250 |
| mouse rat | #250 |
| fragments rats | #250 |
| hyperinflammation | #251 |
| develops | #251 |
| treatment rats | #251 |
| conditional knockout mice | #251 |
| nadph oxidase | #251 |
| mice lymphocytes | #252 |
| mice lack | #252 |
| role model | #252 |
| response disease | #252 |
| dark agouti | #252 |
| lacking | #254 |
| dinitrofluorobenzene | #254 |
| cartilage matrix | #254 |
| onset clinical | #254 |
| proteins glycoproteins | #254 |
| lpr mice | #254 |
| class mhc | #254 |
| inbred c3h | #255 |
| autoimmune response | #255 |
| specific subgroups | #256 |
| inflammatory disorder | #256 |
| anti arthritic | #256 |
| postmenopausal bone | #256 |
| specific neutralizing | #256 |
| disease cell | #257 |
| additive interaction | #258 |
| class mhc molecules | #259 |
| relationship immunologic | #260 |
| chronic granulomatous | #260 |
| mir144 | #260 |
| autoimmune neuritis | #261 |
| denatured | #261 |
| lymphocytes helper | #261 |
| secondary osteoporosis | #261 |
| mice expressing | #261 |
| mediated suppression | #261 |
| immunologic animals | #262 |
| selfantigen | #263 |
| tolerance mice | #265 |
| crossreactive | #265 |
| primary immunization | #265 |
| pregnancy mice | #265 |
| genetic techniques | #265 |
| mouse strain | #265 |
| cysteine proteases | #267 |
| vim2 | #267 |
| antigen specific | #267 |
| rats animals | #267 |
| posttranslational modifications | #268 |
| xid | #268 |
| lentiviral gene | #268 |
| mann whitney | #269 |
| pathogenic roles | #269 |
| complement c5 | #270 |
| oxpl | #270 |
| melatonin effects | #271 |
| monosodium urate crystals | #271 |
| selfantigens | #271 |
| castrated | #271 |
| amino acid transporters | #273 |
| experimental model | #273 |
| lewis rats | #274 |
| synovial lining | #275 |
| inhibitory peptide | #275 |
| hdac1 | #275 |
| nasally | #275 |
| tcells | #275 |
| macrophages dendritic cells | #276 |
| fcgr3b | #276 |
| producing cells | #277 |
| rheumatoid arthritis association | #277 |
| deiminase type | #277 |
| viral female hepatitis | #277 |
| recognize | #278 |
| metabolic properties | #278 |
| colon length | #279 |
| gp70 | #279 |
| interferongamma | #279 |
| induced tolerance | #280 |
| dinucleotide phosphate | #280 |
| recipient mice | #281 |
| neonatal mice | #281 |
| immunological receptors antigen | #281 |
| passive transfer | #281 |
| inflammatory conditions | #281 |
| hemiacetal | #282 |
| inbred nod | #283 |
| disease susceptibility | #283 |
| factor production | #283 |
| isoflavone genistein | #283 |
| igg2b | #283 |
| helper inducer | #284 |
| aire | #284 |
| severe colitis | #284 |
| increased serum levels | #284 |
| idiotope | #285 |
| publication animals antibodies | #285 |
| aureus strain | #285 |
| theilovirus | #285 |
| complete protection | #285 |
| maintained | #285 |
| endophilin | #285 |
| emulsified | #286 |
| hla dr2 | #287 |
| myelin basic protein | #288 |
| antibody production | #288 |
| tlr9 mice | #288 |
| melatonin release | #288 |
| melatonin mice | #288 |
| cells autoimmunity | #289 |
| mice immunized | #289 |
| synovial cells | #291 |
| disease cells | #291 |
| ctla4 expression | #291 |
| autoimmune mechanisms | #292 |
| rheumatic conditions | #292 |
| collagen receptors | #293 |
| induced ros | #293 |
| increased copy | #293 |
| cytokines disease | #293 |
| mouse genes | #294 |
| unique model | #294 |
| c57bl 6 mice | #295 |
| antigen processing | #295 |
| gastric parietal | #295 |
| c3h | #295 |
| immunological receptors | #296 |
| tissue‐specific | #296 |
| 6week | #296 |
| nerve conduction | #296 |
| phosphopyruvate | #297 |
| murine dendritic cells | #297 |
| dnfb | #297 |
| helical peptides | #297 |
| cd19 cells | #298 |
| gene selection | #298 |
| vivo imaging | #298 |
| ppad | #298 |
| solidphase synthesis | #299 |
| citrullination | #299 |
| transplantation antigens | #299 |
| tcr beta | #300 |
| neutrophil extracellular traps | #301 |
| posttranslational rats | #301 |
| peptide antibody | #302 |
| draining lymph | #302 |
| alphabeta | #302 |
| extraembryonic tissues | #302 |
| pathogeneses | #303 |
| strains mice | #303 |
| animals antibodies | #303 |
| 1 interferon | #303 |
| epidemiological investigation | #303 |
| igg glycosylation | #304 |
| conditioned disease models | #304 |
| autoimmune diseases | #304 |
| cgd | #304 |
| mutant strains mice | #305 |
| immunological function | #305 |
| cells tcr | #305 |
| cartilage development | #305 |
| gammaifn | #306 |
| murine colitis | #306 |
| immunological studies | #306 |
| hcdr3 | #306 |
| αgalcer | #306 |
| inpp4b | #307 |
| class histocompatibility | #307 |
| immunisation | #307 |
| basal metabolic rate | #308 |
| chromosome 10 | #309 |
| basal metabolic | #309 |
| arthritis study | #310 |
| articular cattle cells | #310 |
| perpetuation | #311 |
| multiple sclerosis eae | #311 |
| inflamed joints | #312 |
| alleles animals | #312 |
| disease symptoms | #312 |
| synthetic peptide | #312 |
| c3bi | #313 |
| exuberant | #313 |
| epitopes | #313 |
| activatory | #314 |
| induced colitis | #314 |
| r620w | #315 |
| intradermally | #315 |
| mice genes | #315 |
| trypanosoma brucei brucei | #316 |
| onset rheumatoid | #318 |
| classical risk factors | #318 |
| genetic interactions | #319 |
| tubule cells | #319 |
| galactosyl | #319 |
| mice subjected | #320 |
| deiminase | #320 |
| genomewide linkage analysis | #320 |
| spleen bone marrow | #320 |
| cells specific | #323 |
| il21r | #323 |
| daf2 | #324 |
| expressing human | #324 |
| impact disease | #324 |
| ccp1 | #324 |
| expression cells | #325 |
| rat gene | #325 |
| specific cell | #325 |
| surprisingly | #326 |
| mgps | #327 |
| resembles | #327 |
| allelic variant | #328 |
| c57bl mice | #328 |
| immunoenzyme | #329 |
| publication adjuvants | #329 |
| constant light | #329 |
| complex genes | #330 |
| early arthritis | #331 |
| fcgammariia | #332 |
| nucleotide polymorphism | #332 |
| rheumatoid synovial | #332 |
| glycoprotein mog | #332 |
| mouse hepatitis virus | #333 |
| anticcp | #333 |
| 35ssulfate | #334 |
| susceptibility genes | #335 |
| mrl lpr mice | #335 |
| joint tissues | #335 |
| autoimmune inflammation | #336 |
| cell response | #338 |
| cells spleen | #340 |
| epitope specificity | #340 |
| delayed onset | #340 |
| adjuvants immunologic | #341 |
| activation macrophages | #341 |
| rat | #341 |
| ros oxygen species | #341 |
| erosive | #341 |
| specific autoimmune | #342 |
| incident cardiovascular events | #342 |
| 6weeks | #342 |
| animal enzyme inhibitors | #342 |
| rapid spread | #343 |
| rats injection | #343 |
| diabetic mouse | #343 |
| sequence animals | #343 |
| drb1 alleles | #343 |
| monoclonals | #344 |
| 182780 | #344 |
| favor | #345 |
| acpa positivity | #345 |
| energetic costs | #346 |
| intraperitoneal injection | #347 |
| pemphigus vulgaris pv | #348 |
| neuritis | #349 |
| complement activity | #349 |
| reduced capacity | #349 |
| igg autoantibodies | #350 |
| phenotype rats | #351 |
| methylcholanthrene | #352 |
| thymic selection | #352 |
| c3h hej | #353 |
| mice induction | #353 |
| immunoregulation | #353 |
| anti cyclic | #353 |
| mice cd4 | #354 |
| arthritis synovial | #354 |
| autoantigens autoimmune | #354 |
| splenic macrophages | #355 |
| dsg3 | #357 |
| tbetarii | #358 |
| adjuvant activity | #358 |
| cells autoantibodies | #358 |
| enos | #359 |
| neuritogenic | #359 |
| injected | #359 |
| tcrbeta | #360 |
| freund | #361 |
| pvg | #361 |
| tlr3 | #361 |
| hla transgenic | #362 |
| murine lupus | #362 |
| generation ros | #363 |
| allergic encephalomyelitis | #363 |
| determines | #363 |
| mouse chromosome | #363 |
| identification genes | #363 |
| hladr4 | #364 |
| cells anti | #364 |
| recognized | #364 |
| immune deviation | #366 |
| glycoproteins mice | #366 |
| sex chromosomes | #366 |
| european journal | #366 |
| psychosocial stress | #367 |
| antiidiotypic antibodies | #367 |
| 100 micrograms | #368 |
| toxic shock | #368 |
| autoimmune responses | #368 |
| loci | #368 |
| ncf2 | #368 |
| affinity ligand | #368 |
| nasal administration | #369 |
| histocompatibility antigens | #369 |
| pentameric | #369 |
| immune pathogenesis | #370 |
| increased production | #370 |
| regulate | #371 |
| clinical onset | #371 |
| serum transfer | #371 |
| role mif | #372 |
| newborn antibodies | #372 |
| alternative activation | #373 |
| rheumatoid cell | #375 |
| autoantigens | #375 |
| acutephase proteins | #376 |
| undifferentiated arthritis | #376 |
| glucose6 | #377 |
| gia | #379 |
| reparixin | #380 |
| mouse monoclonal antibody | #381 |
| induced lupus | #381 |
| oxidase deficiency | #381 |
| fia | #382 |
| fragments immunoglobulin | #382 |
| granulomatous | #383 |
| c1a | #384 |
| granulomatous disease | #384 |
| naive rats | #384 |
| specific loci | #384 |
| postmenopausal bone loss | #385 |
| shock syndrome | #385 |
| cell specificity | #386 |
| pc4 | #386 |
| backcrosses | #387 |
| antioxid | #387 |
| filaggrin | #387 |
| ptpn22 gene | #387 |
| phase response | #388 |
| inbred nod receptors | #388 |
| downregulating | #389 |
| greater 50 | #390 |
| ovulation rate | #390 |
| deficient | #390 |
| peptidylarginine | #391 |
| radiological progression | #391 |
| anaphylatoxin c5a | #391 |
| finetune | #392 |
| rf1 | #394 |
| il4 il10 | #394 |
| ameliorating | #395 |
| autoantibody levels | #397 |
| draining | #397 |
| induced metabolic | #397 |
| juvenile chronic arthritis | #398 |
| protein myelin | #399 |
| regulation animals | #399 |
| immunized mice | #399 |
| reactive oxygen species | #400 |
| inflammatory reactions | #400 |
| genes cells | #401 |
| antibody formation | #401 |
| biacore | #403 |
| inflammation demyelination | #403 |
| immunopeptidome | #403 |
| beta chain | #404 |
| fcγriib | #404 |
| experimental | #405 |
| basic protein | #405 |
| n31 | #407 |
| rheumatoid case | #407 |
| effects models | #407 |
| pam3csk4 | #408 |
| immunogenetics | #409 |
| major locus | #409 |
| intracellular processing | #410 |
| 3hproline | #410 |
| diabetes loci | #410 |
| cd43 | #412 |
| hladrb1 | #412 |
| cell phenotypes | #412 |
| titres | #413 |
| susceptibility loci | #413 |
| characteristic feature | #414 |
| reproductive performance | #414 |
| cultured collagen | #415 |
| igk | #415 |
| female mice | #416 |
| levels autoantibodies | #416 |
| lupus mice | #417 |
| synovial inflammation | #417 |
| spontaneous mutation | #417 |
| genetically modified mice | #418 |
| molecular interactions | #419 |
| wtccc | #419 |
| class hdacs | #419 |
| induced pain | #419 |
| ameliorate | #420 |
| hiit | #420 |
| tcell | #421 |
| dr4 | #422 |
| lower affinity | #422 |
| lipidomic | #423 |
| restricted | #424 |
| subsets animals | #424 |
| hyaline cartilage | #425 |
| inflammatory cells | #426 |
| congenic strain | #426 |
| regulatory animals | #426 |
| carbohydrate moiety | #429 |
| postimmunization | #430 |
| epitopes humans | #430 |
| nod mouse | #430 |
| nonimmunogenic | #430 |
| immunoregulatory | #431 |
| patients healthy individuals | #433 |
| il10 mice | #433 |
| cells antibodies | #434 |
| factor 5 | #435 |
| spontaneous autoimmune | #435 |
| reactivities | #436 |
| cells beta | #436 |
| mass spectrometric analysis | #437 |
| crystallizable | #437 |
| chromosomes chromosome | #437 |
| decalcified | #437 |
| specific antigens | #438 |
| immunised | #438 |
| helperinducer tlymphocytes | #438 |
| mice effects | #438 |
| cells | #439 |
| joint swelling | #439 |
| wildtype mice | #440 |
| nod | #440 |
| normal rats rats | #441 |
| female immunoglobulin | #441 |
| vitro techniques leukocytes | #441 |
| effector functions | #441 |
| patients population | #442 |
| complete adjuvant | #442 |
| mice activation | #442 |
| methylβcyclodextrin | #443 |
| mhc class molecules | #443 |
| tlr2 expression | #444 |
| myelin basic | #444 |
| genomewide scan | #445 |
| systemic mice | #445 |
| skeletal muscle function | #445 |
| mice humans | #445 |
| mouse models | #445 |
| ros production | #447 |
| induced mice | #448 |
| inbred strains receptors | #448 |
| control mice | #448 |
| pain model | #448 |
| synovial tissue | #449 |
| complement factor | #449 |
| tcell responses | #449 |
| innate adaptive | #450 |
| apcs | #451 |
| igg anti | #451 |
| reduced production | #452 |
| heterologous | #452 |
| hybridoma cells | #452 |
| differs | #454 |
| lglutamine | #456 |
| cells chronic | #456 |
| inbred c57bl tlymphocytes | #457 |
| raloxifene | #457 |
| priming | #459 |
| lung macrophages | #459 |
| eae cns | #459 |
| rheumatoid cells | #459 |
| resembling | #459 |
| antibodies monoclonal | #460 |
| 256 | #462 |
| autoantigen | #462 |
| neutrophil functions | #462 |
| gilt | #463 |
| fab fragments | #464 |
| autoantibody production | #465 |
| receptor tcr | #466 |
| salivary glands | #466 |
| cells lymph | #467 |
| titers | #469 |
| earlier onset | #469 |
| antibody mediated | #474 |
| arthritic rats | #474 |
| disease mice | #474 |
| anticyclic citrullinated peptide | #474 |
| cartilage cells | #475 |
| human autoimmune | #476 |
| mice exhibited | #477 |
| cluster genes | #477 |
| therapeutic vaccination | #478 |
| mediated inflammation | #478 |
| laboratory rat | #479 |
| female hla | #479 |
| apoptosis arthritis | #479 |
| aggravated | #480 |
| quantitative trait loci | #480 |
| deacetylase 1 | #480 |
| anti idiotypic | #482 |
| polymorphonuclear cells | #482 |
| immune reactions | #484 |
| immunologists | #485 |
| immunoglobulin male | #486 |
| controlling | #487 |
| oxyntic | #487 |
| tcralpha | #487 |
| jca | #487 |
| insulitis | #488 |
| invariant natural | #488 |
| specific immune | #488 |
| gland animals | #489 |
| normal mice | #490 |
| cytoplasmic calcium | #494 |
| nacetylglucosaminidase | #495 |
| reactive nitrogen | #496 |
| h2b | #496 |
| gammadelta cells | #496 |
| early rheumatoid | #496 |
| conclude | #496 |
| small effects | #498 |
| mbp | #498 |
| receptor 9 | #499 |
| biologicals | #500 |
| immunoenzyme techniques | #503 |
| autoreactive cd4 | #503 |
| nadph | #503 |
| pathogenic | #506 |
| immunofluorescence analysis | #507 |
| chondrocytes collagen | #507 |
| mineral oil | #508 |
| persistent pain | #508 |
| mab mabs | #508 |
| isopropyl | #508 |
| immunization passive | #509 |
| orosomucoid | #509 |
| gingipain | #509 |
| mhc class | #510 |
| mice knockout mice | #510 |
| differential gene | #511 |
| deficient mice | #511 |
| systemic spread | #511 |
| 812 | #511 |
| c3h hej mice | #511 |
| blymphocytes | #512 |
| mrp8 | #515 |
| hydroxyquinolines | #517 |
| behavioral alterations | #517 |
| antibody complex | #518 |
| u1 | #518 |
| chronic granulomatous disease | #519 |
| suggestive linkage | #519 |
| inflammation | #519 |
| tcr recognition | #520 |
| modified form | #521 |
| pcorr | #522 |
| dextran sulfate sodium | #522 |
| ttg | #522 |
| inflammation role | #523 |
| data peptide | #523 |
| litter size | #524 |
| p47phox | #524 |
| encephalitogenic | #524 |
| neutrophil granulocytes | #525 |
| mnc | #526 |
| mechanical hypersensitivity | #526 |
| tconv | #526 |
| maternal antibodies | #527 |
| spleen cells | #527 |
| disease acute | #527 |
| tolonium | #528 |
| vaccinates | #528 |
| primed | #528 |
| larsen | #528 |
| tolllike receptor tlr4 | #529 |
| displayed | #529 |
| ifa | #529 |
| rat rats | #529 |
| cell antibodies | #530 |
| isac | #530 |
| antigen presentation | #530 |
| pathogenesis sle | #530 |
| autoantibody | #530 |
| ratg | #531 |
| bred | #532 |
| epistatic | #532 |
| lyt2 | #533 |
| complex role | #533 |
| posttranslational receptors | #534 |
| translational modification | #536 |
| resorptions | #536 |
| spleen lymphocytes | #536 |
| urokinase | #537 |
| synovial | #537 |
| cells inflammatory | #538 |
| animals | #538 |
| experimental rats | #538 |
| fibroblast synoviocytes | #540 |
| joints | #540 |
| antigen recognition | #540 |
| suppressive | #540 |
| membrane attack complex | #541 |
| rheumatoid humans | #543 |
| specific autoantibodies | #544 |
| regulating | #545 |
| protein tyrosine phosphatase | #545 |
| hypomorphic | #546 |
| tlymphocytes | #547 |
| animal gene | #547 |
| shortcut | #547 |
| immunohistochemical methods | #548 |
| formyl peptide receptors | #548 |
| entheses | #548 |
| mog | #550 |
| immunoglobulin fab | #552 |
| mixed lymphocyte reaction | #553 |
| nox activity | #554 |
| breeder | #555 |
| stronger association | #557 |
| cell epitopes | #557 |
| beta animals | #557 |
| cells control | #558 |
| early onset | #559 |
| healthy mice | #560 |
| elispot assay | #561 |
| transgenic molecular | #562 |
| ptdins3p | #563 |
| inbred strains | #563 |
| negative selection | #563 |
| neutrophil depletion | #564 |
| therapeutic treatment | #565 |
| deeper layers | #565 |
| darkness | #566 |
| earlier | #566 |
| immunoglobulin heavy chains | #566 |
| target tissue | #566 |
| crucial | #567 |
| outbred | #568 |
| disease loci | #568 |
| interferon signature | #568 |
| cells pathogenesis | #569 |
| mycobacteria | #569 |
| neutrophilia | #569 |
| concomitantly | #570 |
| mice compared | #571 |
| btla | #572 |
| transgenic mouse models | #572 |
| keratin8 | #573 |
| col2 | #574 |
| presenting | #576 |
| pepstatins | #576 |
| terpenes | #577 |
| estrogen treatment | #577 |
| prolactin prl | #578 |
| keratinocyte growth factor | #578 |
| ptm | #579 |
| sera patients | #579 |
| triple helix | #580 |
| methotrexate mice | #581 |
| f1 hybrids | #581 |
| production ifngamma | #583 |
| inflammatory joint | #583 |
| hybridoma | #583 |
| exaggerated | #584 |
| time onset | #584 |
| lymphocyte antigens | #584 |
| antibody reactions | #585 |
| traps nets | #590 |
| environmental triggers | #591 |
| antigen antibody | #591 |
| immunological tolerance | #592 |
| oligoclonal | #592 |
| lxrα | #592 |
| transgenic models | #593 |
| noncollagenous | #593 |
| macrophages | #594 |
| adaptive immunity | #594 |
| autoimmune disorders | #594 |
| clonal expansion | #595 |
| multiplexing | #595 |
| th1 cytokines | #595 |
| xanthine oxidoreductase | #596 |
| tcell activation | #599 |
| cells study | #599 |
| develop | #600 |
| spite | #602 |
| n85 | #602 |
| th2 cytokines | #602 |
| augmented | #602 |
| pemphigus vulgaris | #603 |
| common diseases | #603 |
| mouse monoclonal | #603 |
| cells male | #604 |
| phagosomal | #604 |
| cells involved | #604 |
| animal rats | #606 |
| oxa | #606 |
| mice inbred | #606 |
| class humans | #607 |
| genotype hla | #608 |
| frozen sections | #608 |
| spleen animals | #609 |
| inefficiently | #610 |
| regulatory role | #610 |
| production ifn | #611 |
| naive | #611 |
| positive individuals | #612 |
| quantitative trait locus | #615 |
| mutant strains receptors | #616 |
| idiotypic | #616 |
| autoantibodies | #616 |
| th1 type | #616 |
| class antigens | #616 |
| acetophenones | #616 |
| exponential phase | #616 |
| alpha chains | #616 |
| nonobese | #617 |
| oral immunization | #617 |
| beta type | #618 |
| day mice | #619 |
| promiscuous | #620 |
| wistar restraint | #620 |
| consequent | #621 |
| receptor 3 | #621 |
| inflammatory role | #621 |
| nicotinamide adenine | #622 |
| receptors antigen | #624 |
| fluorine18 | #624 |
| chronic stage | #625 |
| loci identified | #625 |
| animal mice | #628 |
| cytoplasmic ca2 | #628 |
| local injection | #629 |
| cross reactions | #630 |
| inflammatory disease | #630 |
| reactive antibodies | #632 |
| healthy rats | #632 |
| development eae | #633 |
| fibromodulin | #634 |
| highintensity interval training | #634 |
| langerhans cells | #635 |
| vivo binding | #635 |
| nabs | #637 |
| ifn beta | #637 |
| class genes | #638 |
| cells inhibition | #638 |
| inflammation autoimmunity | #640 |
| estrogens female | #640 |
| biotinylated | #643 |
| mouse lung | #644 |
| cell binding | #645 |
| immune serum | #646 |
| haplotype | #649 |
| antigen specificity | #650 |
| patients sera | #650 |
| genetic disease | #652 |
| hexadecane | #654 |
| idiotypic antibodies | #654 |
| antibody titres | #655 |
| interphalangeal | #655 |
| new pathway | #658 |
| genetic linkage | #658 |
| axotomized | #659 |
| cyba | #660 |
| sialoprotein | #660 |
| inbred cba mice | #661 |
| acute inflammation | #661 |
| peptide binding | #661 |
| mutated | #662 |
| cartilage destruction | #663 |
| ifng | #664 |
| delayed hypersensitivity | #665 |
| animal ear | #665 |
| receptors igg | #666 |
| lymphoid organs | #666 |
| 264 | #666 |
| superantigens | #666 |
| reactive | #666 |
| activation mice | #669 |
| apeced | #670 |
| drb1 | #670 |
| disease autoimmune | #671 |
| purified proteins | #673 |
| cells induce | #674 |
| treatment protocol | #674 |
| desmoglein | #675 |
| pyramidal neurons | #675 |
| genetic epistasis | #675 |
| strikingly | #676 |
| adherent cells | #677 |
| idiotypes | #677 |
| germinal center | #677 |
| china cohort | #678 |
| il12p70 | #679 |
| major genes | #679 |
| igg response | #679 |
| thelper | #680 |
| lymphocytes mice | #682 |
| cells role | #682 |
| normal animals | #683 |
| inbred c57bl mice | #683 |
| puzzle | #683 |
| specific antibody | #684 |
| helper cell | #684 |
| intradermal injection | #686 |
| transgenic receptors | #687 |
| βarrestin | #688 |
| delayed | #689 |
| foot joints | #689 |
| subsets | #689 |
| early rheumatoid arthritis | #690 |
| rendered | #690 |
| production autoantibodies | #691 |
| disease genes | #692 |
| knockout polymorphism | #695 |
| muscle glucose | #695 |
| igg antibodies | #696 |
| paam | #696 |
| anas | #697 |
| luminex | #697 |
| mice model | #698 |
| disease hla | #698 |
| uterus | #700 |
| heavy chain genes | #701 |
| microspectroscopy | #703 |
| inbred | #704 |
| quantitative trait | #704 |
| complete freund | #706 |
| fibroblastlike synoviocytes | #707 |
| histopathological analysis | #707 |
| extracellular trap | #708 |
| specific cells | #710 |
| estradiol female | #710 |
| igl | #712 |
| posttranslational | #713 |
| predetermined | #716 |
| spleens | #716 |
| mice lacking | #717 |
| antibodies patients | #718 |
| acute bout | #718 |
| lymphocyte depletion | #719 |
| proliferative response | #720 |
| regulatory function | #720 |
| buf | #721 |
| deficiency syndromes | #721 |
| surrounding tissues | #722 |
| th1 th17 | #723 |
| macrophages mice mice | #725 |
| human hand | #725 |
| cd1d | #728 |
| dmaema | #728 |
| mhc molecules | #729 |
| ccps | #729 |
| th2 cytokine | #729 |
| cdk6 | #730 |
| cholesterol metabolism | #732 |
| administrated | #732 |
| animals antigens antigens | #732 |
| cns inflammation | #732 |
| excessive inflammation | #734 |
| finding | #735 |
| rats treatment | #736 |
| net formation | #736 |
| locus | #737 |
| cheeks | #739 |
| operates | #740 |
| c57bl | #740 |
| cd5 cells | #741 |
| species specificity | #741 |
| nkt | #742 |
| tissue destruction | #742 |
| cell responses | #743 |
| vivo mice | #743 |
| immunologic deficiency | #743 |
| treatment anti | #744 |
| role disease | #746 |
| mycobacterial infections | #747 |
| keratinocyte | #749 |
| nonobese diabetic mice | #749 |
| autoantibodies autoimmunity | #749 |
| intensity interval | #749 |
| transferred | #751 |
| preclinical phase | #751 |
| control disease | #753 |
| metabolomic | #755 |
| tlr activation | #755 |
| ere | #755 |
| hapten | #755 |
| mice anti | #757 |
| disease protection | #758 |
| phenotypic differences | #758 |
| autoantibodies type | #758 |
| reacted | #759 |
| hyperinflammatory | #759 |
| linkage region | #760 |
| knockout tlymphocytes | #760 |
| ifngamma production | #761 |
| ccp | #761 |
| polycytidylic | #762 |
| immunocap | #763 |
| gamma ifn | #765 |
| glut4 translocation | #767 |
| periarticular | #772 |
| redox signal | #773 |
| cells apcs | #773 |
| hkexchanging | #773 |
| peripheral tolerance | #774 |
| afflicted | #777 |
| fab fragment | #778 |
| diseases cell | #778 |
| interacted | #779 |
| inbred nzb | #780 |
| acid transporters | #781 |
| development autoimmunity | #782 |
| nox1 | #782 |
| pathogenic role | #782 |
| arthritis osteoarthritis | #782 |
| arthritis psa | #783 |
| chronic colitis | #784 |
| clinical scores | #786 |
| transgenic mutation | #789 |
| peptide fragments | #790 |
| inflammatory lesions | #790 |
| transgenic receptors antigen | #790 |
| reduced incidence | #790 |
| pineal gland | #791 |
| polyarthritis | #792 |
| cell gamma | #793 |
| antibodies directed | #794 |
| cell humans | #794 |
| interval training | #796 |
| neutrophil extracellular | #796 |
| neutrophil function | #796 |
| pathogen free | #797 |
| genes immunoglobulin | #798 |
| lymphocyte proliferation | #798 |
| carbohydrate moieties | #800 |
| polyi | #801 |
| matrix proteins | #801 |
| blymphocyte chain genes | #802 |
| thy1 | #802 |
| innate adaptive immunity | #802 |
| monoclonal binding | #802 |
| induces | #805 |
| helper cells | #805 |
| redox control | #805 |
| count male | #805 |
| multinucleated giant cells | #808 |
| backcrossing | #809 |
| bone erosion | #810 |
| function mutation | #811 |
| catabolism | #811 |
| acc1 | #812 |
| resident cells | #812 |
| strains receptors | #812 |
| febuxostat | #813 |
| nonreceptor type | #815 |
| arginines | #817 |
| ctb | #817 |
| leads | #820 |
| auricle | #820 |
| collagen cross | #821 |
| cd8 antigens | #821 |
| leukocyte infiltration | #822 |
| piece | #823 |
| colocalizes | #824 |
| humoral immune response | #824 |
| electroporated | #824 |
| genetic environmental | #825 |
| psoriasis psoriatic arthritis | #825 |
| prominently | #825 |
| muscle training | #826 |
| response animals | #826 |
| chondroid | #827 |
| growth factor beta | #829 |
| class antigen | #829 |
| effects immune | #830 |
| producing | #830 |
| cross reactivity | #834 |
| lpr | #841 |
| inbred c57bl | #841 |
| peyers patches | #842 |
| immunoglobulin mice | #842 |
| therapeutic approaches | #844 |
| diabetic nod | #844 |
| il25 | #845 |
| chronic active | #845 |
| mice transgenic | #846 |
| inflammatory arthritis | #846 |
| induce | #848 |
| intermingled | #850 |
| macroscopically | #851 |
| antigen cell | #852 |
| lymphocyte | #852 |
| leukocyte migration | #854 |
| new possibilities | #854 |
| tcell receptors antigen | #855 |
| ms275 | #855 |
| strongest association | #856 |
| importantly | #856 |
| alveolar mice mice | #856 |
| mcv | #858 |
| post translational | #861 |
| immune defence | #862 |
| treatment reduced | #865 |
| lyme | #866 |
| mediated inflammatory | #867 |
| mice reduced | #867 |
| knockin mice | #867 |
| factor anti | #867 |
| strongest | #868 |
| cross reactive | #868 |
| lentiviral | #869 |
| parietal cells | #869 |
| hinge region | #869 |
| lnc | #872 |
| dextran sulfate | #873 |
| immune tolerance | #873 |
| lower expression | #874 |
| parasitemia | #874 |
| elisas | #875 |
| cells expressing | #876 |
| granulomas | #877 |
| fcγri | #878 |
| synovial fluid patients | #878 |
| arthritis inflammatory | #879 |
| adoptive | #881 |
| antigen4 | #881 |
| pregnancy animal | #882 |
| systemic autoimmune diseases | #882 |
| testosterone treatment | #883 |
| fluid synovial | #884 |
| cartilaginous | #888 |
| standard therapies | #890 |
| psoriasis vulgaris | #891 |
| genetic dissection | #891 |
| basic | #893 |
| regulator | #895 |
| completely | #896 |
| inflammation mediators | #897 |
| intranasal administration | #897 |
| ctla4 antigen | #898 |
| interleukin1alpha | #898 |
| phosphatase receptor | #902 |
| granulocytes | #904 |
| partly | #904 |
| inception cohort | #905 |
| infiltrations | #906 |
| γδ cells | #906 |
| rats inbred | #907 |
| lipocalins | #908 |
| extracellular traps | #909 |
| immunohistochemical analyses | #910 |
| immunoglobulin levels | #911 |
| single injection | #911 |
| liu | #911 |
| chromosome 16 | #912 |
| mitochondrial ros | #913 |
| lectin pathway | #913 |
| pneumonitis | #914 |
| ciita | #914 |
| enolase | #915 |
| allelic variation | #915 |
| proliferate | #915 |
| immunemediated diseases | #916 |
| cytokine response | #923 |
| psoriatic arthritis psa | #924 |
| neutrophil chemotaxis | #924 |
| antibodies antibody | #924 |
| chromosome mapping | #925 |
| fluorobenzene | #925 |
| cd200 | #925 |
| phenotypic analysis | #926 |
| nkt cells | #926 |
| repertoires | #929 |
| burst | #930 |
| tissue transglutaminase | #931 |
| data role | #932 |
| hydratase | #933 |
| citrulline | #933 |
| alpha animals | #935 |
| macropinocytosis | #936 |
| alters | #937 |
| arthritides | #938 |
| lymphocyte activation | #938 |
| synovia | #939 |
| 1040 | #939 |
| rns | #940 |
| analysed | #940 |
| immune reactivity | #940 |
| vitro stimulation | #941 |
| disease model | #941 |
| collagen structure | #941 |
| genetic analysis | #941 |
| mediated autoimmune | #944 |
| sciatic nerves | #945 |
| association hla | #945 |
| mice mice | #947 |
| fluid patients | #948 |
| clinical observations | #948 |
| inflammatory pathways | #948 |
| humanized mice | #949 |
| vivo | #950 |
| riii | #950 |
| l3t4 | #954 |
| environmental determinants | #955 |
| nos1 | #957 |
| carrying | #958 |
| differentiation tlymphocyte antigens | #959 |
| levels ros | #962 |
| mhc peptide | #962 |
| chronic disease | #963 |
| cellular immunization | #965 |
| cells lymphocytes | #967 |
| cytotoxic tlymphocytes | #967 |
| animals cytokines | #967 |
| monoclonal antigens | #967 |
| cell transfer | #969 |
| lower frequency | #969 |
| chromosome 15 | #971 |
| draining lymph nodes | #972 |
| secreting cells | #973 |
| susceptibility locus | #978 |
| cartilage articular | #979 |
| synovial membrane | #981 |
| genes chromosome | #982 |
| w5 | #982 |
| lymphocytes | #982 |
| binding peptides | #983 |
| pain behavior | #984 |
| tbb | #987 |
| tallele | #988 |
| microspectrophotometry | #990 |
| macrophages cells | #991 |
| knockout models | #991 |
| allergic contact dermatitis | #992 |
| immunodominance | #992 |
| cells reactive | #993 |
| 510 | #994 |
| transgenic expression | #994 |
| patients rp | #994 |
| cartilage bone | #995 |
| hej | #995 |
| knee joints | #997 |
| formyl peptide | #997 |
| spontaneously | #997 |
| laminin fibronectin | #998 |
| antigen expression | #999 |
| immunoglobulin fragments | #1000 |
| lymphocyte subpopulations | #1002 |
| multiple loci | #1003 |
| aggravate | #1004 |
| processing presentation | #1004 |
| expands | #1004 |
| protective role | #1007 |
| igg subclasses | #1011 |
| nrc | #1012 |
| cyclic peptides | #1012 |
| interleukin21 | #1013 |
| 95 stroke | #1013 |
| model multiple | #1015 |
| igg | #1015 |
| direct comparison | #1015 |
| cellular composition | #1016 |
| nerve roots | #1016 |
| cells mast | #1016 |
| aged arthritis | #1017 |
| melatonin levels | #1019 |
| patients early | #1019 |
| cd4 antigens | #1020 |
| immunoglobulin variable | #1022 |
| cysteine protease | #1025 |
| diseases animals | #1026 |
| genetic humans | #1027 |
| innate killer cells | #1028 |
| il4 | #1029 |
| dr1 | #1031 |
| baseline 24 months | #1031 |
| mice treated | #1032 |
| oxidase | #1034 |
| major regulator | #1036 |
| species production | #1039 |
| tramp | #1040 |
| arthritis psoriatic | #1041 |
| expression mrna | #1042 |
| complementary genes | #1043 |
| das28 | #1045 |
| myelin proteins | #1050 |
| parental strain | #1050 |
| patients rheumatoid | #1051 |
| chromosome 5 | #1052 |
| gamma delta | #1055 |
| inflammatory macrophages | #1055 |
| antigens differentiation | #1056 |
| immune defense | #1056 |
| mannans | #1057 |
| rat cells | #1060 |
| morula | #1062 |
| lymphocytes cells | #1062 |
| sterile inflammation | #1062 |
| transgenic | #1063 |
| tarsus | #1066 |
| decidua | #1069 |
| role immune | #1069 |
| oxazoles | #1069 |
| disease humans polymorphism | #1069 |
| synovial fluids | #1071 |
| transgenic cells | #1075 |
| fcγ | #1076 |
| radiological | #1077 |
| peptidylarginine deiminase | #1078 |
| epistasis | #1079 |
| key steps | #1080 |
| adjuvant cfa | #1080 |
| reestablishment | #1082 |
| lymphoid cells | #1082 |
| irf1 | #1086 |
| dependent regulation | #1087 |
| al2 | #1088 |
| haplotypes | #1089 |
| uppsala | #1089 |
| enlarged | #1091 |
| inflamed | #1092 |
| osteoclast formation | #1093 |
| 7 weeks | #1096 |
| oligodendrocyte | #1098 |
| inkt cells | #1102 |
| igs | #1103 |
| effector mechanisms | #1104 |
| cells increased | #1105 |
| arginine deiminase | #1114 |
| fibril | #1115 |
| molecular mimicry | #1115 |
| subdominant | #1115 |
| sclerosis myelin | #1116 |
| clinical disease | #1116 |
| genetic factors | #1117 |
| disulfide | #1117 |
| deamidation | #1117 |
| antitoxin | #1117 |
| animal immunity | #1117 |
| cd5 | #1117 |
| antigenic peptides | #1118 |
| pil | #1121 |
| lymphocytes regulatory | #1123 |
| recognizing | #1126 |
| primary immunodeficiency | #1127 |
| foreign antigens | #1128 |
| predisposing | #1128 |
| humans lymphocyte | #1128 |
| isomerase | #1128 |
| cells ifn | #1128 |
| dissected | #1130 |
| treatment day | #1132 |
| skeletal muscle fibers | #1132 |
| superantigen | #1134 |
| cryosections | #1135 |
| immune response | #1135 |
| glucosyl | #1136 |
| vivo administration | #1136 |
| overlapped | #1136 |
| c57 | #1137 |
| underline | #1138 |
| peptide sequence | #1138 |
| editorial | #1139 |
| anticardiolipin antibodies | #1139 |
| cd4foxp3 | #1142 |
| mice rats | #1146 |
| syntenic | #1147 |
| treatment animals | #1149 |
| helpers | #1149 |
| agonist | #1150 |
| cd4 cells | #1151 |
| subcloned | #1155 |
| disease onset | #1157 |
| antibody affinity | #1160 |
| lxr | #1161 |
| inactivating | #1161 |
| respiratory burst | #1163 |
| prolactin rats | #1164 |
| stainings | #1168 |
| demonstrating | #1168 |
| increased severity | #1170 |
| activated cells | #1171 |
| transduction toll | #1174 |
| gp91phox | #1175 |
| nadph oxidoreductases | #1176 |
| inflamed tissues | #1178 |
| models disease | #1178 |
| 10b | #1179 |
| recombinant interferon | #1180 |
| preponderance | #1180 |
| genetic background | #1181 |
| destructive | #1182 |
| chemiluminescent | #1182 |
| arginine residues | #1184 |
| disease haplotypes humans | #1186 |
| objective investigate | #1186 |
| synovial fibroblasts | #1188 |
| lymphocytes cell | #1188 |
| human type | #1190 |
| ileitis | #1191 |
| splenic cells | #1192 |
| rat human | #1192 |
| antiphospholipid | #1193 |
| primary sjögrens syndrome | #1195 |
| infiltrates | #1195 |
| cells rheumatoid | #1199 |
| antibodies mabs | #1200 |
| antibody | #1200 |
| basic mechanisms | #1200 |
| susceptibility | #1200 |
| somatically | #1201 |
| lung mice mice | #1204 |
| protein arginine | #1208 |
| identified loci | #1210 |
| h2k | #1211 |
| predisposition disease | #1212 |
| onset progression | #1212 |
| c5a | #1213 |
| singlecell | #1214 |
| rationales | #1214 |
| hdacs | #1217 |
| critical issues | #1218 |
| chronic inflammation | #1218 |
| igg subclass | #1220 |
| ilc2 | #1221 |
| mononuclear | #1223 |
| adaptive immune response | #1223 |
| compared wt | #1223 |
| subcellular fractionation | #1224 |
| adaptive immune responses | #1225 |
| tlymphocyte antigens | #1226 |
| chromosome 4 | #1227 |
| linkage analysis | #1229 |
| antimicrobial peptides amps | #1229 |
| analyse | #1230 |
| experimental models | #1231 |
| therapeutically | #1232 |
| subsets lymphocytes | #1233 |
| aps | #1233 |
| host defense | #1238 |
| immunological mechanisms | #1240 |
| human cd4 | #1241 |
| cell lymphocytes | #1244 |
| indel | #1247 |
| mouse | #1250 |
| immune inflammatory | #1251 |
| lining | #1252 |
| animal | #1253 |
| ltb | #1253 |
| dead cells | #1254 |
| animal doseresponse relationship | #1259 |
| mesenteric lymph nodes | #1263 |
| differentiation lymphocyte | #1263 |
| antigen presenting cells | #1264 |
| synovium | #1265 |
| pathogenic mechanisms | #1266 |
| adenine dinucleotide | #1269 |
| suppress | #1269 |
| molecular pathogenesis | #1270 |
| rheumatoid arthritis patients | #1270 |
| suppressive function | #1270 |
| synovial fluid | #1271 |
| rat mouse | #1273 |
| claudin4 | #1274 |
| eae model | #1274 |
| rats mice | #1275 |
| chromosomal regions | #1275 |
| inducer | #1279 |
| rattus norvegicus | #1282 |
| becn1 | #1282 |
| hla molecules | #1283 |
| c4a | #1283 |
| staphylococcal | #1283 |
| rodent models | #1284 |
| spreading | #1286 |
| joint destruction | #1287 |
| attacked | #1288 |
| disease response | #1290 |
| pathological processes | #1294 |
| immunochip | #1295 |
| suppressor cells | #1296 |
| peripheral cells | #1297 |
| day pregnancy | #1297 |
| serm | #1297 |
| nadph oxidase activity | #1299 |
| production anti | #1299 |
| data protein | #1300 |
| publication animals antigens | #1300 |
| restimulation | #1305 |
| hdac3 | #1307 |
| model experimental | #1307 |
| peptide library | #1309 |
| ali | #1310 |
| social isolation | #1310 |
| fab2 | #1312 |
| phagocytic cells | #1313 |
| generated | #1313 |
| introgressed | #1314 |
| permissive | #1315 |
| lymphoproliferation | #1315 |
| detailed characterization | #1316 |
| immune | #1316 |
| increased susceptibility | #1316 |
| protects | #1319 |
| estradiol treatment | #1320 |
| hydrolyzes | #1321 |
| immunoglobulin isotypes | #1321 |
| intrathymic | #1322 |
| healthy human subjects | #1322 |
| phagocytes | #1322 |
| collagen types | #1323 |
| submandibular | #1323 |
| aureus infections | #1325 |
| valuable tool | #1327 |
| acute phase proteins | #1327 |
| therapeutic antibodies | #1328 |
| dietary nitrate | #1329 |
| receptor 2 | #1330 |
| human igg | #1330 |
| immunological memory | #1332 |
| pockets | #1333 |
| identically | #1335 |
| thymectomy | #1335 |
| rats rats | #1336 |
| new therapies | #1336 |
| acute phase response | #1338 |
| cells mice | #1341 |
| induction phase | #1341 |
| adjuvants | #1344 |
| increasing evidence | #1348 |
| knockout mutation | #1349 |
| promiscuity | #1350 |
| galactosylceramides | #1356 |
| allergic contact | #1359 |
| elimination | #1361 |
| position | #1361 |
| alp | #1361 |
| regulatory genes | #1362 |
| believed | #1364 |
| disease activity score | #1364 |
| n44 | #1366 |
| hypersensitivity | #1367 |
| 590 | #1368 |
| bacterial arthritis | #1372 |
| ameliorates | #1374 |
| trait | #1375 |
| betad | #1375 |
| shared | #1375 |
| membrane glycoproteins | #1375 |
| rat spinal cord | #1379 |
| il1r | #1381 |
| abrogates | #1383 |
| immunogen | #1383 |
| surface cells | #1384 |
| exacerbation | #1388 |
| rats humans | #1388 |
| variable region | #1389 |
| suffer | #1389 |
| clinical signs | #1390 |
| regulatory treg | #1390 |
| cd2 | #1390 |
| human patients | #1392 |
| squalene | #1392 |
| phage display | #1393 |
| feto | #1393 |
| cd4cd8 | #1394 |
| effects rats | #1396 |
| disease outcomes | #1397 |
| inbred mice | #1397 |
| positional | #1399 |
| submandibular glands | #1400 |
| joint disease | #1403 |
| early patients | #1403 |
| mononuclear phagocytes | #1406 |
| linkage genetic | #1409 |
| disease phenotypes | #1412 |
| animals disease | #1413 |
| antigens humans | #1415 |
| enzymelinked immunosorbent | #1416 |
| humans immune | #1417 |
| activation neutrophils | #1417 |
| cytokine profile | #1424 |
| class switching | #1425 |
| bacterial infections | #1431 |
| genetic heterogeneity | #1436 |
| gene usage | #1438 |
| stages disease | #1439 |
| cells type | #1440 |
| peptide | #1441 |
| guillainbarré syndrome | #1451 |
| arthritis systemic | #1453 |
| inbred strains mice | #1454 |
| alpha1 | #1458 |
| cell activation | #1458 |
| monoclonal | #1460 |
| knockout rats | #1461 |
| proinflammatory responses | #1461 |
| expression genetic | #1462 |
| lupus | #1464 |
| salt concentrations | #1465 |
| pfp | #1467 |
| opens | #1467 |
| ccr6 | #1467 |
| cell origin | #1468 |
| inflammatory properties | #1469 |
| cells pregnancy | #1472 |
| activation status | #1473 |
| immune deficiency | #1474 |
| cartilage cell | #1474 |
| muscle muscle | #1476 |
| cells activated | #1478 |
| allelic variants | #1479 |
| allotype | #1480 |
| responses animals | #1482 |
| specific gene | #1482 |
| markers genetic | #1483 |
| blisters | #1483 |
| inflammatory diseases | #1486 |
| initiate | #1486 |
| genetic regulation | #1486 |
| cells lung | #1486 |
| stroke 95 | #1487 |
| host defence | #1489 |
| hormone release | #1489 |
| donated | #1490 |
| inbred rats | #1491 |
| mice day | #1491 |
| human cartilage | #1491 |
| humoral immune | #1497 |
| emphysematous | #1499 |
| myelin | #1499 |
| treatment inflammatory | #1504 |
| regulatory effects | #1504 |
| monocytes neutrophils | #1504 |
| specific monoclonal | #1505 |
| vivo vitro | #1505 |
| joint arthritis | #1507 |
| mimicking | #1507 |
| eluate | #1507 |
| fls | #1508 |
| mapped | #1509 |
| inflammatory cell | #1510 |
| hindlimbs | #1511 |
| chromosome 6 | #1512 |
| stimulates | #1515 |
| egfp | #1516 |
| induced ali | #1520 |
| human leukocyte antigen | #1524 |
| lia | #1525 |
| earlier studies | #1525 |
| genes dominant | #1528 |
| knockout mitochondria | #1530 |
| sex steroids | #1531 |
| streptococcus pyogenes | #1533 |
| glutamic acid | #1535 |
| malaise | #1536 |
| lysines | #1537 |
| downregulate | #1540 |
| net release | #1545 |
| protein rna | #1546 |
| production macrophages | #1547 |
| unexpectedly | #1547 |
| increased numbers | #1548 |
| acetylglucosaminidase | #1549 |
| chronic phase | #1554 |
| higher level | #1555 |
| mediated diseases | #1559 |
| intraperitoneally | #1560 |
| copy variations | #1563 |
| 4 humans | #1563 |
| neuroimmunomodulation | #1563 |
| activate | #1564 |
| intradermal | #1565 |
| vsg | #1566 |
| matrix components | #1567 |
| guerin | #1567 |
| mammalian embryo | #1568 |
| immunoglobulin humans | #1568 |
| formyl | #1569 |
| sufficient | #1573 |
| cytotoxic lymphocyte | #1574 |
| pineal | #1574 |
| cochran | #1577 |
| independent | #1577 |
| cathelicidin | #1578 |
| glycolipid | #1580 |
| collagens | #1585 |
| fab | #1592 |
| mac1 | #1593 |
| conserved | #1597 |
| factor beta | #1597 |
| directed | #1597 |
| defines | #1598 |
| cell mediated | #1600 |
| adoptive transfer | #1600 |
| f1 | #1600 |
| twins | #1600 |
| reactive nitrogen species | #1603 |
| autoantibodies biomarkers | #1604 |
| cell receptor | #1605 |
| cells th17 | #1607 |
| estriol | #1607 |
| helical | #1611 |
| stromal cells | #1615 |
| chondrocyte | #1616 |
| chronic inflammatory diseases | #1617 |
| immunity animals | #1617 |
| isosteric | #1619 |
| autoimmune diabetes | #1621 |
| c57bl 6 | #1622 |
| humans immunoglobulin | #1622 |
| anaphylatoxin | #1622 |
| differently | #1625 |
| unreactive | #1626 |
| antigen | #1626 |
| rat spinal | #1629 |
| iggs | #1630 |
| complement component | #1632 |
| immunohistology | #1635 |
| c3b | #1635 |
| collagen fibers | #1639 |
| lund | #1639 |
| type interferon | #1641 |
| mice increased | #1642 |
| p6 | #1644 |
| abrogated | #1644 |
| c4b | #1645 |
| aspartic acid | #1647 |
| intracellular ros | #1651 |
| sjl | #1652 |
| opsonization | #1653 |
| complement activation | #1657 |
| linked | #1658 |
| defence | #1658 |
| complement receptors | #1660 |
| commonly | #1660 |
| immune complexes | #1661 |
| staphylococcal enterotoxin | #1661 |
| transporter type | #1661 |
| enterotoxins | #1662 |
| mice knockout | #1664 |
| tcell receptors | #1665 |
| salt intake | #1668 |
| tumor vasculature | #1669 |
| coincided | #1670 |
| primary sjögren | #1671 |
| isopropylacrylamide | #1672 |
| immunologic epitopes | #1673 |
| pathogenic cells | #1673 |
| gamma production | #1678 |
| single nucleotide | #1683 |
| cd206 | #1686 |
| complement c5a | #1686 |
| cocktail | #1689 |
| auto | #1689 |
| igm antibodies | #1691 |
| method analysis | #1693 |
| agouti | #1694 |
| ido1 | #1694 |
| transgenic mice | #1696 |
| classical pathway | #1696 |
| severity | #1701 |
| precede | #1704 |
| animals autoantigens | #1704 |
| 5 months | #1704 |
| triple | #1704 |
| suppressors | #1706 |
| encoded | #1707 |
| treg cells | #1711 |
| disulfiram | #1711 |
| erosions | #1712 |
| beta chains | #1712 |
| mice neutrophils | #1714 |
| sjögrens syndrome | #1719 |
| ankylosis | #1719 |
| evoke | #1720 |
| pulmonary aspergillosis | #1721 |
| tolerance | #1721 |
| skewing | #1725 |
| oophorectomy | #1727 |
| showing | #1728 |
| mutant mice | #1729 |
| myelin proteolipid | #1729 |
| drug targets | #1732 |
| immune responses | #1734 |
| analysis protein | #1734 |
| 369 | #1734 |
| staphylococcal infections | #1736 |
| sicca | #1737 |
| phagocytic | #1737 |
| fmoc | #1739 |
| intranasally | #1740 |
| arthritis patients | #1742 |
| affinity binding | #1743 |
| 626 | #1744 |
| prophylactic treatment | #1744 |
| cd11 | #1745 |
| osteoclasts | #1746 |
| zap70 | #1748 |
| strain mice | #1748 |
| alternative pathway | #1748 |
| new loci | #1749 |
| responded | #1750 |
| neoplastic disease models | #1753 |
| peroxide | #1758 |
| infiltrating | #1762 |
| endoglycosidase | #1764 |
| dr2 | #1766 |
| inhibitory receptors | #1766 |
| higher frequency | #1770 |
| triggering | #1770 |
| multiple genes | #1770 |
| glycosylation | #1774 |
| peptide antigens | #1775 |
| operate | #1776 |
| blocking | #1781 |
| adoptively | #1782 |
| cnbr | #1783 |
| articular cell | #1784 |
| ll37 | #1784 |
| local administration | #1788 |
| immunohistological | #1789 |
| compartmentalized | #1791 |
| carbohydrates | #1792 |
| pathogenesis | #1793 |
| dogma | #1794 |
| render | #1794 |
| competed | #1797 |
| immune recognition | #1800 |
| disease pathogenesis | #1801 |
| polymorphism genetic | #1801 |
| rat models | #1802 |
| cd19 antigens | #1803 |
| rechallenge | #1803 |
| peyer | #1804 |
| obese diabetic | #1805 |
| aureus infection | #1808 |
| immunogenic | #1810 |
| predisposed | #1810 |
| activated lymphocytes | #1811 |
| complement pathway | #1811 |
| elucidation | #1811 |
| psoriatic | #1813 |
| recovery phase | #1814 |
| pregnancy rats | #1817 |
| nonfunctional | #1817 |
| il2r | #1818 |
| ossification | #1818 |
| promoting | #1818 |
| intravenously | #1819 |
| blymphocyte | #1819 |
| crossed | #1823 |
| katpase | #1824 |
| myelin sheath | #1825 |
| hydroxylated | #1825 |
| neurodegenerative diseases | #1827 |
| deplete | #1830 |
| female sex | #1833 |
| genetic susceptibility | #1836 |
| new treatments | #1839 |
| pathogenesis disease | #1841 |
| trif | #1843 |
| resolution inflammation | #1844 |
| clinical score | #1846 |
| subsequently | #1846 |
| inflammation macrophages | #1847 |
| estrogen | #1848 |
| cultured disease | #1849 |
| pyogenes | #1852 |
| genetic variance | #1854 |
| specific immunity | #1854 |
| cd8 lymphocytes | #1856 |
| macrophages neutrophils | #1856 |
| humoral | #1857 |
| rac2 | #1858 |
| barre | #1858 |
| cocktails | #1860 |
| haenszel | #1862 |
| secreting | #1863 |
| structural basis | #1864 |
| aggravation | #1864 |
| lacrimal apparatus | #1865 |
| silastic | #1871 |
| rats groups | #1871 |
| immunoadsorption | #1873 |
| inkt | #1874 |
| carries | #1875 |
| major | #1876 |
| cartilages | #1879 |
| subsequent development | #1879 |
| candidate | #1883 |
| antigen humans | #1890 |
| inflammation lung | #1892 |
| polyclonal | #1893 |
| bacterial clearance | #1894 |
| ovalbumin | #1897 |
| cyanogen | #1900 |
| striking | #1902 |
| lymphatics | #1903 |
| tcr repertoire | #1903 |
| complexity | #1905 |
| indicating | #1905 |
| proteins rats | #1907 |
| model rats | #1908 |
| mediated | #1910 |
| gammadelta | #1910 |
| enzyme linked | #1911 |
| cell maturation | #1912 |
| cells neutrophils | #1912 |
| interferon gamma | #1914 |
| erythematosus sle | #1916 |
| chromosome | #1916 |
| totally | #1918 |
| 6 hours | #1920 |
| cartilage tissue | #1923 |
| anti | #1924 |
| 721 | #1924 |
| gαq | #1926 |
| pronounced | #1927 |
| ears | #1929 |
| isoantigens | #1931 |
| bcell receptors | #1933 |
| expression cytokines | #1934 |
| trypanosoma brucei | #1937 |
| animals lymphocytes | #1937 |
| sialyltransferases | #1939 |
| mice receptors | #1940 |
| antigen tcell receptors | #1944 |
| type plasminogen | #1945 |
| predisposition | #1949 |
| subclasses | #1950 |
| prevented | #1950 |
| constituting | #1955 |
| cardiac allografts | #1956 |
| snakes | #1957 |
| perforin | #1957 |
| agp | #1959 |
| mmc | #1962 |
| iga igg | #1967 |
| pinocytosis | #1967 |
| edition | #1967 |
| levels serum | #1967 |
| fcγ receptor | #1969 |
| possibilities | #1969 |
| strong | #1971 |
| intravenous injection | #1972 |
| react | #1975 |
| mip | #1977 |
| stimulations | #1978 |
| carp | #1979 |
| synovial tissues | #1979 |
| inbred cba | #1980 |
| ova | #1980 |
| cd154 | #1982 |
| pregnant rats | #1983 |
| cell clone | #1985 |
| disease pathology | #1985 |
| milder | #1988 |
| spans | #1997 |
| mast cell | #1999 |
| cd18 | #2000 |
| transgenic rats | #2001 |
| microglia activation | #2002 |
| presenting cell | #2006 |
| heteroplasmy | #2007 |
| contact dermatitis | #2008 |
| rats effects | #2008 |
| reverted | #2008 |
| prototypic | #2011 |
| abca1 | #2016 |
| response infection | #2016 |
| barré syndrome | #2018 |
| knockout | #2020 |
| tissue inflammation | #2021 |
| immunoglobulin | #2023 |
| genes | #2025 |
| cell | #2027 |
| mabs | #2028 |
| cytokine secretion | #2028 |
| demyelination | #2030 |
| chord | #2031 |
| tetramers | #2032 |
| c5ar | #2033 |
| mesenteric lymph | #2035 |
| beta gene | #2035 |
| conformational epitopes | #2035 |
| 4 tlr4 | #2041 |
| factor mif | #2041 |
| mab | #2042 |
| diethyldithiocarbamate | #2043 |
| immunomodulatory properties | #2044 |
| sex chromosome | #2045 |
| cell immunity | #2047 |
| hypergammaglobulinemia | #2050 |
| oestrogens | #2050 |
| species signal | #2053 |
| cell function | #2053 |
| castration | #2053 |
| coinciding | #2055 |
| emphysema | #2056 |
| glycosylation humans | #2057 |
| increased frequency | #2058 |
| innate inflammation | #2058 |
| dramatically | #2059 |
| vitro vivo | #2061 |
| activation complement | #2061 |
| accompanied | #2067 |
| genetic differences | #2068 |
| dominant | #2070 |
| contributors | #2071 |
| proteomics analysis | #2072 |
| hyaluronoglucosaminidase | #2072 |
| mdsc | #2076 |
| polyradiculoneuropathy | #2077 |
| mature cells | #2077 |
| respiratory tract | #2079 |
| lysine residues | #2080 |
| antiphospholipid syndrome | #2081 |
| cell depletion | #2082 |
| mice pregnancy | #2083 |
| complement | #2094 |
| methotrexate mtx | #2094 |
| conditional deletion | #2095 |
| lysine | #2096 |
| addressed | #2097 |
| bioreactor | #2100 |
| αβ | #2100 |
| suggested | #2102 |
| evokes | #2103 |
| led | #2103 |
| antigens hla | #2104 |
| patients rheumatoid arthritis | #2105 |
| human chondrocytes | #2110 |
| nose | #2117 |
| lentiviral vectors | #2120 |
| glycan | #2122 |
| pulmonary inflammation | #2122 |
| immune functions | #2126 |
| pad4 | #2127 |
| oxidants | #2129 |
| total igg | #2130 |
| secondary receptors | #2133 |
| inducing | #2136 |
| occurring | #2139 |
| histopathological | #2140 |
| target tissues | #2141 |
| selective estrogen | #2141 |
| dissection | #2142 |
| plasminogen | #2143 |
| transduction lymphocytes | #2145 |
| extracellular calcium | #2146 |
| subphenotypes | #2146 |
| bound | #2147 |
| h2d | #2147 |
| circulating monocytes | #2149 |
| immunohistochemical analysis | #2151 |
| 129 strain mice | #2151 |
| reality | #2153 |
| clinical aspects | #2157 |
| periphery | #2161 |
| major histocompatibility complex | #2162 |
| moabs | #2165 |
| late stages | #2165 |
| rheumatoid biomarkers | #2165 |
| prone | #2169 |
| entire | #2174 |
| syringes | #2176 |
| mimics | #2177 |
| animal model | #2179 |
| immune regulation | #2180 |
| human leukocytes | #2181 |
| psoriatic arthritis | #2184 |
| dynorphins | #2184 |
| dnp | #2185 |
| native | #2188 |
| injury ali | #2200 |
| dss | #2203 |
| lps stimulation | #2204 |
| structural requirements | #2211 |
| molecular pathways | #2213 |
| confirming | #2214 |
| 12th | #2215 |
| interleukin2 | #2216 |
| therapeutic effects | #2216 |
| activation cells | #2217 |
| animal mice mice | #2217 |
| naïve | #2219 |
| regulates | #2220 |
| galactose | #2220 |
| suggesting | #2221 |
| wt mice | #2224 |
| immunoreactivity | #2225 |
| shrna | #2232 |
| mammalian | #2232 |
| neutralized | #2233 |
| governs | #2233 |
| presentation | #2234 |
| accelerates | #2236 |
| reduced susceptibility | #2239 |
| autoimmune conditions | #2239 |
| ctla4 | #2239 |
| lacked | #2240 |
| graft rejection | #2244 |
| inflammatory phenotype | #2248 |
| cholera toxin | #2248 |
| cell priming | #2252 |
| exacerbated | #2253 |
| monoclonal antibodies | #2254 |
| cell receptors | #2256 |
| tcell proliferation | #2261 |
| sjögren | #2263 |
| regulation immune | #2265 |
| involved pathogenesis | #2267 |
| hla | #2269 |
| progeny | #2274 |
| mph | #2274 |
| immunospot | #2278 |
| antigenic | #2279 |
| murine | #2279 |
| mice treatment | #2280 |
| neutrophil apoptosis | #2280 |
| lymph nodes | #2281 |
| dependent | #2284 |
| inflammatory | #2288 |
| immunizations | #2289 |
| homologous | #2292 |
| plasmatic | #2293 |
| determining | #2296 |
| modified proteins | #2296 |
| histological evaluation | #2296 |
| cba mice | #2297 |
| regulatory mechanisms | #2299 |
| knockout mice | #2300 |
| apocynin | #2302 |
| segregating | #2308 |
| infiltrating macrophages | #2309 |
| presentation antigens | #2310 |
| wounding | #2312 |
| drastically | #2315 |
| genetic basis | #2315 |
| il10 | #2317 |
| healthy donors | #2318 |
| hydroxylation | #2320 |
| barré | #2320 |
| inflammatory mechanisms | #2321 |
| sera | #2325 |
| throughput nucleotide | #2325 |
| p00002 | #2326 |
| antigens histocompatibility | #2328 |
| wild | #2329 |
| cells induced | #2331 |
| demyelinating disease | #2336 |
| n24 | #2338 |
| lewis | #2345 |
| gk | #2347 |
| reciprocal | #2353 |
| receptor α | #2353 |
| ethylenes | #2358 |
| specific igg | #2358 |
| illness stress | #2361 |
| monosaccharide | #2363 |
| hyaline | #2364 |
| biological agents | #2365 |
| acrylamides | #2366 |
| lectins type | #2366 |
| sex hormone | #2366 |
| degradative | #2367 |
| phosphoproteins | #2369 |
| eliminated | #2374 |
| wf | #2374 |
| peptides derived | #2375 |
| lymphotoxin | #2375 |
| immunogens | #2375 |
| genetic selection | #2376 |
| treatment rheumatoid arthritis | #2376 |
| amps | #2382 |
| cxcl1 | #2382 |
| antinociceptive | #2383 |
| nonalcoholic steatohepatitis | #2384 |
| contaminating | #2386 |
| mouse model | #2386 |
| phenotypes | #2391 |
| sidechain | #2391 |
| receptor transforming | #2392 |
| syngeneic | #2394 |
| knock | #2394 |
| septic arthritis | #2396 |
| systemic lupus erythematosus | #2397 |
| hla genes | #2398 |
| inflammatory reaction | #2400 |
| p38 mapk | #2400 |
| serum autoantibodies | #2408 |
| increased incidence | #2409 |
| mice models | #2411 |
| equina | #2413 |
| intraperitoneal injections | #2418 |
| genetic receptors | #2420 |
| genetic studies | #2420 |
| structure analysis | #2423 |
| realtime pcr | #2424 |
| mice expression | #2426 |
| tlr2 tlr4 | #2429 |
| lentivirus | #2430 |
| acute phase | #2430 |
| suggestive evidence | #2430 |
| unmodified | #2431 |
| lymphocytes cd4 | #2432 |
| cytokines chemokines | #2432 |
| collagen fibrils | #2432 |
| cko | #2432 |
| cells antigens | #2434 |
| early phases | #2440 |
| agents arthritis | #2440 |
| inflammatory activity | #2442 |
| mice multiple | #2446 |
| genetic predisposition | #2449 |
| receptors complement | #2450 |
| b6 | #2450 |
| 551 | #2451 |
| lipoxin | #2458 |
| inflammatory demyelinating | #2459 |
| animal disease models | #2463 |
| exemplified | #2466 |
| idiotype | #2468 |
| antibody responses | #2469 |
| strains | #2471 |
| animals cd4 | #2473 |
| administration intranasal | #2473 |
| translational modifications | #2477 |
| axotomy | #2477 |
| additively | #2477 |
| quantitative | #2480 |
| class | #2480 |
| regulatory | #2487 |
| animal experiments | #2492 |
| specific | #2493 |
| organ specific | #2497 |
| transforming growth factor | #2498 |
| negative feedback | #2501 |
| albeit | #2502 |
| alleviated | #2502 |
| cystatin | #2504 |
| mhc class genes | #2505 |
| multiparous | #2511 |
| transgenic microscopy | #2512 |
| bystander | #2515 |
| il17a | #2516 |
| ppd | #2518 |
| dichotomous | #2519 |
| chemokines cytokines | #2519 |
| contribute | #2522 |
| naturally | #2523 |
| treatment rheumatoid | #2524 |
| hyperostosis | #2525 |
| amiloride | #2526 |
| nod mice | #2527 |
| microsatellite markers | #2534 |
| pathogenicity | #2534 |
| infiltration | #2541 |
| resemblance | #2542 |
| undertaken | #2545 |
| postmenopausal osteoporosis | #2546 |
| proteolipid | #2552 |
| dapsone | #2560 |
| similarities | #2561 |
| igm iga | #2562 |
| plp | #2563 |
| kynurenine | #2563 |
| deprotection | #2564 |
| nox | #2566 |
| succeeded | #2567 |
| fine | #2573 |
| transferring | #2573 |
| passive | #2574 |
| rp patients | #2575 |
| dying cells | #2575 |
| tumor models | #2576 |
| quantitative traits | #2577 |
| incomplete | #2577 |
| complementarity | #2580 |
| peptides | #2585 |
| chick | #2589 |
| calgranulin | #2590 |
| peritoneal macrophages | #2591 |
| antibody levels | #2591 |
| misinterpretation | #2593 |
| interferon type | #2595 |
| sex hormones | #2597 |
| fibrinolysin | #2598 |
| onset | #2603 |
| antiinflammatory properties | #2603 |
| unlinked | #2605 |
| zymosan | #2610 |
| induction | #2611 |
| postulated | #2614 |
| exert | #2615 |
| antimicrobial peptides | #2618 |
| surprising | #2621 |
| interferon beta | #2623 |
| proteolipid protein | #2632 |
| ifn α | #2634 |
| single chain | #2639 |
| sialoglycoproteins | #2643 |
| plasmin | #2647 |
| unable | #2649 |
| asparagine | #2651 |
| tlr9 | #2653 |
| antigens | #2656 |
| disease genotype | #2658 |
| hla antigens | #2659 |
| functional impact | #2663 |
| submandibular gland | #2663 |
| antinuclear | #2663 |
| eluted | #2666 |
| osteonectin | #2667 |
| invading | #2670 |
| brucei | #2670 |
| n22 | #2670 |
| microliters | #2671 |
| biological pathways | #2673 |
| bordetella | #2680 |
| ease | #2683 |
| new therapeutic strategies | #2683 |
| leukocyte antigen | #2688 |
| th1 | #2690 |
| acd | #2696 |
| day treatment | #2697 |
| allelic | #2697 |
| genetic variations | #2698 |
| igg3 | #2698 |
| animal encephalomyelitis | #2702 |
| neutrophils macrophages | #2703 |
| gamma mice | #2711 |
| peptides protein | #2714 |
| γδ | #2716 |
| treatment mice | #2717 |
| rat model | #2718 |
| human complement | #2725 |
| patients anti | #2727 |
| polymorphic | #2729 |
| biased | #2730 |
| lymphocyte subsets | #2730 |
| ifngamma | #2730 |
| post partum | #2731 |
| fumigatus | #2735 |
| lamina propria | #2735 |
| serum anti | #2738 |
| fragment | #2743 |
| vav | #2743 |
| mice exposed | #2750 |
| leucocyte | #2754 |
| resemble | #2762 |
| bromocriptine | #2768 |
| transgenic mouse | #2772 |
| depleting | #2773 |
| human leukocyte | #2774 |
| tyrosine phosphatase | #2774 |
| strong evidence | #2777 |
| qtls | #2777 |
| cytolysis | #2777 |
| iga igm | #2780 |
| detectable | #2780 |
| enigmatic | #2780 |
| genetically | #2782 |
| explanation | #2785 |
| finemapping | #2785 |
| treated rats | #2786 |
| alcoholic steatohepatitis | #2786 |
| intraperitoneal | #2787 |
| tolerogenic | #2789 |
| bone cartilage | #2790 |
| sjogren syndrome | #2791 |
| inbred mrl | #2798 |
| current review | #2798 |
| animal encephalomyelitis autoimmune | #2799 |
| hk | #2801 |
| callithrix | #2804 |
| spleen | #2812 |
| 261 | #2813 |
| neuropathology | #2817 |
| genistein | #2819 |
| alpha | #2821 |
| lack | #2822 |
| activated macrophages | #2825 |
| hyaluronidase | #2830 |
| conventionally | #2831 |
| narrowed | #2832 |
| prl | #2835 |
| olive oil | #2838 |
| demyelinating diseases | #2841 |
| resistant | #2842 |
| hallmark | #2843 |
| glucose uptake | #2846 |
| beta receptor | #2847 |
| beta tgf | #2848 |
| bind | #2848 |
| demyelinating | #2852 |
| th1 response | #2852 |
| polymorphonuclear leukocytes | #2856 |
| phases | #2858 |
| treg cell | #2859 |
| dependent cell | #2859 |
| interleukin receptors | #2864 |
| polymorphonuclear | #2864 |
| antibodies antinuclear | #2864 |
| splenocytes | #2865 |
| characterising | #2865 |
| interleukin33 | #2869 |
| rats inbred strains | #2869 |
| cyanogen bromide | #2874 |
| disease characterized | #2875 |
| guillain | #2875 |
| cells cd8 | #2881 |
| periodontitis | #2882 |
| parvalbumin | #2884 |
| reveals | #2885 |
| clone cells | #2885 |
| exacerbate | #2888 |
| igg iga | #2891 |
| migration inhibitory | #2892 |
| costimulatory molecules | #2895 |
| tgfbeta | #2895 |
| dce | #2896 |
| innate immune responses | #2896 |
| antigens class humans | #2898 |
| dq | #2905 |
| antigen hla | #2907 |
| atp synthase | #2909 |
| linked immunosorbent | #2911 |
| enhancement | #2911 |
| studying | #2918 |
| diseases disease | #2920 |
| shortly | #2920 |
| allogenic | #2921 |
| ergometry | #2921 |
| vaccine development | #2925 |
| steadily | #2925 |
| type lectin | #2926 |
| obvious | #2927 |
| ifn γ | #2931 |
| autoimmune disorder | #2935 |
| dextran | #2939 |
| female flow | #2943 |
| expression macrophages | #2944 |
| injections | #2944 |
| ifn gamma | #2945 |
| proteins peptides | #2946 |
| cd68 | #2947 |
| patients antibodies | #2949 |
| interleukin4 | #2950 |
| cells immune | #2955 |
| eventually | #2956 |
| toll receptor | #2961 |
| cell infiltration | #2962 |
| expressions | #2963 |
| calcium ions | #2964 |
| qtl | #2965 |
| suppressed | #2967 |
| histocytochemistry | #2967 |
| hnrnp | #2980 |
| genetics | #2982 |
| ifn response | #2985 |
| cepacia | #2988 |
| antirheumatic agents | #2993 |
| elusive | #2994 |
| hdac | #2995 |
| thymus gland | #2997 |
| swedish | #2998 |
| respective | #3000 |
| lineage commitment | #3003 |
| time points | #3009 |
| indoleamine | #3009 |
| cells female | #3010 |
| therapeutic strategies | #3014 |
| innate | #3014 |
| illustrating | #3017 |
| anthrax | #3019 |
| interferon ifn | #3020 |
| wild type mice | #3026 |
| defensins | #3027 |
| vdr | #3031 |
| lung inflammation | #3033 |
| accelerating | #3033 |
| macrophage migration | #3036 |
| t‐cell | #3039 |
| endo | #3039 |
| synthetic peptides | #3040 |
| appearance | #3045 |
| quinoxalines | #3047 |
| cd8 | #3048 |
| immunomodulator | #3050 |
| model mice | #3051 |
| longterm treatment | #3052 |
| twin studies | #3053 |
| complex traits | #3055 |
| ppt | #3058 |
| interleukin23 | #3061 |
| profound | #3067 |
| sjögren syndrome | #3069 |
| prevailing | #3073 |
| salivary | #3076 |
| mediated immune | #3077 |
| role cell | #3078 |
| beta | #3080 |
| destruction | #3082 |
| irrespective | #3083 |
| model human | #3083 |
| gene expression profiling | #3086 |
| impairing | #3087 |
| nodes | #3091 |
| glutamic | #3092 |
| inhibitory factors | #3092 |
| parvalbumins | #3093 |
| inbred balb mice | #3098 |
| receptor 4 | #3098 |
| genetic deletion | #3100 |
| detailed description | #3101 |
| postpartum period | #3107 |
| germinal | #3108 |
| antirheumatic | #3109 |
| staphylococcus | #3114 |
| type wt | #3120 |
| neuronal cell | #3123 |
| effects treatment | #3124 |
| suspect | #3127 |
| igm igg | #3130 |
| specificity | #3131 |
| glycans | #3136 |
| monoclonal antibody | #3137 |
| receptors tlrs | #3142 |
| psoriasis | #3142 |
| logarithm | #3146 |
| cd4 cd8 | #3147 |
| preformed | #3151 |
| immune systems | #3152 |
| possibility | #3153 |
| cell activity | #3154 |
| molecule | #3155 |
| propria | #3155 |
| cba | #3164 |
| posttranslational modification | #3167 |
| sjogren | #3171 |
| massively | #3172 |
| accumulated | #3180 |
| cell specific | #3185 |
| precedes | #3185 |
| blockage | #3187 |
| dynorphin | #3191 |
| tissue specific | #3191 |
| pertussis toxin | #3192 |
| adult mice | #3193 |
| cells rats | #3193 |
| keratinocytes | #3194 |
| unravel | #3199 |
| reactivity | #3202 |
| helper | #3204 |
| modified | #3205 |
| ovx | #3208 |
| serum levels | #3210 |
| erbeta | #3211 |
| antiinflammatory | #3211 |
| phagosomes | #3212 |
| nitroarginine | #3212 |
| abs | #3216 |
| publication arthritis | #3224 |
| cells animals | #3224 |
| gpi | #3226 |
| chromosome 1 | #3237 |
| class iii | #3239 |
| clarified | #3242 |
| permitting | #3246 |
| collagenous | #3247 |
| macrophage | #3247 |
| lod score | #3252 |
| bacterial antibodies | #3254 |
| backbone | #3257 |
| nonalcoholic steatohepatitis nash | #3260 |
| female gonadal | #3263 |
| treated animals | #3264 |
| acrylic | #3265 |
| chronic inflammatory | #3267 |
| meps | #3270 |
| immunosorbent assay | #3272 |
| implicate | #3274 |
| proteoglycans | #3278 |
| inflammation interferon | #3278 |
| sch | #3280 |
| nephritis | #3283 |
| arthralgia | #3283 |
| gonadal steroid | #3284 |
| normal rats | #3287 |
| abundantly | #3289 |
| igg1 | #3298 |
| models genetic | #3298 |
| immunoglobulin heavy | #3303 |
| erythematosus | #3305 |
| adaptations | #3309 |
| proteins mice | #3309 |
| elicits | #3314 |
| characterise | #3314 |
| blastocyst | #3315 |
| nociception | #3316 |
| absence | #3318 |
| diseases autoimmune | #3321 |
| beta receptors | #3325 |
| publication animals | #3325 |
| mice protein | #3327 |
| anticardiolipin | #3328 |
| confirmed | #3329 |
| gc cells | #3331 |
| serologically | #3332 |
| suppression | #3338 |
| regional lymph nodes | #3341 |
| macromolecular | #3343 |
| clinical phenotypes | #3345 |
| cd62l | #3353 |
| influenced | #3355 |
| trypanosoma | #3358 |
| akr | #3371 |
| vitamin d3 | #3373 |
| editor | #3377 |
| antinuclear antibodies | #3382 |
| sle | #3384 |
| genetic polymorphisms | #3385 |
| ovariectomy | #3386 |
| mechanistic studies | #3395 |
| macroporous | #3395 |
| levels inflammatory | #3395 |
| explains | #3396 |
| mount | #3397 |
| tubercle | #3402 |
| somatic mutations | #3406 |
| receptors transforming | #3410 |
| early phase | #3413 |
| haptens | #3413 |
| positions | #3418 |
| erythematosus systemic | #3419 |
| nk cells | #3419 |
| neutrophil activation | #3421 |
| reacts | #3421 |
| penetrant | #3425 |
| reply | #3432 |
| proving | #3434 |
| receptor type | #3434 |
| dendritic cells | #3436 |
| serum igg | #3437 |
| alleles | #3440 |
| permitted | #3441 |
| cauda | #3443 |
| 4 months | #3444 |
| injection | #3445 |
| superoxide production | #3446 |
| protein tyrosine | #3447 |
| obscure | #3448 |
| humans immunization | #3448 |
| increased sensitivity | #3449 |
| antimicrobial peptide | #3451 |
| diffusely | #3459 |
| characterised | #3469 |
| h5n1 | #3470 |
| patients sle | #3470 |
| flow cytometry | #3476 |
| modifying | #3477 |
| inflammatory mediators | #3491 |
| multimers | #3491 |
| proteoglycan | #3496 |
| successes | #3497 |
| il21 | #3500 |
| ly | #3501 |
| elucidate | #3503 |
| developed | #3505 |
| classical | #3505 |
| protein processing | #3506 |
| salivary gland | #3507 |
| publication animals animals | #3509 |
| neutrophilic | #3510 |
| pathobiology | #3511 |
| pathological features | #3517 |
| specific cd4 | #3519 |
| globulins | #3526 |
| deoxyguanosine | #3528 |
| 267 | #3528 |
| germline | #3529 |
| phenotypically | #3529 |
| predispose | #3532 |
| lacrimal | #3534 |
| micrometer | #3534 |
| transglutaminases | #3535 |
| radiolabelled | #3539 |
| cyclosporins | #3540 |
| regulatory cells tregs | #3540 |
| mbq | #3541 |
| dominantly | #3548 |
| histological examination | #3554 |
| investigate | #3559 |
| infections staphylococcus | #3561 |
| mast cells | #3563 |
| cultured disease models | #3568 |
| socs1 | #3570 |
| humans interferon | #3571 |
| histological | #3574 |
| homogenate | #3576 |
| interesting | #3580 |
| gamma | #3580 |
| negative patients | #3583 |
| artificially | #3584 |
| role development | #3585 |
| cytolytic | #3589 |
| hindlimb | #3590 |
| il33 | #3593 |
| compared wild | #3597 |
| triggered | #3597 |
| usage | #3601 |
| immunohistochemical staining | #3608 |
| upregulation | #3612 |
| previous findings | #3617 |
| intranasal | #3619 |
| tcr | #3622 |
| cleave | #3624 |
| potential roles | #3624 |
| genetic association | #3629 |
| attenuate | #3633 |
| rp | #3633 |
| mapping chromosomes | #3634 |
| valuable | #3637 |
| genetic | #3637 |
| adhere | #3638 |
| today | #3645 |
| cultured culture media | #3651 |
| allele | #3655 |
| gene deletion | #3657 |
| enhances | #3657 |
| cd4 positive | #3659 |
| exerts | #3663 |
| clinical severity | #3665 |
| tolllike receptor | #3665 |
| luminol | #3667 |
| 95 association | #3671 |
| cd44 | #3678 |
| il23 | #3690 |
| tgf beta | #3691 |
| female genes | #3694 |
| fibronectins | #3697 |
| toll receptors | #3700 |
| igg igm | #3702 |
| heavy chain | #3705 |
| synovitis | #3708 |
| publication animals humans | #3708 |
| cyclohexanecarboxylic | #3709 |
| aggregated | #3717 |
| inbred nod mice | #3730 |
| systemic male | #3735 |
| sequence deletion | #3740 |
| dh | #3742 |
| 378 | #3746 |
| cells produce | #3750 |
| therapeutic benefit | #3752 |
| macrophage cell | #3753 |
| mediate | #3754 |
| contributing | #3754 |
| complement c4 | #3758 |
| immunochemistry | #3759 |
| type 4 | #3763 |
| biomedicine | #3763 |
| lymphocytes tumor | #3766 |
| epitope mapping | #3767 |
| identification | #3771 |
| partum | #3772 |
| mtdna | #3773 |
| d3 | #3775 |
| th17 | #3786 |
| jakob | #3786 |
| reduced expression | #3787 |
| diphtheria | #3803 |
| immunohistochemical | #3805 |
| hind | #3808 |
| skewed | #3820 |
| superoxide | #3822 |
| integrins | #3822 |
| ribonucleoprotein | #3823 |
| new opportunities | #3831 |
| models immunological | #3834 |
| encompassing | #3838 |
| puerperal | #3839 |
| mmp9 expression | #3839 |
| noncoding rna | #3840 |
| unclear | #3847 |
| amelioration | #3854 |
| il17 | #3858 |
| postulate | #3858 |
| identical | #3859 |
| housed | #3861 |
| genetic dna | #3867 |
| cells treg | #3873 |
| genetic promoter regions | #3880 |
| kinase2 | #3887 |
| prominent | #3887 |
| glycoside | #3887 |
| reacting | #3888 |
| dinucleotide | #3894 |
| decreased levels | #3896 |
| synoviocytes | #3900 |
| microsatellite repeats | #3903 |
| superoxides | #3904 |
| dominate | #3907 |
| recognition | #3912 |
| endogenous | #3918 |
| established | #3919 |
| animal studies | #3926 |
| rats messenger | #3931 |
| hladr | #3934 |
| immunophenotyping | #3941 |
| manifestations | #3942 |
| nerves | #3944 |
| toes | #3946 |
| neutrophils | #3947 |
| affect | #3947 |
| polymorphism | #3949 |
| gingivalis | #3957 |
| nets | #3958 |
| mechanisms involved | #3961 |
| involvement | #3973 |
| disrupted | #3975 |
| associate | #3975 |
| 297 | #3982 |
| adult arthritis | #3988 |
| stimulate | #3992 |
| heavy chains | #3992 |
| ifn β | #3999 |
| question | #3999 |
| broader | #4001 |
| patients osteoarthritis | #4009 |
| elevated levels | #4012 |
| sinuses | #4016 |
| superoxide dismutase | #4018 |
| chondrocytes | #4018 |
| individual patients | #4028 |
| ags | #4029 |
| inflammatory processes | #4033 |
| influences | #4034 |
| higher expression | #4034 |
| efficiently | #4050 |
| glycoproteins | #4054 |
| hla alleles | #4059 |
| expression cell | #4063 |
| conferred | #4065 |
| c1q | #4069 |
| fragments | #4072 |
| produce | #4072 |
| hinge | #4074 |
| eliciting | #4075 |
| stat4 | #4076 |
| requirement | #4076 |
| glycoprotein | #4077 |
| plethora | #4077 |
| contrast | #4085 |
| llc | #4089 |
| upregulated | #4090 |
| systemic lupus | #4092 |
| expression type | #4098 |
| fine mapping | #4102 |
| atpases | #4103 |
| leukocyte | #4105 |
| glands | #4107 |
| conferring | #4108 |
| neutrophil | #4113 |
| creutzfeldt | #4115 |
| current concepts | #4116 |
| gelatin | #4120 |
| absent | #4121 |
| therapy genetic | #4122 |
| sclerosis animals | #4124 |
| drives | #4126 |
| regulatory cells | #4126 |
| protect | #4131 |
| mycobacterial | #4133 |
| promoter polymorphism | #4137 |
| stat1 | #4144 |
| functionally | #4147 |
| articular cartilage | #4161 |
| lupus erythematosus | #4162 |
| hla dq | #4165 |
| motor neurons | #4166 |
| polygenic | #4169 |
| placenta pregnancy | #4173 |
| tumour necrosis factor | #4177 |
| stimulatory | #4178 |
| early pregnancy | #4180 |
| immunology | #4183 |
| effector | #4184 |
| systemic disease | #4187 |
| superoxide anion | #4191 |
| infiltrating lymphocytes | #4192 |
| spe | #4193 |
| monocyte | #4201 |
| breeders | #4203 |
| enterotoxin | #4206 |
| ici | #4207 |
| porphyromonas gingivalis | #4207 |
| beads | #4213 |
| antigens cd8 | #4214 |
| animal drug | #4222 |
| depletion | #4223 |
| cytometric analysis | #4224 |
| parathyroid | #4225 |
| long noncoding | #4227 |
| mutant | #4232 |
| inbred balb | #4239 |
| treated mice | #4242 |
| macrophage infiltration | #4244 |
| kidneys | #4244 |
| granulocytic | #4249 |
| continuously | #4250 |
| chondrosarcoma | #4250 |
| witnessed | #4252 |
| conjunction | #4256 |
| immunological | #4257 |
| immunity innate | #4258 |
| bout | #4260 |
| igh | #4262 |
| lymphoid | #4264 |
| cell repertoire | #4268 |
| day1 | #4270 |
| denominator | #4270 |
| complex | #4272 |
| suggestive | #4276 |
| dermatitis | #4285 |
| experimental mice | #4285 |
| clues | #4286 |
| gene targeting | #4290 |
| cd4 | #4291 |
| balb | #4292 |
| disease genetic | #4294 |
| repertoire | #4302 |
| provocation | #4303 |
| molecular modeling | #4303 |
| sciatic | #4307 |
| shares | #4307 |
| tuberculin | #4308 |
| positive cells | #4309 |
| functional role | #4310 |
| receptors interleukin2 | #4317 |
| cell populations | #4317 |
| suppressive effects | #4320 |
| hydroxy2deoxyguanosine | #4331 |
| pparγ | #4350 |
| new insight | #4353 |
| trypanosomiasis | #4358 |
| glutamine | #4364 |
| fungal infection | #4364 |
| peritonitis | #4365 |
| wildtype | #4370 |
| immunoassays | #4373 |
| swelling | #4375 |
| penetrance | #4381 |
| caused | #4381 |
| cell clones | #4396 |
| disease chronic | #4402 |
| mucous | #4402 |
| prevents | #4414 |
| restored | #4417 |
| joint | #4420 |
| modulating | #4426 |
| closer | #4434 |
| receptor beta | #4434 |
| disturbed | #4434 |
| buprenorphine | #4435 |
| model systems | #4443 |
| early | #4453 |
| acute chronic | #4454 |
| aspartic | #4458 |
| parathyroid glands | #4470 |
| confers | #4473 |
| inflammatory pain | #4477 |
| disease duration | #4480 |
| thymocytes | #4481 |
| calmette | #4488 |
| strains rats | #4489 |
| synthase type | #4490 |
| treg | #4493 |
| thickened | #4503 |
| neutralizing antibodies | #4503 |
| human cell | #4505 |
| genetic loci | #4510 |
| extensively | #4516 |
| colitis | #4526 |
| derived cells | #4532 |
| therapeutic implications | #4534 |
| immunotoxins | #4535 |
| beta cells | #4539 |
| cells th2 | #4541 |
| challenged | #4542 |
| lymphocytes cd8 | #4545 |
| 101 | #4546 |
| cytotoxic lymphocytes | #4547 |
| articular chondrocytes | #4553 |
| interleukin5 | #4558 |
| messenger rats rats | #4564 |
| beta cell | #4566 |
| extracellular ca2 | #4576 |
| homing | #4576 |
| hydrolases | #4577 |
| fasl | #4578 |
| cell separation | #4580 |
| proliferative | #4581 |
| neurosecretory | #4585 |
| immunologic | #4592 |
| production inflammatory | #4593 |
| suggests | #4596 |
| inbred shr rats | #4607 |
| modulatory | #4608 |
| ros levels | #4613 |
| igg antibody | #4613 |
| interact | #4613 |
| confer | #4616 |
| depleted | #4639 |
| conditioned medium | #4642 |
| environmental factors | #4643 |
| positive selection | #4658 |
| fashion | #4658 |
| porphyromonas | #4666 |
| visualized | #4667 |
| endorphins | #4669 |
| implicated | #4670 |
| determinant | #4675 |
| causing | #4678 |
| langerhans | #4681 |
| chains | #4681 |
| monocytes macrophages | #4683 |
| animals antigens | #4693 |
| 259 | #4696 |
| female rats | #4699 |
| lymph | #4707 |
| protecting | #4707 |
| inherited | #4709 |
| defined | #4710 |
| destabilization | #4716 |
| facs | #4718 |
| human studies | #4720 |
| orthomyxoviridae infections | #4725 |
| humans inflammation | #4729 |
| cell population | #4734 |
| positive patients | #4736 |
| α1 | #4739 |
| clone | #4741 |
| mediating | #4744 |
| factor 88 | #4750 |
| panel | #4753 |
| gout | #4757 |
| new drugs | #4764 |
| histopathology | #4767 |
| orchiectomy | #4773 |
| cellular localization | #4775 |
| alveolar macrophages | #4776 |
| e4 | #4776 |
| purified | #4778 |
| differing | #4793 |
| eralpha | #4798 |
| male membrane | #4800 |
| rodents | #4801 |
| osteoclastogenesis | #4809 |
| displaying | #4809 |
| hydrolyzed | #4815 |
| tumor antigens | #4816 |
| effector cells | #4819 |
| cytokines | #4821 |
| paw | #4821 |
| cd4 cd8 cells | #4821 |
| cholera | #4822 |
| distinct | #4831 |
| coincides | #4833 |
| litters | #4843 |
| stress rats | #4846 |
| tissue injury | #4847 |
| rats receptors | #4850 |
| interferon γ | #4852 |
| matrix ecm | #4852 |
| stemness | #4860 |
| articular | #4861 |
| venules | #4863 |
| infiltrate | #4868 |
| th17 cells | #4872 |
| tlr2 | #4880 |
| hpa axis | #4882 |
| ifn | #4885 |
| exocrine | #4888 |
| multifactorial | #4889 |
| 116 | #4891 |
| lod | #4892 |
| specific binding | #4893 |
| ige | #4896 |
| humoral immunity | #4897 |
| induced lung | #4899 |
| preimplantation | #4905 |
| essential roles | #4915 |
| discuss | #4916 |
| immunosorbent | #4917 |
| correlating | #4923 |
| interleukins | #4927 |
| deacetylases | #4928 |
| closely | #4932 |
| timepoints | #4940 |
| humans multiple | #4945 |
| deficiency | #4946 |
| naturally occurring | #4962 |
| disease process | #4962 |
| monitored | #4964 |
| elicit | #4966 |
| forelimb | #4967 |
| contradictory | #4975 |
| point mutation | #4976 |
| cell antigen | #4990 |
| understand | #4995 |
| male rats | #4998 |
| kupffer cells | #5001 |
| thymic | #5003 |
| innate immune | #5004 |
| eosinophilia | #5004 |
| modulates | #5011 |
| isotype | #5012 |
| wt | #5012 |
| upa | #5014 |
| opened | #5018 |
| sh3 | #5019 |
| granuloma | #5021 |
| gland | #5024 |
| enhancing | #5026 |
| vimentin | #5026 |
| expand | #5026 |
| poliomyelitis | #5041 |
| explaining | #5042 |
| il5 | #5044 |
| diamines | #5048 |
| heterozygous | #5049 |
| coculture techniques | #5051 |
| cd8 cells | #5055 |
| caveolin | #5065 |
| linkage | #5067 |
| th1 cells | #5067 |
| phospholipid | #5071 |
| arthritis juvenile | #5072 |
| sitedirected mutagenesis | #5076 |
| molecular basis | #5084 |
| cells blood | #5085 |
| bcg | #5086 |
| alum | #5087 |
| autologous | #5087 |
| olive | #5088 |
| new treatment | #5089 |
| multiple sclerosis | #5098 |
| master regulator | #5100 |
| osteopontin | #5109 |
| aged anti | #5110 |
| occurs | #5112 |
| elispot | #5112 |
| sulfasalazine | #5115 |
| isoantibodies | #5120 |
| dq antigens | #5134 |
| contributes | #5139 |
| lesser | #5145 |
| traditionally | #5148 |
| cytosolic | #5152 |
| epidermis | #5158 |
| connection | #5165 |
| cytokines female | #5170 |
| titrated | #5171 |
| preceded | #5175 |
| antigen receptor | #5178 |
| lymphocytes cytotoxic | #5179 |
| binding | #5185 |
| sex characteristics | #5186 |
| transfer | #5187 |
| polymorphism single | #5188 |
| phenotypic | #5191 |
| complement proteins | #5192 |
| molecular level | #5196 |
| ovariectomized | #5210 |
| popliteal | #5224 |
| ers | #5235 |
| serves | #5238 |
| beta2 | #5238 |
| chimeric | #5241 |
| immunosuppressive | #5246 |
| epidermal | #5250 |
| mucus | #5258 |
| cognate | #5258 |
| cd86 | #5261 |
| tested | #5262 |
| deleterious effects | #5266 |
| progenitors | #5270 |
| costimulation | #5275 |
| detects | #5277 |
| osteoclast | #5277 |
| erosion | #5278 |
| prolactin | #5280 |
| therapeutic intervention | #5280 |
| maternally | #5289 |
| gels | #5292 |
| leu | #5294 |
| plasmapheresis | #5298 |
| clinical findings | #5299 |
| neutralization | #5301 |
| drug humans | #5301 |
| key component | #5301 |
| amino | #5310 |
| suggestion | #5312 |
| staphylococcus aureus | #5312 |
| anhydrases | #5315 |
| c57bl 6j | #5320 |
| manner | #5320 |
| spontaneous | #5321 |
| lipopolysaccharides macrophages | #5345 |
| genetic mapping | #5348 |
| ketoglutarate | #5350 |
| opposing | #5352 |
| proinflammatory | #5365 |
| clathrin | #5369 |
| multiplexed | #5371 |
| glomerulonephritis | #5377 |
| modifies | #5379 |
| cultured human | #5386 |
| expansion | #5387 |
| il1α | #5391 |
| tolllike receptors | #5397 |
| oxidation reduction | #5398 |
| new strategies | #5401 |
| mice molecular | #5402 |
| positive lymphocytes | #5402 |
| tnf α | #5411 |
| antiinflammatory agents | #5417 |
| epigenetic mechanisms | #5417 |
| adversely | #5418 |
| activation | #5420 |
| fulvestrant | #5420 |
| dendritic | #5428 |
| antigens surface | #5429 |
| compartments | #5429 |
| signaling molecules | #5432 |
| mif | #5457 |
| cell culture | #5458 |
| wide spectrum | #5473 |
| sideeffects | #5478 |
| multitude | #5482 |
| located | #5499 |
| immunoglobulins | #5500 |
| reproduced | #5507 |
| histological analysis | #5507 |
| lactating | #5515 |
| cytotoxic | #5519 |
| cytokines humans | #5525 |
| balb mice | #5542 |
| therapeutic | #5547 |
| thymus | #5551 |
| immunosuppressive agents | #5559 |
| sexual dimorphism | #5560 |
| pv | #5560 |
| nociceptive | #5565 |
| redox | #5572 |
| cell expansion | #5578 |
| acute lung | #5583 |
| t1d | #5585 |
| percentage | #5588 |
| allergic reactions | #5592 |
| typed | #5596 |
| lipopolysaccharide lps | #5598 |
| potently | #5600 |
| acute lung injury | #5603 |
| oxidase activity | #5613 |
| control animals | #5614 |
| structural homology | #5616 |
| sequence amino | #5621 |
| synthases | #5633 |
| biotinylation | #5642 |
| bead | #5645 |
| pemphigus | #5649 |
| urgent | #5650 |
| type ifn | #5655 |
| proliferative responses | #5658 |
| abolished | #5660 |
| explants | #5660 |
| regarded | #5663 |
| 198 | #5671 |
| directing | #5676 |
| lung mice | #5677 |
| heterotrimeric | #5684 |
| antioxidant defense | #5685 |
| numbers | #5685 |
| aetiology | #5687 |
| triggers | #5689 |
| keratins | #5695 |
| progression disease | #5697 |
| cytokine expression | #5697 |
| skeletal muscle | #5698 |
| experimental animals | #5700 |
| immune mediated | #5710 |
| avenues | #5715 |
| effective treatments | #5735 |
| altogether | #5737 |
| variable | #5759 |
| integrases | #5760 |
| hfd | #5762 |
| ecm | #5776 |
| mechanisms | #5794 |
| mast | #5802 |
| b16 | #5808 |
| linking | #5808 |
| frozen | #5808 |
| inflammatory disorders | #5809 |
| diabetes t1d | #5814 |
| allergic | #5820 |
| splenic | #5829 |
| bal | #5830 |
| hampered | #5832 |
| toxoid | #5835 |
| earliest | #5837 |
| key regulators | #5844 |
| gabapentin | #5847 |
| type receptors | #5850 |
| large proportion | #5851 |
| proteinases | #5862 |
| cfa | #5868 |
| stronger | #5871 |
| disease genotype humans | #5872 |
| deleted | #5875 |
| hyaluronan receptors | #5875 |
| vitro experiments | #5880 |
| microtomography | #5882 |
| single cells | #5896 |
| evidence role | #5898 |
| modulation | #5900 |
| ace2 | #5917 |
| standardization | #5918 |
| abp | #5919 |
| synthetic | #5920 |
| low doses | #5925 |
| bronchoalveolar lavage fluid | #5925 |
| ics | #5932 |
| subclass | #5941 |
| identifying | #5941 |
| depend | #5947 |
| genomic regions | #5947 |
| explain | #5951 |
| interfere | #5953 |
| biobank | #5960 |
| cytokine production | #5962 |
| expression humans | #5965 |
| nerve regeneration | #5966 |
| factor 1 | #5968 |
| avidin | #5970 |
| foxp3 | #5975 |
| costimulatory | #5977 |
| clarify | #5980 |
| symptom onset | #5983 |
| denaturation | #5986 |
| inability | #5988 |
| knee joint | #5990 |
| eosinophils | #5991 |
| cell subset | #6000 |
| glyburide | #6010 |
| immunity | #6010 |
| 88 | #6014 |
| tetanus | #6019 |
| stress induced | #6022 |
| consisting | #6023 |
| fluorescent dyes | #6044 |
| cnvs | #6045 |
| stimulated | #6056 |
| nih | #6065 |
| igm | #6073 |
| cleared | #6074 |
| tumor infiltrating | #6074 |
| laminin | #6075 |
| genetic therapy | #6077 |
| relapsing remitting | #6083 |
| sle patients | #6089 |
| responsible | #6091 |
| undertook | #6097 |
| messengers | #6100 |
| cages | #6103 |
| stat6 | #6105 |
| ligated | #6107 |
| bone diseases | #6115 |
| uncoupling | #6115 |
| telomeric | #6122 |
| infection mice | #6127 |
| unique | #6140 |
| replacing | #6149 |
| plasma cells | #6150 |
| lowers | #6156 |
| inguinal | #6166 |
| responses | #6171 |
| susceptibility gene | #6171 |
| prophylactic | #6183 |
| genomewide association studies | #6193 |
| cell functions | #6210 |
| instances | #6210 |
| models human | #6217 |
| interferon | #6220 |
| translation | #6222 |
| humans lupus | #6235 |
| characterized | #6236 |
| progesterone | #6253 |
| introduction | #6260 |
| cell type | #6265 |
| exclusively | #6269 |
| protective | #6270 |
| microarray | #6272 |
| serum concentration | #6278 |
| sexes | #6280 |
| immune cell | #6285 |
| myelomonocytic | #6286 |
| histone | #6287 |
| biological evaluation | #6290 |
| difficult | #6298 |
| dermis | #6313 |
| sheath | #6316 |
| monolithic | #6318 |
| minor | #6320 |
| allowed | #6320 |
| tracheal | #6322 |
| estrus | #6336 |
| immunomodulatory | #6337 |
| lymphocyte count | #6339 |
| localize | #6347 |
| tumor immune | #6348 |
| borrelia burgdorferi | #6355 |
| cell biology | #6355 |
| remitting | #6355 |
| microsatellite | #6356 |
| virgin | #6356 |
| signs | #6360 |
| tears | #6363 |
| tryptic | #6370 |
| pertussis | #6372 |
| unresolved | #6378 |
| ros generation | #6379 |
| cells cell | #6381 |
| metalloproteinase | #6392 |
| human subjects | #6394 |
| nicotinamide | #6408 |
| registers | #6410 |
| prodromal | #6450 |
| gonadal | #6451 |
| neuropathological | #6454 |
| models molecular | #6455 |
| peritoneum | #6460 |
| express | #6470 |
| biologic | #6473 |
| transgenes | #6474 |
| c4 | #6475 |
| immunity mucosal | #6476 |
| inoculation | #6477 |
| genetic variants | #6477 |
| severe | #6501 |
| gene function | #6502 |
| demonstrates | #6508 |
| organ specificity | #6511 |
| cell numbers | #6513 |
| stages | #6515 |
| chronic | #6523 |
| synergy | #6523 |
| nitrite | #6523 |
| share | #6539 |
| played | #6540 |
| apc | #6559 |
| proteins animals | #6559 |
| antibody titers | #6572 |
| cytotoxicity immunologic | #6575 |
| pace | #6583 |
| rheumatic | #6588 |
| proteases | #6588 |
| toll | #6603 |
| expression genes | #6603 |
| stain | #6604 |
| major source | #6614 |
| translocating | #6615 |
| parturition | #6635 |
| hpa | #6636 |
| whitney | #6639 |
| solid phase | #6644 |
| affinity | #6645 |
| regulation | #6650 |
| parenchyma | #6650 |
| presently | #6651 |
| sclerosis | #6655 |
| memory cell | #6657 |
| cystine | #6658 |
| cells cd4 | #6665 |
| subfamily | #6672 |
| animals antioxidants | #6683 |
| melatonin | #6683 |
| current understanding | #6687 |
| burgdorferi | #6696 |
| macrophages alveolar | #6701 |
| long noncoding rnas | #6715 |
| histone deacetylases | #6742 |
| normal levels | #6747 |
| pups | #6747 |
| estrogens | #6749 |
| demonstration | #6755 |
| relevant | #6761 |
| comparative genomics | #6768 |
| elastase | #6774 |
| cd8 positive | #6776 |
| helpful | #6782 |
| interleukin18 | #6782 |
| cytometric | #6804 |
| demonstrate | #6812 |
| study role | #6813 |
| glucose transport | #6814 |
| crystal structure | #6819 |
| intra articular | #6825 |
| induced acute | #6825 |
| eosinophil | #6829 |
| cterminal | #6829 |
| cd19 | #6829 |
| conflicting | #6830 |
| lname | #6833 |
| antilymphocyte | #6836 |
| molecules | #6840 |
| case control | #6852 |
| aspergillosis | #6852 |
| lymphoid tissues | #6854 |
| participates | #6855 |
| periodontal disease | #6855 |
| vascular endothelium | #6862 |
| sciatic nerve | #6863 |
| alter | #6865 |
| bioreactors | #6867 |
| activating | #6871 |
| facial nerve | #6873 |
| cell communication | #6882 |
| tool | #6883 |
| cytokine release | #6887 |
| lethality | #6889 |
| inflammatory responses | #6893 |
| lung injury | #6900 |
| ankle joint | #6907 |
| harboring | #6908 |
| gastritis | #6915 |
| tumour necrosis | #6921 |
| recessive | #6922 |
| acetaldehyde | #6925 |
| induced pulmonary | #6931 |
| alternative | #6934 |
| microarray analysis | #6937 |
| cyclic | #6951 |
| inflammatory response | #6953 |
| sulfones | #6960 |
| player | #6974 |
| likewise | #6976 |
| exacerbations | #6984 |
| cdr | #6993 |
| equally | #7001 |
| rac1 | #7013 |
| biological function | #7014 |
| mapping | #7016 |
| degrade | #7020 |
| translational | #7020 |
| mimic | #7025 |
| fewer | #7033 |
| assay elisa | #7033 |
| suppressing | #7047 |
| th1 th2 | #7048 |
| histology | #7056 |
| nucleotide | #7060 |
| target cells | #7063 |
| genome wide | #7063 |
| heterogeneous | #7071 |
| aureus | #7072 |
| subjected | #7072 |
| immune cells | #7075 |
| serine proteases | #7082 |
| proportion | #7083 |
| reduced | #7086 |
| glomeruli | #7088 |
| finally | #7092 |
| atherosclerotic lesions | #7094 |
| orthomyxoviridae | #7108 |
| lyme disease | #7115 |
| thp1 cells | #7121 |
| apoptotic cells | #7124 |
| dividing | #7134 |
| mounted | #7137 |
| autophagy | #7144 |
| extracellular | #7153 |
| immunity cellular | #7161 |
| genetic markers | #7162 |
| messenger rats | #7166 |
| cascades | #7175 |
| synteny | #7188 |
| moiety | #7194 |
| promoted | #7198 |
| higher incidence | #7202 |
| lymphoid tissue | #7205 |
| bovine serum albumin | #7219 |
| dependency | #7223 |
| amino acid | #7225 |
| relevance | #7233 |
| mtx | #7237 |
| recognised | #7238 |
| polysaccharides | #7242 |
| sirt1 | #7251 |
| participate | #7253 |
| prevalent | #7262 |
| immuno | #7265 |
| role pathogenesis | #7272 |
| breeding | #7286 |
| inheritance | #7292 |
| rolling | #7300 |
| prime | #7313 |
| dissecting | #7326 |
| avidity | #7332 |
| expressed genes | #7334 |
| adhesins | #7335 |
| inflammasome | #7342 |
| potential targets | #7343 |
| secreted | #7347 |
| disease specific | #7350 |
| uncontrolled | #7353 |
| metalloendopeptidases | #7355 |
| microglobulin | #7363 |
| adulthood | #7369 |
| transduction animals | #7370 |
| oxide nitric | #7377 |
| array | #7387 |
| analyses | #7391 |
| nervous | #7406 |
| transglutaminase | #7410 |
| interleukin6 | #7411 |
| chemokines | #7411 |
| proven | #7418 |
| supernatants | #7428 |
| genotyping | #7446 |
| immunocytochemistry | #7453 |
| fusion protein | #7456 |
| cells peripheral | #7461 |
| β2 | #7467 |
| airways | #7489 |
| adjuvant | #7493 |
| inhibitory factor | #7500 |
| cytotoxic cells | #7518 |
| disease incidence | #7535 |
| anchor | #7536 |
| eliminate | #7540 |
| early disease | #7541 |
| il1 beta | #7545 |
| lesser extent | #7547 |
| interleukin1beta | #7549 |
| necrotic | #7550 |
| activity relationship | #7553 |
| responder | #7562 |
| elevations | #7589 |
| interacting | #7594 |
| micrograms | #7596 |
| appeared | #7610 |
| hydrocarbon | #7610 |
| arginine | #7621 |
| evident | #7628 |
| cytometry | #7630 |
| unexplained | #7632 |
| allogeneic | #7640 |
| peripheral nervous | #7645 |
| sustain | #7654 |
| receptors immunologic | #7659 |
| component | #7661 |
| graft survival | #7661 |
| murine model | #7665 |
| considerable | #7704 |
| histone deacetylase | #7707 |
| placental | #7712 |
| differentially expressed | #7721 |
| chromosomes | #7722 |
| activators | #7728 |
| motifs | #7730 |
| critical roles | #7731 |
| diagnostics | #7735 |
| bacterial toxins | #7735 |
| initiation | #7745 |
| 325 | #7749 |
| rodent | #7751 |
| chain | #7753 |
| granulocyte | #7754 |
| leukocytes mononuclear | #7766 |
| candidate genes | #7769 |
| mer | #7772 |
| activates | #7772 |
| 37°c | #7773 |
| manuscript | #7780 |
| resolving | #7797 |
| carbonic | #7798 |
| cells tregs | #7800 |
| cell surface receptors | #7807 |
| diet fat | #7810 |
| tgf beta1 | #7831 |
| lipopolysaccharides | #7836 |
| patients levels | #7843 |
| strain | #7844 |
| cells pbmcs | #7853 |
| sirtuin | #7854 |
| retinoid | #7862 |
| interleukin1 | #7866 |
| ifnγ | #7872 |
| gene therapy | #7878 |
| amenable | #7895 |
| analyze | #7897 |
| illness | #7901 |
| lymphopenia | #7909 |
| 2nd | #7917 |
| th2 | #7918 |
| fact | #7925 |
| mann | #7929 |
| myocarditis | #7932 |
| discoveries | #7955 |
| cellular immune | #7957 |
| immunodiffusion | #7959 |
| transform infrared | #7960 |
| positive | #7982 |
| nitrites | #7983 |
| candidate gene | #7987 |
| scoring | #7989 |
| direct effects | #7991 |
| tregs | #7991 |
| unknown | #7993 |
| immune function | #7994 |
| oxidative | #7996 |
| fertilized | #8002 |
| identifies | #8007 |
| haplotypes humans | #8011 |
| polymorphisms | #8012 |
| psa | #8015 |
| essential | #8017 |
| hydroxy | #8030 |
| capacity | #8031 |
| raised | #8040 |
| lncrna | #8047 |
| macroscopic | #8049 |
| myeloid differentiation | #8054 |
| respiratory distress | #8063 |
| address | #8064 |
| drive | #8066 |
| evaluation preclinical | #8067 |
| factor signal | #8077 |
| ascertained | #8077 |
| spanning | #8085 |
| hypophyseal | #8087 |
| appearing | #8088 |
| tetramer | #8088 |
| clinical evaluation | #8089 |
| suboptimal | #8101 |
| physiological | #8105 |
| prolongation | #8108 |
| homozygosity | #8108 |
| considerably | #8109 |
| intronic | #8113 |
| prerequisite | #8120 |
| reasons | #8130 |
| nash | #8133 |
| bovine | #8133 |
| latest | #8134 |
| macrophages peritoneal | #8141 |
| definition | #8141 |
| dying | #8148 |
| trachea | #8156 |
| peripheral nerve | #8160 |
| relapses | #8166 |
| conditioned | #8167 |
| elevated | #8167 |
| characterize | #8170 |
| harbor | #8170 |
| bacterial infection | #8176 |
| expression | #8180 |
| member | #8181 |
| induced inflammation | #8186 |
| rescue | #8192 |
| sacrificed | #8197 |
| cassette | #8198 |
| analysing | #8209 |
| underlying | #8214 |
| preferential | #8216 |
| sulphate | #8225 |
| genetic associations | #8225 |
| defective | #8238 |
| ors | #8241 |
| marginal zone | #8244 |
| foster | #8245 |
| wide | #8261 |
| cultured cytokines | #8268 |
| ppar | #8274 |
| fibrinogen | #8275 |
| bone resorption | #8290 |
| clinical manifestations | #8294 |
| disease genome | #8295 |
| differ | #8295 |
| subcutaneous injection | #8300 |
| streptococcal | #8302 |
| oxygen | #8304 |
| combined treatment | #8309 |
| monoester | #8310 |
| remodeling | #8311 |
| peptide1 | #8316 |
| 11 | #8316 |
| aspergillus fumigatus | #8316 |
| genetically modified | #8320 |
| tlr | #8339 |
| cov2 infection | #8349 |
| boronic | #8363 |
| vh | #8363 |
| frequency | #8364 |
| parietal | #8367 |
| firstly | #8379 |
| fibrils | #8388 |
| migrate | #8391 |
| expressed | #8400 |
| poly | #8401 |
| residue | #8401 |
| p001 | #8404 |
| cd11b | #8408 |
| unaffected | #8411 |
| hydrophilicity | #8420 |
| advancement | #8424 |
| notion | #8424 |
| macrophage activation | #8429 |
| highlights | #8433 |
| defense | #8436 |
| viable | #8460 |
| 14 | #8468 |
| lamina | #8472 |
| manifestation | #8482 |
| protein conformation | #8485 |
| damaging | #8500 |
| promotes | #8502 |
| booster | #8512 |
| inflammatory process | #8516 |
| involves | #8520 |
| cells express | #8525 |
| mildly | #8527 |
| phenotype | #8539 |
| drug development | #8539 |
| burkholderia | #8540 |
| forkhead transcription | #8544 |
| human neutrophils | #8545 |
| estradiol | #8546 |
| copy | #8554 |
| tubule | #8558 |
| adaptive | #8568 |
| inflammatory cytokines | #8576 |
| responsive | #8580 |
| cellular functions | #8582 |
| marginal | #8600 |
| productive | #8609 |
| region | #8618 |
| stress reactive | #8622 |
| chickens | #8638 |
| xanthine | #8641 |
| positivity | #8659 |
| uncovered | #8689 |
| inducers | #8705 |
| outline | #8708 |
| experimental mice mice | #8716 |
| vigorous | #8717 |
| constitutive expression | #8717 |
| ccaat | #8720 |
| staphylococci | #8725 |
| regulatory cell | #8734 |
| cytokine | #8750 |
| recovered | #8751 |
| resorption | #8757 |
| rejection | #8759 |
| larynx | #8761 |
| subset | #8775 |
| chemokine receptor | #8777 |
| impaired | #8781 |
| highlight | #8782 |
| promoter | #8789 |
| cells human | #8790 |
| homozygous | #8792 |
| 4 weeks | #8792 |
| generate | #8799 |
| fungal infections | #8807 |
| human serum | #8808 |
| occasionally | #8808 |
| parotid | #8809 |
| chemically | #8809 |
| generates | #8811 |
| female male | #8812 |
| cytokine levels | #8825 |
| correlated | #8830 |
| kupffer | #8836 |
| cell phenotype | #8866 |
| pathway | #8867 |
| precisely | #8877 |
| bovis | #8882 |
| pathways | #8883 |
| unidentified | #8885 |
| frequencies | #8890 |
| deletion | #8893 |
| key regulator | #8903 |
| endopeptidases | #8922 |
| flow cytometric | #8932 |
| hypothalamo | #8941 |
| strengthen | #8941 |
| and or | #8942 |
| staining | #8944 |
| chemiluminescence | #8945 |
| modulate | #8948 |
| pge2 | #8966 |
| pitfalls | #8967 |
| subpopulation | #8967 |
| attack | #8975 |
| neonatal | #8981 |
| gene | #8983 |
| endosomal | #8987 |
| 129 | #8990 |
| vasculature | #9008 |
| rna long | #9017 |
| adrenocorticotropic | #9019 |
| chemoattractant | #9019 |
| discriminate | #9043 |
| thp1 | #9068 |
| leading | #9074 |
| positioned | #9075 |
| specific role | #9081 |
| glut4 | #9084 |
| hl60 | #9115 |
| cd4 cell | #9129 |
| differentially | #9131 |
| human | #9131 |
| cell surface | #9135 |
| pad | #9136 |
| ongoing | #9160 |
| reconstitution | #9166 |
| negative | #9175 |
| causative | #9182 |
| preincubation | #9186 |
| secrete | #9196 |
| tnf | #9198 |
| lethal | #9205 |
| serologic | #9213 |
| respiratory syndrome | #9222 |
| started | #9233 |
| innate immunity | #9233 |
| sequence | #9238 |
| cells isolated | #9241 |
| glomerulus | #9242 |
| immortalized | #9244 |
| severely | #9250 |
| offer | #9255 |
| orphan | #9255 |
| millions | #9268 |
| ubiquitous | #9272 |
| matrix | #9273 |
| killer | #9278 |
| crystal structures | #9313 |
| clear | #9315 |
| smoking status | #9329 |
| sdspage | #9335 |
| copolymers | #9346 |
| carbohydrate | #9368 |
| neutralizing | #9381 |
| immunoblot | #9395 |
| sweden | #9420 |
| functionality | #9425 |
| cysteine | #9458 |
| ifnα | #9459 |
| lacks | #9460 |
| treatment strategies | #9463 |
| immunomodulation | #9473 |
| luminescent | #9474 |
| molecular | #9484 |
| endotoxins | #9487 |
| tlr4 | #9501 |
| immobilized | #9505 |
| immunofluorescence | #9519 |
| hormonal | #9519 |
| cyclosporin | #9519 |
| sensitized | #9523 |
| detrimental | #9524 |
| heritable | #9530 |
| preexisting | #9543 |
| neuroinflammation | #9558 |
| factor beta1 | #9560 |
| interferon regulatory | #9572 |
| regulated | #9576 |
| culture techniques | #9577 |
| analogous | #9593 |
| entering | #9608 |
| affinities | #9614 |
| steroid hormones | #9615 |
| pretreated | #9624 |
| vaccinated | #9638 |
| gestation | #9639 |
| mammalian cells | #9643 |
| attached | #9647 |
| genetic models | #9655 |
| basement membrane | #9657 |
| key | #9658 |
| vehicle | #9670 |
| cell adhesion | #9678 |
| dramatic | #9694 |
| slight | #9694 |
| accessible | #9708 |
| snp | #9709 |
| azathioprine | #9721 |
| ear | #9723 |
| environment interaction | #9730 |
| humanized | #9753 |
| livers | #9753 |
| maintenance | #9756 |
| metabolic syndrome mets | #9758 |
| functional analysis | #9772 |
| blocked | #9776 |
| cleavage | #9781 |
| microscopic | #9784 |
| adhesion cell | #9784 |
| nasal | #9786 |
| plasminogen activator | #9788 |
| structure activity | #9789 |
| infectious | #9804 |
| lowered | #9804 |
| sterile | #9810 |
| driven | #9836 |
| fibronectin | #9846 |
| delineation | #9856 |
| rheumatology | #9870 |
| phage | #9872 |
| memory cells | #9874 |
| nonhuman primates | #9876 |
| pathogens | #9902 |
| serological | #9907 |
| coculture | #9927 |
| interleukin8 | #9936 |
| healthy control | #9938 |
| reactions | #9953 |
| monkeys | #9973 |
| anticipated | #9993 |
| nucleic acids | #10007 |
| flare | #10014 |
| inflammatory cytokine | #10023 |
| genotype | #10053 |
| serum | #10061 |
| leukocytes | #10067 |
| administered | #10070 |
| differentiation factor | #10076 |
| inflammation male | #10091 |
| generating | #10093 |
| surface receptors | #10102 |
| fibrin | #10105 |
| cells patients | #10110 |
| virulence factors | #10110 |
| activated | #10122 |
| ccl4 | #10125 |
| il1beta | #10131 |
| edge | #10132 |
| new strategy | #10136 |
| host cells | #10139 |
| mitogens | #10140 |
| kappa | #10143 |
| cell signaling | #10143 |
| th2 cells | #10147 |
| retroviridae | #10157 |
| postmenopausal | #10172 |
| traps | #10177 |
| hydrogen peroxide | #10184 |
| placenta | #10185 |
| named | #10188 |
| tlrs | #10207 |
| delta | #10218 |
| summarize | #10236 |
| day | #10244 |
| molecular biology | #10259 |
| rats spraguedawley receptors | #10277 |
| arg | #10279 |
| reproducible | #10283 |
| animals anti | #10304 |
| germ | #10305 |
| gene environment | #10307 |
| tendency | #10317 |
| scid | #10324 |
| lectins | #10329 |
| dismutase | #10332 |
| avian influenza | #10343 |
| reductive | #10347 |
| complete | #10365 |
| mediators | #10378 |
| nterminal | #10392 |
| partially | #10400 |
| lasting | #10406 |
| promote | #10424 |
| determine | #10429 |
| cterminus | #10432 |
| refined | #10437 |
| kill | #10441 |
| cattle | #10446 |
| assays | #10447 |
| indirectly | #10460 |
| mediates | #10474 |
| thioredoxin | #10475 |
| occur | #10477 |
| motif | #10479 |
| redundant | #10502 |
| receptor binding | #10504 |
| developing | #10513 |
| behavior animal | #10515 |
| promoter regions | #10545 |
| phosphate | #10548 |
| produced | #10552 |
| exception | #10554 |
| dysregulated | #10557 |
| critical | #10564 |
| influence | #10568 |
| understood | #10572 |
| converting enzyme | #10584 |
| progressive | #10597 |
| rise | #10608 |
| female | #10609 |
| shortened | #10612 |
| small molecule | #10616 |
| nf kappa | #10617 |
| extracellular matrix | #10620 |
| paralysis | #10632 |
| primers | #10636 |
| collectively | #10637 |
| underlie | #10642 |
| testosterone | #10659 |
| macrophage colony | #10664 |
| selective inhibitor | #10667 |
| aged osteoarthritis | #10675 |
| summary | #10684 |
| repeats | #10685 |
| pbs | #10702 |
| respond | #10705 |
| cerebrospinal fluid | #10708 |
| 17 | #10713 |
| disruption | #10729 |
| issue | #10762 |
| conformation | #10767 |
| il18 | #10770 |
| generation | #10781 |
| cleaved | #10800 |
| 103 | #10811 |
| conditional | #10821 |
| capture | #10822 |
| operated | #10824 |
| seropositive | #10826 |
| cellular mechanisms | #10838 |
| belonging | #10857 |
| saline | #10857 |
| restraint | #10864 |
| phosphatase | #10866 |
| immunoblotting | #10872 |
| factor1 | #10880 |
| base | #10885 |
| connective tissue | #10896 |
| multifunctional | #10904 |
| phagocytosis | #10904 |
| avoid | #10909 |
| ineffective | #10909 |
| luciferase | #10915 |
| bronchoalveolar | #10916 |
| promise | #10920 |
| secondary | #10926 |
| pivotal | #10926 |
| mulatta | #10929 |
| mannose | #10934 |
| persisted | #10939 |
| concluded | #10955 |
| methotrexate | #10967 |
| myeloid cells | #10978 |
| airway inflammation | #10982 |
| degrading | #10983 |
| immunoassay | #10984 |
| subcutaneously | #10984 |
| characterization | #10986 |
| governing | #10998 |
| ethanol | #11000 |
| septic | #11000 |
| tnfα | #11003 |
| mpo | #11010 |
| cell subsets | #11012 |
| originally | #11016 |
| 263 | #11027 |
| immunohistochemistry | #11028 |
| occurrence | #11030 |
| scid mice | #11030 |
| messenger | #11037 |
| hyper | #11040 |
| optical imaging | #11045 |
| skin | #11056 |
| establish | #11066 |
| calcitriol | #11067 |
| tumor progression | #11088 |
| paternal | #11094 |
| add | #11096 |
| freezing | #11102 |
| systemic | #11112 |
| infection animals | #11117 |
| focusing | #11144 |
| genetic polymorphism | #11161 |
| male | #11167 |
| innate immune response | #11167 |
| osteoarthritis | #11176 |
| influx | #11177 |
| receptors | #11177 |
| subsequent | #11177 |
| affinity chromatography | #11186 |
| genes involved | #11187 |
| ankylosing spondylitis | #11197 |
| article | #11201 |
| directly | #11208 |
| bsa | #11210 |
| limited | #11223 |
| sorting | #11229 |
| elicited | #11230 |
| interleukin10 | #11232 |
| disulfides | #11233 |
| contributed | #11248 |
| peptidase | #11251 |
| human blood | #11281 |
| ability | #11284 |
| extensive | #11297 |
| humans influenza | #11314 |
| genotyped | #11318 |
| compared controls | #11322 |
| depends | #11323 |
| oxidant | #11344 |
| caution | #11347 |
| addressing | #11351 |
| tissue damage | #11352 |
| correlate | #11354 |
| extra | #11356 |
| histopathologic | #11376 |
| neuroglia | #11384 |
| modifications | #11385 |
| experimental evidence | #11409 |
| increased expression | #11410 |
| pharmacology | #11413 |
| oxidative phosphorylation | #11428 |
| eosinophilic | #11432 |
| interleukin12 | #11437 |
| quantified | #11438 |
| receptor | #11445 |
| hla class | #11447 |
| cell death | #11460 |
| enhance | #11461 |
| reduces | #11466 |
| governed | #11476 |
| initiating | #11479 |
| contrasting | #11480 |
| melanoma cells | #11488 |
| compared healthy | #11489 |
| cd8 cell | #11498 |
| ankle | #11508 |
| serine | #11525 |
| cytosol | #11542 |
| recipient | #11546 |
| ca2 | #11559 |
| therapeutic interventions | #11561 |
| mets | #11566 |
| jurkat | #11569 |
| backgrounds | #11570 |
| inflammatory effects | #11595 |
| culture medium | #11599 |
| differential expression | #11606 |
| alteration | #11627 |
| frequently | #11627 |
| chicken | #11649 |
| swiss | #11652 |
| enhanced | #11661 |
| exerted | #11663 |
| immunologic memory | #11672 |
| transforming growth | #11678 |
| relief | #11691 |
| synergism | #11703 |
| psychotic | #11730 |
| controls | #11730 |
| toxin | #11735 |
| aiming | #11737 |
| innovative | #11751 |
| amyotrophic | #11769 |
| cell lineage | #11773 |
| constitutes | #11774 |
| inoculated | #11781 |
| commentary | #11785 |
| multiple | #11805 |
| selective | #11814 |
| display | #11817 |
| moderately | #11819 |
| altered | #11829 |
| insufficient | #11830 |
| sequence homology | #11840 |
| 9 | #11857 |
| graft | #11866 |
| analogues | #11871 |
| forkhead | #11888 |
| stained | #11890 |
| enzyme | #11942 |
| augmentation | #11943 |
| classic | #11944 |
| supplied | #11946 |
| gastrointestinal tract | #11958 |
| animals bone | #11966 |
| reveal | #11966 |
| maternal fetal | #11968 |
| adherent | #11980 |
| stress response | #11991 |
| contribution | #11998 |
| tgf | #12005 |
| biomarker | #12016 |
| antiserum | #12017 |
| cricetulus | #12021 |
| deacetylase | #12050 |
| encoding | #12051 |
| plasma cell | #12059 |
| aethiops | #12067 |
| propose | #12072 |
| fat diet | #12104 |
| immunologic factors | #12106 |
| protection | #12107 |
| downstream | #12107 |
| il2 | #12111 |
| tyrosine | #12113 |
| lung | #12116 |
| effectively | #12118 |
| replaced | #12144 |
| induced cell | #12147 |
| bromide | #12152 |
| humans | #12155 |
| quiescent | #12181 |
| switched | #12181 |
| genetic vectors | #12203 |
| oligodeoxyribonucleotides | #12204 |
| histologic | #12222 |
| myd88 | #12222 |
| lectin | #12223 |
| therapeutics | #12230 |
| mesenteric | #12231 |
| toxic | #12231 |
| represents | #12233 |
| receptors estrogen | #12236 |
| corticosterone | #12242 |
| noncoding | #12244 |
| diabetic mice | #12257 |
| fibroblasts humans | #12268 |
| recombinant | #12270 |
| splice | #12271 |
| involving | #12273 |
| fluorescent antibody | #12276 |
| mineral | #12297 |
| tnf alpha | #12300 |
| streptococcus | #12310 |
| harmful | #12319 |
| depending | #12361 |
| acid | #12363 |
| leukocyte count | #12369 |
| syndromes | #12371 |
| tradeoff | #12389 |
| interplay | #12412 |
| origin | #12416 |
| clonal | #12420 |
| microfilament | #12423 |
| reversed | #12439 |
| publication adaptor proteins | #12462 |
| weaker | #12464 |
| protein expression | #12503 |
| pain | #12532 |
| hydrochloride | #12535 |
| drug design | #12567 |
| functional | #12573 |
| rats treated | #12596 |
| suppressor | #12596 |
| binding site | #12597 |
| monomeric | #12605 |
| cells natural | #12637 |
| medullary | #12637 |
| explained | #12643 |
| macaca | #12645 |
| notably | #12664 |
| fetuses | #12665 |
| chronic diseases | #12665 |
| adenine | #12679 |
| cdnas | #12679 |
| 6 weeks | #12681 |
| p38 mitogen | #12681 |
| investigation | #12697 |
| instance | #12709 |
| persistent | #12729 |
| alveolar | #12729 |
| receptor alpha | #12743 |
| modulators | #12770 |
| interactions | #12785 |
| aimed | #12791 |
| nature | #12795 |
| influencing | #12800 |
| diminished | #12804 |
| initiated | #12813 |
| tibia | #12813 |
| sole | #12814 |
| metalloproteinases | #12819 |
| thought | #12823 |
| twin | #12854 |
| isolated | #12871 |
| solely | #12882 |
| disadvantages | #12886 |
| sulfhydryl | #12921 |
| sustained | #12922 |
| assay | #12926 |
| breakdown | #12984 |
| cell division | #13004 |
| embryonic development | #13020 |
| damage | #13056 |
| removing | #13067 |
| tryptophan | #13079 |
| tightly | #13087 |
| crystallography | #13101 |
| hyaluronic | #13102 |
| enabling | #13133 |
| time pcr | #13141 |
| publications | #13143 |
| receptors cell | #13145 |
| stereoisomerism | #13158 |
| distress syndrome | #13175 |
| ancestral | #13179 |
| retained | #13203 |
| valine | #13205 |
| division | #13213 |
| suffering | #13215 |
| single nucleotide polymorphisms | #13234 |
| opportunity | #13243 |
| opportunities | #13258 |
| 1 protein | #13270 |
| chemotaxis | #13279 |
| modulator | #13283 |
| lavage fluid | #13293 |
| transgene | #13297 |
| ascending | #13302 |
| regulators | #13320 |
| elucidated | #13323 |
| purity | #13330 |
| bronchoalveolar lavage | #13334 |
| nk | #13353 |
| fisher | #13357 |
| inhibitory effects | #13362 |
| lymphoproliferative | #13372 |
| amyotrophic lateral | #13377 |
| facilitating | #13380 |
| overexpressed | #13383 |
| scattered | #13389 |
| borrelia | #13393 |
| intact | #13410 |
| independently | #13433 |
| thiol | #13434 |
| fibroblast | #13447 |
| oocytes | #13463 |
| embryos | #13465 |
| marrow derived | #13484 |
| spraguedawley receptors | #13488 |
| overcome | #13489 |
| endopeptidase | #13500 |
| aspect | #13523 |
| lateral sclerosis | #13577 |
| tail | #13589 |
| selectively | #13591 |
| lipopolysaccharide | #13598 |
| elisa | #13612 |
| heritability | #13616 |
| vertebrates | #13627 |
| renal disease | #13634 |
| cure | #13674 |
| peripheral | #13689 |
| reproductive | #13755 |
| clones | #13757 |
| requires | #13783 |
| profiling gene | #13808 |
| lavage | #13811 |
| exon | #13822 |
| arising | #13831 |
| secretory | #13835 |
| techniques | #13873 |
| 6 | #13879 |
| killer cells | #13891 |
| exposed | #13917 |
| cloned | #13927 |
| iga | #13936 |
| hepatocytes | #13938 |
| tolerant | #13992 |
| lncrnas | #14002 |
| anti inflammatory | #14010 |
| killed | #14033 |
| selectin | #14034 |
| sensitization | #14035 |
| environmental | #14057 |
| insertion | #14063 |
| recombinant proteins | #14070 |
| neighboring | #14098 |
| reflects | #14102 |
| great | #14120 |
| preclinical | #14123 |
| highlighting | #14145 |
| preventing | #14148 |
| healthy individuals | #14159 |
| administration | #14164 |
| vaccination | #14176 |
| potent | #14183 |
| retroviral | #14208 |
| multigene | #14246 |
| advances | #14275 |
| amino acids | #14298 |
| ester | #14310 |
| oxidative stress | #14315 |
| cord | #14319 |
| incidence | #14322 |
| impairs | #14323 |
| domain | #14325 |
| psychosis | #14326 |
| p38 | #14329 |
| bovine serum | #14329 |
| isolation | #14334 |
| differentiation | #14342 |
| multiprotein | #14366 |
| mineral density | #14406 |
| #14414 | |
| differentiation cells | #14414 |
| resolve | #14420 |
| colony stimulating | #14421 |
| consistently | #14448 |
| kinases animals | #14452 |
| paracrine | #14452 |
| adenoviridae | #14472 |
| chlorocebus | #14481 |
| marrow transplantation | #14485 |
| targeted | #14490 |
| pathology | #14492 |
| il1 | #14500 |
| integrative | #14510 |
| cells vitro | #14537 |
| monocytes | #14540 |
| bone density | #14589 |
| infectious diseases | #14593 |
| biomedical | #14605 |
| nitrate | #14616 |
| nf kappab | #14627 |
| recombinant human | #14632 |
| divergent | #14638 |
| pathological | #14640 |
| enzyme activation | #14658 |
| lupus nephritis | #14661 |
| smoking | #14673 |
| transforming | #14675 |
| gfp | #14681 |
| inborn | #14696 |
| hand | #14698 |
| green fluorescent | #14703 |
| scarce | #14718 |
| risk developing | #14724 |
| substances | #14724 |
| nitrates | #14728 |
| oxide synthase | #14731 |
| p005 | #14732 |
| particulate | #14751 |
| oxidoreductases | #14753 |
| protein binding | #14757 |
| blood vessels | #14759 |
| human cells | #14768 |
| interferon alpha | #14780 |
| il1β | #14800 |
| degenerative | #14815 |
| proteinase | #14817 |
| originating | #14824 |
| vitro | #14829 |
| overlapping | #14835 |
| biocompatible | #14851 |
| prostaglandins | #14881 |
| controlled | #14895 |
| interaction | #14916 |
| chronically | #14923 |
| genomic dna | #14929 |
| potential therapeutic | #14939 |
| colleagues | #14950 |
| plays | #15011 |
| cross | #15041 |
| implications | #15063 |
| escape | #15078 |
| granule | #15079 |
| receptor gene | #15089 |
| phosphoric | #15090 |
| converting | #15126 |
| acute respiratory | #15173 |
| spinal cord | #15185 |
| seroepidemiologic | #15205 |
| bmd | #15213 |
| proliferation cells | #15219 |
| covalently | #15234 |
| preferentially | #15252 |
| adhesion | #15299 |
| fetus | #15300 |
| processed | #15329 |
| allografts | #15337 |
| synthase | #15339 |
| bone mineral density | #15340 |
| accelerate | #15346 |
| neurodegenerative | #15377 |
| pretreatment | #15379 |
| blood mononuclear | #15414 |
| interleukin6 il6 | #15440 |
| comparative | #15474 |
| selected | #15486 |
| antigens bacterial | #15511 |
| cells dcs | #15513 |
| locally | #15521 |
| transcriptase polymerase | #15530 |
| influenza human | #15537 |
| basis | #15540 |
| hormone | #15542 |
| central nervous | #15566 |
| estrogen receptor | #15572 |
| transduction | #15579 |
| vaccines | #15623 |
| responsiveness | #15647 |
| rna interference | #15649 |
| binds | #15651 |
| accelerator | #15673 |
| limitation | #15675 |
| pyruvate | #15682 |
| sequenced | #15696 |
| conformational | #15701 |
| cd28 | #15708 |
| connective | #15748 |
| gastric | #15775 |
| single | #15789 |
| fluorescent | #15793 |
| bone loss | #15832 |
| induced expression | #15835 |
| protein structure | #15849 |
| spinal | #15861 |
| vasculitis | #15884 |
| treating | #15887 |
| kappab | #15894 |
| gcsf | #15908 |
| competitive | #15910 |
| positron emission | #15913 |
| downregulation | #15914 |
| systemic inflammation | #15944 |
| methylated | #15945 |
| neurodegeneration | #15945 |
| involve | #15980 |
| ap1 | #15985 |
| plasmon resonance | #15986 |
| reflected | #15993 |
| chromatographic | #16019 |
| cnv | #16065 |
| oligonucleotide array | #16092 |
| 106 | #16097 |
| responding | #16105 |
| pluripotent | #16135 |
| bone mineral | #16141 |
| undetectable | #16148 |
| skeletal | #16151 |
| neurons | #16154 |
| tissue distribution | #16155 |
| disequilibrium | #16156 |
| beta1 | #16172 |
| exhibited | #16189 |
| response treatment | #16236 |
| grafted | #16238 |
| array sequence | #16239 |
| glandular | #16252 |
| functional studies | #16273 |
| responders | #16278 |
| new class | #16282 |
| subunit | #16293 |
| required | #16309 |
| animals base | #16310 |
| subclinical | #16311 |
| linkage disequilibrium | #16342 |
| receptor signaling | #16351 |
| difference | #16367 |
| remarkably | #16382 |
| molecular structure | #16391 |
| form | #16409 |
| signalling | #16414 |
| molecular mechanism | #16419 |
| publication antibodies | #16433 |
| cd40 | #16468 |
| shr | #16471 |
| capable | #16496 |
| grouped | #16512 |
| subcutaneous | #16522 |
| fibroblasts | #16525 |
| revealing | #16544 |
| targeting | #16552 |
| respiratory | #16585 |
| node | #16585 |
| organs | #16586 |
| tumor cells | #16600 |
| antibodies bacterial | #16603 |
| subunits | #16626 |
| profiling | #16651 |
| necrosis | #16655 |
| negatively | #16709 |
| establishing | #16709 |
| uric | #16743 |
| irradiated | #16757 |
| nick | #16765 |
| intramolecular | #16795 |
| deeper | #16801 |
| instrumental | #16812 |
| detected | #16851 |
| clinically | #16859 |
| immunoreactive | #16859 |
| serve | #16878 |
| inhibitory | #16881 |
| documented | #16904 |
| greatly | #16907 |
| colony | #16928 |
| turn | #16941 |
| immunosuppression | #16942 |
| mmps | #16957 |
| inhibition | #16959 |
| receptor 1 | #16964 |
| additionally | #16970 |
| humans hydrogen | #16982 |
| structurally | #16985 |
| prior | #16994 |
| additional | #17005 |
| binding protein | #17006 |
| recombinant fusion | #17013 |
| sulfate | #17069 |
| b7 | #17077 |
| count | #17083 |
| il12 | #17096 |
| sex factors | #17111 |
| consist | #17113 |
| minimal | #17116 |
| alpha subunit | #17119 |
| lysosomal | #17126 |
| unexpected | #17137 |
| tissue | #17148 |
| pluripotent stem | #17151 |
| receptors tumor | #17172 |
| csf | #17185 |
| activator | #17202 |
| lymph node | #17208 |
| underlying mechanisms | #17217 |
| stimulation | #17249 |
| starting | #17298 |
| peritoneal | #17299 |
| cell proliferation | #17318 |
| fluid | #17330 |
| propensity | #17345 |
| generations | #17377 |
| humans immunity | #17410 |
| constitute | #17425 |
| demonstrated | #17444 |
| membrane | #17466 |
| muscle skeletal | #17479 |
| allowing | #17505 |
| types | #17505 |
| transcriptase | #17515 |
| fibrous | #17515 |
| type iii | #17546 |
| localization | #17547 |
| constitutive | #17559 |
| cytometry humans | #17570 |
| discovery | #17583 |
| treatments | #17596 |
| peripheral blood | #17615 |
| variation | #17616 |
| packed | #17678 |
| differed | #17683 |
| expanded | #17687 |
| proved | #17691 |
| plasmon | #17698 |
| longitudinally | #17713 |
| pbmcs | #17728 |
| stimulating factor | #17743 |
| somatic | #17805 |
| inflammatory bowel disease | #17815 |
| dcs | #17827 |
| relating | #17861 |
| alpha tnf | #17880 |
| neuroendocrine | #17920 |
| oligonucleotide | #17954 |
| homology | #17962 |
| surface plasmon | #17971 |
| pregnancy | #17985 |
| chromosomal | #17994 |
| post | #17998 |
| inhibit | #18002 |
| labelled | #18004 |
| damaged | #18064 |
| osmolar | #18107 |
| 2 4 | #18130 |
| creating | #18142 |
| cytoplasm | #18155 |
| released | #18157 |
| trigger | #18161 |
| corticosteroids | #18164 |
| species | #18168 |
| endocrine | #18192 |
| vertebrate | #18206 |
| labeled | #18208 |
| subcellular | #18231 |
| rna messenger | #18235 |
| protein serine | #18279 |
| limiting | #18281 |
| reverse transcriptase | #18325 |
| evidenced | #18329 |
| truncated | #18336 |
| net | #18345 |
| avian | #18345 |
| males | #18375 |
| critically | #18389 |
| assumed | #18433 |
| modulated | #18444 |
| rats wistar | #18448 |
| pathogen | #18464 |
| immunogenicity | #18486 |
| acids | #18490 |
| reaching | #18494 |
| nonparametric | #18512 |
| constitutively | #18518 |
| hyaluronan | #18609 |
| processing | #18609 |
| sulfonamides | #18643 |
| investigating | #18651 |
| 15 | #18656 |
| 22 | #18658 |
| verify | #18669 |
| signal transduction | #18682 |
| agents steroidal | #18685 |
| remaining | #18721 |
| cerebrospinal | #18788 |
| aim | #18788 |
| created | #18803 |
| balanced | #18823 |
| cultured | #18823 |
| carry | #18829 |
| pathophysiological | #18830 |
| production | #18927 |
| nerve | #18943 |
| nested | #18957 |
| nfκb | #18987 |
| failed | #18988 |
| sequence analysis | #19002 |
| specific antigen | #19050 |
| observations | #19062 |
| provided | #19067 |
| bone marrow | #19084 |
| lungs | #19111 |
| stimulating | #19136 |
| protein | #19164 |
| bearing | #19167 |
| publication administration | #19185 |
| gained | #19200 |
| mitochondrial | #19260 |
| symptoms | #19288 |
| lost | #19298 |
| majority | #19304 |
| intra | #19311 |
| interacts | #19344 |
| hormones | #19441 |
| fatal | #19464 |
| interferons | #19489 |
| analyzing | #19515 |
| exogenous | #19526 |
| adrenal | #19553 |
| cytoskeletal | #19553 |
| rapidly | #19574 |
| inducible | #19616 |
| etiology | #19652 |
| environment | #19668 |
| implanted | #19680 |
| lps | #19681 |
| mice scid | #19683 |
| vesicular | #19701 |
| lineage | #19719 |
| markers | #19789 |
| histologically | #19817 |
| offers | #19826 |
| cutaneous | #19834 |
| precise | #19836 |
| pharmacological | #19854 |
| fetal | #19862 |
| shifted | #19875 |
| newly | #19892 |
| supporting | #19915 |
| vitro techniques | #19945 |
| yielded | #19948 |
| 8 | #19978 |
| cns | #19979 |
| 28 | #19979 |
| response relationship | #20014 |
| transient | #20038 |
| modify | #20055 |
| designated | #20056 |
| reverse | #20057 |
| casecontrol study | #20088 |
| mutagenesis | #20118 |
| illustrated | #20126 |
| downregulated | #20133 |
| ultimately | #20202 |
| κb | #20256 |
| 1 diabetes | #20263 |
| hypothalamic | #20285 |
| primary | #20303 |
| entered | #20310 |
| nitric | #20316 |
| gene expression | #20364 |
| markedly | #20453 |
| genotype humans | #20460 |
| mature | #20491 |
| microglia | #20561 |
| circulating | #20574 |
| overexpressing | #20593 |
| human pair | #20604 |
| polyacrylamide | #20612 |
| marrow | #20651 |
| defining | #20660 |
| pregnant | #20665 |
| equal | #20678 |
| resting | #20729 |
| injured | #20739 |
| mild | #20819 |
| local | #20825 |
| discovered | #20835 |
| cricetinae | #20839 |
| reduction | #20847 |
| illustrate | #20874 |
| lactic | #20908 |
| hypothesized | #20913 |
| tended | #20919 |
| 10 | #20952 |
| successful | #20952 |
| cell derived | #20955 |
| aberrant | #20961 |
| animals biomarkers | #21033 |
| 2 | #21085 |
| attractive | #21228 |
| acute | #21279 |
| produces | #21297 |
| transfected | #21316 |
| marked | #21340 |
| decreased | #21383 |
| maternal | #21389 |
| emerged | #21445 |
| survived | #21524 |
| confirms | #21558 |
| membrane proteins | #21585 |
| forming | #21593 |
| preserved | #21732 |
| contained | #21802 |
| previous | #21805 |
| 16 | #21813 |
| doses | #21835 |
| immunodeficiency | #21852 |
| electrophoresis | #21867 |
| mellitus type | #21871 |
| natural killer | #21877 |
| cell count | #21898 |
| prolonged | #21903 |
| heavy | #21965 |
| increasing | #21979 |
| polymeric | #22042 |
| gradually | #22067 |
| glial | #22202 |
| selecting | #22242 |
| extremely | #22248 |
| 4 | #22274 |
| opportunistic | #22307 |
| accepted | #22356 |
| emission tomography | #22395 |
| enable | #22402 |
| humans models | #22445 |
| initially | #22458 |
| microscopy confocal | #22466 |
| physiologic | #22470 |
| appears | #22488 |
| releasing | #22497 |
| suitable | #22522 |
| humans immunosuppressive | #22529 |
| confirm | #22553 |
| chemokine | #22558 |
| metabolic | #22585 |
| actins | #22597 |
| loss | #22611 |
| nf | #22756 |
| reactive protein | #22834 |
| utilizing | #22899 |
| transformed | #22917 |
| progression female | #22918 |
| detailed | #23005 |
| natural | #23089 |
| cell types | #23132 |
| sex | #23234 |
| null | #23277 |
| untranslated | #23305 |
| signaling | #23324 |
| syndrome | #23335 |
| bone | #23397 |
| necrosis factor | #23407 |
| rich | #23430 |
| cells tumor | #23467 |
| nucleic | #23501 |
| continued | #23663 |
| cellular | #23667 |
| expression gene | #23728 |
| attenuated | #23757 |
| mitogen | #23814 |
| serine threonine | #23835 |
| examine | #23864 |
| fusion proteins | #23968 |
| organ | #23990 |
| remained | #23998 |
| prevent | #24026 |
| confined | #24245 |
| oxidized | #24325 |
| called | #24330 |
| discussed | #24334 |
| genomic | #24394 |
| covering | #24485 |
| embryonic | #24490 |
| interleukin | #24583 |
| varying | #24640 |
| weeks | #24698 |
| mechanistic | #24796 |
| putative | #24897 |
| sarcoidosis | #24963 |
| detect | #24963 |
| remains | #25082 |
| controversial | #25175 |
| implies | #25192 |
| stromal | #25269 |
| type 1 diabetes | #25410 |
| enriched | #25470 |
| relation | #25543 |
| attributed | #25618 |
| 7 | #25632 |
| proteins | #25644 |
| tumor necrosis | #25683 |
| dysregulation | #25711 |
| cytoplasmic | #25732 |
| inflammatory agents | #25735 |
| energetic | #25813 |
| healthy | #25887 |
| representing | #25917 |
| challenging | #25976 |
| threonine | #25988 |
| mechanisms underlying | #26094 |
| signal | #26163 |
| tnfalpha | #26432 |
| frequent | #26487 |
| individuals | #26568 |
| antibodies viral | #26579 |
| growth factor | #26602 |
| validated | #26686 |
| lower | #26708 |
| treat | #26713 |
| 3 | #26751 |
| tolerated | #26780 |
| pathophysiology | #26782 |
| explored | #26850 |
| tumor necrosis factor | #26925 |
| comparable | #26955 |
| normal | #27016 |
| define | #27055 |
| exist | #27121 |
| presented | #27123 |
| consists | #27152 |
| intracellular | #27233 |
| invariant | #27331 |
| animals cells | #27339 |
| adaptor proteins | #27447 |
| chromosomes human | #27524 |
| associations | #27560 |
| kda | #27648 |
| tract | #27680 |
| possess | #27765 |
| exclude | #27824 |
| cell tumor | #27826 |
| attributable | #28018 |
| proteins humans | #28150 |
| heterozygote | #28266 |
| treated | #28436 |
| observe | #28472 |
| remain | #28560 |
| regulation humans | #28667 |
| threonine kinases | #28809 |
| hypothesis | #28819 |
| require | #28838 |
| examined | #29041 |
| infection | #29082 |
| 5 | #29247 |
| animals apoptosis | #29491 |
| intracellular signaling | #29517 |
| easily | #29557 |
| effective | #29656 |
| 005 | #29706 |
| fully | #29936 |
| exhibit | #29947 |
| gtp binding | #29997 |
| intravenous | #30185 |
| cell movement | #30520 |
| oxide | #30546 |
| reached | #30655 |
| active | #30908 |
| versus | #30963 |
| 1 | #31228 |
| cell differentiation | #31374 |
| vary | #31548 |
| blotting western | #31843 |
| free | #32409 |
| expression regulation | #32516 |
| needed | #32543 |
| objectives | #32805 |
| generally | #33368 |
| inhibited | #33394 |
| clinical | #33439 |
| sought | #34008 |
| reduce | #34128 |
| biological | #34247 |
| reflect | #34701 |
| separately | #34818 |
| agents | #34868 |
| assess | #34935 |
| polymerase | #35201 |
| nuclear | #35715 |
| polymerase chain | #36180 |
| formed | #36819 |
| chain reaction | #36949 |
| 001 | #36954 |
| measured | #42007 |
运行报告 | |
Prominent publications by Rikard Holmdahl
KOL-Index: 15284
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of CII in RTlu haplotype rats and to determine if, when used as a synthetic peptide, it would induce tolerance to protect against CIA. A dominant epitope corresponding to residues 184-198 included in the sequence of the CB11 fragment of bovine CII was identified in proliferation assay using peptides in an epitope scanning system using synthetic peptides of 15 amino acids, overlapping by 12 amino acids. ...
| 闻名 Mucosal Tolerance | Synthetic Peptide | Cell Epitope | Cia Cii | Collagen‐induced Arthritis |
KOL-Index: 14658
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four ...
| 闻名 Collagen Antibody | Induced Arthritis | Monoclonal Antibodies | Mice Inbred | Specific Epitopes |
KOL-Index: 13984
The Aq major histocompatibility complex (MHC) class II molecule is associated with susceptibility to murine collagen-induced arthritis (CIA), whereas the closely related H-2Ap molecule is not. To understand the molecular basis for this difference, we have analyzed the ability of H-2Aq and H-2Ap molecules (referred to as Aq and Ap) to bind and present collagen type II (CII)-derived glycosylated and non-glycosylated peptides. T cell clones specific for the immunodominant CII 256-270 ...
| 闻名 Collagen‐induced Arthritis | Transgenic Models | Aq Molecule | Structural Basis | C3h Mice |
KOL-Index: 13727
BACKGROUND: Autoantibodies to cyclic citrullinated peptides (anti-CCP) are present in most patients with rheumatoid arthritis (RA), and associate with HLA-DRB1 shared epitope (SE) alleles.
OBJECTIVE: To investigate reactivities of anti-CCP to various citrullinated proteins/peptides, which represent potential autoantigens in RA, and to examine the relationship between such antibodies, and their association with genetic variants within HLA-DRB1 SE alleles.
METHODS: Serum samples from 291 ...
| 闻名 Citrullinated Antigens | Rheumatoid Arthritis | Drb1 Alleles | Ccp Patients | Antibody Reactivities |
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice
[ PUBLICATION ]
Type II collagen-induced arthritis (CIA) in mice is an autoimmune experimental model for rheumatoid arthritis. Susceptibility to CIA is associated with certain major histocompatibility complex class II haplotypes. The two very closely related haplotypes H-2q and H-2p differ in susceptibility to CIA. Only mice of H-2q (DBA/1, B10G strains) but not mice of H-2p-expressing strains (like strain B10P) develop CIA and an autoimmune response to type II collagen (CII) after immunization with ...
| 闻名 Mice Cia | Beta Chain | Rheumatoid Arthritis | H2q Haplotype | Type Collagen Cii |
KOL-Index: 13513
INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent ...
| 闻名 Citrullinated Peptides | Onset Symptoms | Development Rheumatoid Arthritis | Combination Acpa | Hlase Smoking |
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
[ PUBLICATION ]
OBJECTIVE: High titers of specific anti-citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well-defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their ...
| 闻名 Citrullinated Antigens | Synovial Fluid | Rheumatoid Arthritis Patients | Type Collagen | Antibodies Acpas |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats
[ PUBLICATION ]
INTRODUCTION: Toll-like receptors (TLRs) are involved in both innate and adaptive immune responses and are likely to play a complex role in the pathogenesis of human rheumatoid arthritis (RA) and experimental arthritis. The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis.
METHODS: Arthritis in DA rats was induced by pristane and the severity was evaluated ...
| 闻名 Induced Arthritis | Tlr3 Expression | Rats Pristane | Receptor 3 | Inbred Strains Severity |
KOL-Index: 12776
Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis1,2. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined3,4, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but ...
| 闻名 Multiple Sclerosis | Transgenic Mice | Hla Dr2 | Humanized Model | Spontaneous Disease |
KOL-Index: 12721
Polymorphism of the major histocompatibility complex (MHC) influences susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein (MBP) in rats. Current concepts relate such influences to the capacity of class II molecules to present relevant peptides to autoreactive T cells. We have here analyzed the MHC influence on the immune response and the development of EAE after immunization with the immunodominant peptide MBP-63-88. Analysis of MHC-congenic ...
| 闻名 Myelin Basic Protein | Experimental Autoimmune | Major Histocompatibility | Rats Eae | Immune Response |
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
[ PUBLICATION ]
OBJECTIVE: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms.
METHODS: A case-control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood ...
| 闻名 Citrullinated Peptides | Rheumatoid Arthritis | Onset Symptoms | Antibodies Cep1 | Type Collagen |
KOL-Index: 12510
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have ...
| 闻名 Collagen Type | Arthritis Mice | Antigen Tcell | Antibodies Cii | Adaptive Immune |
KOL-Index: 12427
The nonobese diabetic (NOD) mouse spontaneously develops autoimmune-mediated diseases such as diabetes and Sjögren's syndrome. To investigate whether NOD genes also promote autoimmune-mediated arthritis we established a NOD strain with an MHC class II fragment containing the A(q) class II gene predisposing for collagen induced arthritis (NOD.Q). However, this mouse was resistant to arthritis in contrast to other A(q) expressing strains such as B10.Q and DBA/1. To determine the major ...
| 闻名 Genetic Control | Complement Factor | Induced Arthritis | Locus Chromosome | Mice Inbred |
关键人物 Rheumatoid Arthritis
世界顶级科尔斯
Rikard Holmdahl:专家影响
哪个概念Rikard Holmdahl具有直接影响:Rheumatoid arthritis, Induced arthritis, Experimental arthritis, Collagen type, Type collagen, Animal models, Reactive oxygen species, Autoimmune diseases.
Rikard Holmdahl:KOL的影响
与其他作者的工作有关的概念for which Rikard Holmdahl 有影响力:Rheumatoid arthritis, Multiple sclerosis, Autoimmune diseases, Oxidative stress, Animal models, Reactive oxygen species, Nadph oxidase.
Tools
这是您的个人资料吗？ 要求您的个人资料 复制URL 嵌入到您的个人资料的链接 |